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1 Abstract 
Our body constantly faces all kinds immunological challenges, ranging from sterile wounds 
to non-pathogenic and sometimes pathogenic microorganisms. The innate immune system 
represents the first line of defense against these challenges. It is capable of detecting invading 
microorganisms and tissue damage by conserved, germline-encoded pattern recognition 
receptors (PRRs) and launches a first counterstrike through mechanisms including 
phagocytosis, reactive oxygen species (ROS) or anti-microbial peptides. Concomitant 
production and secretion of cytokines alerts the adaptive immune system and initializes are 
very potent, highly specific and sustained immune response governed by the activation and 
expansion of T- and B-cells.  
Inflammasomes are one important class of cytosolic PRRs as they recognize a large variety 
of pathogens. Engagement of inflammasome pathways leads to death of the infected host cell 
by pyroptosis and secretion of pro-inflammatory cytokines like IL-1b and IL-18. The recently 
discovered non-canonical inflammasome pathway is triggered by intracellular bacterial 
lipopolysaccharide (LPS), which binds to caspase-11 to activate it. Active caspase-11 triggers 
pyroptosis and activates a canonical Nlrp3 inflammasome to promote caspase-1 activation 
and IL-1 secretion.  
The molecular details of pyroptosis execution and the signaling events downstream of 
caspase-11 have not been thoroughly characterized, which is why this was the main interest 
underlying my PhD work. I investigated the connection between caspase-11 activation and 
cytokine release triggered by the canonical NLRP3 inflammasome. I could show that 
caspase-11 stimulates NLRP3 activation by promoting potassium efflux, a well characterized 
trigger for the NLRP3 inflammasome, in a cell autonomous manner. Subsequently I got 
interested in the molecular mechanisms underlying pyroptosis induction by Gasdermin-D. 
We could characterize pore formation by the Gasdermin-D N-terminal fragment as the final 
step of pyroptosis. Finally, I investigated if cells are capable of preventing or delaying 
pyroptosis downstream of caspase-11/gasdermin-D. I found that removal of Gasdermin-D 
pores by ESCRT-III mediated membrane repair represents one mechanism by which cells 
prevent Gasdermin-D dependent cell death. Overall my results revealed connections between 
innate immunity signaling pathways, uncovered a novel form of cellular pore forming toxins 
and demonstrated an unexpected regulation of pyroptosis by cellular survival pathways. 
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3 Introduction 
 
3.1 Cells of the innate immune system 
 
Cells of the innate immune system are responsible to detect the presence of foreign, 
pathogenic microorganisms like viruses and bacteria. They express germline encoded, 
conserved pattern recognition receptors to orchestrate the initial (<96 hours) inflammatory 
response to pathogenic or sterile insults. The cells of the innate immune system reside 
naturally with many tissues like the gut, liver or skin where they react to invading 
microorganisms or tissue damage.  
Macrophages develop from precursor cells residing in the bone-marrow. They represent an 
important first line of defense as they are capable of engulfing and degrading foreign matter 
and dead host cells without the help of the adaptive immune system. They express a variety 
of PRRs allowing them to sense pathogen or host derived molecules. Their primary functions 
are to produce cytokines to recruit other immune cells (Cader & Kaser, 2013; Zigmond & 
Jung, 2013)and present antigens of engulfed microorganisms to cells of the adaptive immune 
system.  
Dendritic cells (DCs) are the main antigen-presenting-cells (APCs) of the immune system as 
they are extremely proficient in digesting and presenting microorganisms and proteins. As 
macrophages, they originate from a common granulocyte macrophage precursor (GMP) from 
the bone marrow and they are found in various tissues like the skin, the gut or the spleen. 
Plasmacytoid DCs are circulating in the periphery and are crucial components of the anti-
viral response, as they produce large amounts of type-I interferons upon stimulation. DCs get 
easily stimulated by a variety of signals, as they express different receptors, which leads to 
secretion of various inflammatory cytokines(Dzopalic et al, 2012; Farache et al, 2013) . 
Despite their importance for the induction of the adaptive immune response, DCs also 
function to terminate the immune response, by rendering T-cells inactive or by promoting the 
development of regulatory T-cells(Farache et al, 2013). 
Neutrophils have long been neglected as an important part of the innate immune response. 
They have been considered short lived ‘cannon fodder’ to initiate the acute phase of 
inflammation and control extracellular pathogens (Borregaard, 2010; Mantovani et al, 2011; 
Amulic et al, 2012). They possess a high phagocytic activity, store anti-microbial 
components in their secretory granules and are important producers of cytokines upon tissue 
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damage or microbial invasion(Chen et al, 2014; Jaillon et al). They are capable of fighting 
several bacteria and viruses by the formation of neutrophil extracellular traps (NETs) 
(Brinkmann & Zychlinsky, 2007) and are important for communication to other cells of the 
innate immune system like NK cells(Jaeger et al, 2012; Costantini et al, 2011; 2010). 
Other cells of the innate immune system are innate lymphoid cells (ILCs), which are made 
up of ILC1, ILC2 and ILC3 and mast cells. Both cell types are important producers of 
cytokines in order to communicate to other innate immune cells or the adaptive immune 
system. Their exact properties and functions are reviewed elsewhere(Hwang & McKenzie, 
2013; John & Abraham, 2013). 
 
3.2 Pattern recognition receptors 
 
The innate immune system uses germline encoded, conserved receptors to recognize 
pathogen associated molecular patterns (PAMPs) or endogenous, danger-associated 
molecular patterns (DAMPs). The ligands for these pattern recognition receptors (PRRs) are 
usually conserved molecules, essential to the survival of pathogenic microorganisms and are 
therefore invariable in their molecular composition (Kumar et al, 2011). Most of the 
receptors can be classified into five families, based on their protein homology domain. These 
families are the Toll-like receptors (TLRs), C-type lectin receptors (CLRs), nucleotide- 
binding domain, leucine-rich repeat (LRR)-containing (or NOD-like) receptors (NLRs), RIG-
I- like receptors (RLRs), and the AIM2-like receptors (ALRs) (Table 1)(Kumar et al, 2011). 
Family Members Shared domains Localization 
TLR 1-10 in humans, 1-9 
and 11-13 in mice 
LRR, TIR Cell surface, 
endosomal 
compartments 
CLR Dectins C-type lectin Cell surface 
NLR NLRC1&2 
(=NOD1&2). 
NLRC3-5, NLRP1-
9, and 11-14, 
NAIP1, -2, -5, -6 
Nucleotide binding, 
LRR 
Cytoplasm, plasma 
and endosomal 
membrane 
associated 
RLR RIG-I, MDA5, 
LGP2 
DExD/H, helicase Cytoplasm 
ALR AIM2, IFI16 Pyrin, HIN-200 Cytoplasm and 
nucleus (IFI16) 
Table 1 Overview of PRRs of the innate immune system 
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TLRs and CLRs are membrane bound receptors and sample the endosomal and the 
extracellular space for the presence of microbial ligands. NLRs, RLRs and ALRs are 
cytosolic proteins, which are activated by intracellular pathogens or components thereof. One 
major consequence of PRR activation is the production of pro-inflammatory cytokines and 
interferons. Beyond these transcriptional responses, PRR also induce non-transcriptional 
consequences like phagocytosis, autophagy, cell death and cytokine processing(Drummond 
& Brown, 2011; Deretic et al, 2013; Broz & Dixit, 2016). The coordination of all these 
pathways initiates an innate immune response, which is essential for microbial control and 
induction of an appropriate adaptive immune response(Palm & Medzhitov, 2009). 
A common theme that has emerged in the PRR field is the use of adaptor proteins. These 
proteins are capable of integrating signals, often from multiple types of receptors and couple 
 these receptors to enzymatic effector proteins. Some of the adaptor proteins and their 
receptors are summarized in Table 2. The role of these adaptors often seems to go beyond a 
simple coupling-protein function connecting the sensor protein/s to the effector protein/s. 
Indeed, most of these adaptors for oligomers or filamentous assemblies (ASC speck, 
Myddosome) which are thought to be necessary for signal amplification (Dick et al, 2016; 
Lin et al, 2010; Qiao et al, 2013) 
Adaptor or 
Adaptor set 
Receptor 
interaction 
Examples for 
receptors using 
adaptor 
Signaling 
interaction 
Localization 
TIRAP/MyD88 TIR domain TLR2,4,5 Death domain Cell surface, 
endosomal 
compartments 
TRAM/TRIF TIR domain TLR3,4 TRAF binding, 
RHIM domain 
Cell surface, 
endosomal 
compartments 
MAVS CARD domain RIG-I Proline-rich 
region, TRAF 
binding 
Mitochondrial, 
peroxisomal and 
mitochondria 
associated 
membranes 
ASC Pyrin domain NLRs, AIM2 CARD domain Cytosol 
Table 2 Adaptor proteins of PRRs 
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Charles Janeway predicted two key features of innate immunity: 1) The ability to distinguish 
self from non-self and 2) the ability to activate the innate immune system(Janeway, 1989). 
Since his predictions, researcher could show that a variety of microbial molecules are 
recognized by PRRs and how these pathways lead to the mounting of an effective immune 
response(Akira & Takeda, 2004; Geijtenbeek & Gringhuis, 2009; Chen et al, 2009; Loo & 
Gale, 2011; Hornung & Latz, 2010). 
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3.3 PRR signaling from the plasma membrane 
3.3.1 Toll like receptors 
TLR4 is the best studied member of this family and possesses some unique features that 
distinguishes it from the other members of the TLR family. TLR4 recognizes a variety of 
bacterial and endogenous ligands but is best known for its high sensitivity for 
Lipopolysaccharide (LPS) from gram-negative bacteria(Poltorak et al, 1998). Activation of 
TLR4 by LPS requires a multi-receptor complex composed of LPS-binding protein (LBP), 
CD14 and MD2, which are required to bind LPS and transfer it to TLR4 to induce its 
dimerization(Schumann et al, 1990; Eckert et al, 2013; da Silva Correia et al, 2001; 
Gioannini & Weiss, 2007). The sequential transfer of LPS from one molecule to another is 
thought to enable high sensitivity of TLR4 for LPS. It has been estimated that enough LPS 
monomers can be extracted from one bacterium to activate TLR4 signaling on 1000 
macrophages (Gioannini & Weiss, 2007). Upon activation, TLR4 recruits TIRAP (TIR 
Domain-Containing Adaptor Protein) and MyD88, which culminates in the activation of NF-
kB and AP-1 leading to expression of pro-inflammatory cytokines like IL-1ß or TNFa 
(Figure 3.1). TLR4 is also internalized to endosomes, where it recruits different adaptor 
proteins and engages additional signaling pathways (discussed below).  
Other TLRs present on the plasma membrane are TLR1, -2, -5 and -6. All these receptors 
engage MyD88 (Myeloid differentiation primary response 88) dependent NF-kB (nuclear 
factor 'kappa-light-chain-enhancer' of activated B-cells) activation. TLR2 mainly acts as 
heterodimer with other TLRs(Ozinsky et al, 2000). TLR2 forms heterodimers with either 
TLR-1 or TLR6, and  is activated by a variety of lipopeptides and viruses(Buwitt-Beckmann 
et al, 2006; Boehme et al, 2006; Szomolanyi-Tsuda et al, 2006; Kurt-Jones et al, 2004; 
Chang et al, 2007; Erridge, 2010). Similar to TLR4, these heterocomplexes signal from lipid 
rafts(Triantafilou et al, 2004) and use co-receptors, for example CD36 (Hoebe et al, 2005). In 
a cell type specific manner (Plasmacytoid DCs), TLR2 can lead to interferon (IFN) 
production upon endocytosis(Barbalat et al, 2009; Dietrich et al, 2010). 
TLR5 is expressed on neutrophils, monocytes, DCs and epithelial cells(Shibata et al; Gewirtz 
et al, 2001) and is the receptor for bacterial flagellin(Hayashi et al, 2001; Smith et al, 2003). 
TLR5 also activates MyD88 dependent signaling(Hayashi et al, 2001), however it is not clear 
if TIRAP is required in all cell types(Choi et al, 2012). 
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Figure 3.1 TLR4 signaling 
 
TLR4 signals from the plasma membrane and endosomes. TLR4 requires translocation to lipid rafts 
enriched with TIRAP for signaling from the plasma membrane. This facilitates interactions with 
MyD88 upon ligand binding for the formation of the myddosome containing MyD88, TIRAP, and 
IRAKs. The IRAKs recruit the E3 ubiquitin ligase TRAF6, which interacts with a complex formed 
by TAB1, TAB2, TAB3, and TAK1. This complex regulates NF-κB activation via IKKs. TAK1 
release into the cytoplasm also directs MAPK activation. CD14 controls the movement of TLR4 
from the plasma membrane into endosomes through the activation of ITAM, Syk, and PLCγ2. 
From endosomes, TLR4 interacts with the sorting adaptor TRAM and the signaling adaptor TRIF 
to sustain NF-κB activation and to induce IRF3-mediated type I IFN production. IRF3 activation 
controls type I IFN production and requires TRAF3 recruitment to TRIF. TRAF3 then interacts 
with TANK (or TANK-related proteins) to recruit IKKγ, IKKε, and TBK1, which activate IRF3. 
(Solid lines indicate signal transduction; dotted lines indicate trafficking events.) (Abbreviations: 
IKK, IκB kinase; IRAK, interleukin-1 receptor-associated kinase; IRF, IFN regulatory factor; 
ITAM, immunoreceptor tyrosine-based activation motif; MAPK, mitogen-activated protein kinase; 
NF-κB, nuclear factor-κB; PLCγ2, phospholipase Cγ2; TAK, TGF-β-activated kinase; TANK, 
TRAF family member–associated NF-κB activator; TBK, TANK-binding kinase; TIRAP, TIR-
containing adaptor protein; TRADD, TNF receptor type 1–associated death domain; TRAF, TNF 
receptor–associated factor.) Adapted from (Brubaker et al, 2015). 
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3.3.2 Dectins 
 
CLRs are a heterogeneous group of hundreds of receptors, which share a characteristic C-
type lectin-like domain (CTLD). The CTLD was identified as a double-loop domain capable 
of binding calcium and carbohydrates but up to today, CLRs have been shown to bind a 
variety of different ligands. Dectin-1 and -2 are the best studied members of this class of 
receptors, which is further divided into 17 sub-families(Brubaker et al, 2015). Most dectins 
act as opsonins, however for example Dectin-1 is capable of activating NF-kB upon 
recognition of fungal beta-1,3-glucans, which promotes phagocytosis and downstream 
signaling. Dectin-1 activates Syk kinases(Fuller et al, 2007), which are responsible for NF-
kB activation and in turn are also capable of activating PLC(phospholipase-c) γ2, which 
promotes additional NFAT (nuclear factor of activated T-cells) activation (Tassi et al, 2009). 
Dectin-1 has been shown to be essential for anti-fungal-defense in both mice and 
humans(Brown et al, 2003; Ferwerda et al, 2009). 
 
3.4 Signaling from endosomes 
 
3.4.1 TLR signaling from endosomes 
 
As mentioned above, TLR4 undergoes endocytosis but interestingly, signaling is not 
terminated at this point, like for many other receptors e.g. GPCRs (G-protein coupled 
receptors). TLR4 continues to signal from endosomes inducing a late wave of NF-kB 
activation and, importantly, type I IFN production. Both pathways are dependent on the 
adaptors TRAM (TIR Domain-Containing Adaptor Protein) and TRIF(TIR-domain-
containing adaptor inducing interferon-β)(Yamamoto et al, 2003a; 2003b). TRAM moves 
independently of CD14 from the plasma membrane to endosomes and it is thought that 
TRAM displaces TIRAP from TLR4, leading to engagement of the TRIF dependent signaling 
pathways(Kagan et al, 2008; Enokizono et al, 2013; Piao et al, 2013). TRIF is capable of 
recruiting TRAF3 to induce TBK1 and subsequent IRF3 activation, leading to type I IFN 
production (Figure 3.1)(Häcker et al, 2006; Fitzgerald et al, 2003; Hemmi et al, 2004; 
McWhirter et al, 2004). How TRIF controls late NF-kB activation is not entirely clear, 
though it seems to be dependent on RIPK1, TRADD and caspase-8(Weng et al, 2014; 
Brubaker et al, 2015). 
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Other TLRs that signal from endosomes recognize different varieties of nucleic acids and 
induce type I IFNs, partially in a cell type specific manner. TLR3 recognizes dsRNA 
molecules and induces type I IFN production through, TRIF, but independently of TRAM, as 
the TIR domain of TLR3 is capable of directly binding TRIF(Brown et al, 2006; Ulrichts & 
Tavernier, 2008). In pDCs, TLR7/9 are capable of inducing type I IFN production through a 
MyD88/IRF7 dependent signaling axis, however which other factors are required for this 
process is not entirely clear(Honda et al, 2005). 
 
3.4.2 NOD1/2 signaling from endosomes 
 
With their N-terminal CARD (Caspase activation and recruitment domain), their central 
NACHT and their C-terminal LRR (Leucine rich repeat) domain, NOD1/2 are prototypical 
members of the NLR (Nod like receptor) family(Saleh, 2011). They recognize components of 
the bacterial outer membranes or cell wall like γD-glutamyl-meso-diaminopimelic acid (iE-
DAP) or muramyl dipeptide (MDP)(Girardin et al, 2003a; 2003b; Chamaillard et al, 2003). 
Upon activation, they associate with RIPK2 to induce MAPK and NF-kB activation(Park et 
al, 2007). Although synthesized in the cytosol, NOD1 and NOD2 have been observed to 
localize to endosomes(Barnich et al, 2005; Irving et al, 2014; Nakamura et al, 2014; 
Travassos et al, 2010). Interestingly a Crohn´s disease associated NOD2 mutant, which is not 
activated by MDP, also shows aberrant subcellular localization(Barnich et al, 2005). 
Independent of NF-kB activation, NODs can induce autophagy to eliminate bacterial 
pathogens(Travassos et al, 2010). This function is also impaired in cells expressing the 
Crohn´s disease –associated NOD2 variant. 
 
3.5 PRR signaling in the cytosol 
 
3.5.1 Rig-I like receptors 
 
Three DExH/D box helicases, retinoic acid-inducible gene-I (RIG-I), melanoma 
differentiation gene 5 (MDA5) and laboratory of genetics and physiology 2 (LGP2), make up 
the RLR family. All of these proteins detect the presence of RNA in the cytosol(Yoneyama et 
al, 2005; 2004) and although they are generally depicted as cytosolic proteins, they might 
localize to specific locations, where viral entry or replication takes place. To distinguish self 
from viral RNA, RLRs detect motifs and features, specific to viral genomes or replication 
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intermediates like 5’ triphosphate RNA, long dsRNA and specific sequences such as the 
poly-U region of the hepatitis C virus RNA(Hornung et al, 2006; Pichlmair et al, 2009; 2006; 
Kato et al, 2008; Saito et al, 2008; Uzri & Gehrke, 2009). Upon activation by cytosolic RNA, 
MDA5 and RIG-I bind to MAVS (mitochondrial anti-viral signaling protein) via CARD-
CARD interaction for further downstream signaling(Seth et al, 2005; Kawai et al, 2005; 
Meylan et al, 2005; Xu et al, 2005). Similar to TLRs, RIG-I undergoes ligand induced 
translocation to the limiting membranes of mitochondria, peroxisomes and the mitochondrial 
outer membrane (MAM), where MAVS are localized(Seth et al, 2005; Dixit et al, 2010; 
Horner et al, 2011). Upon activation, MAVS undergo CARD mediated self-polymerization, 
which leads to recruitment of the ubiquitin ligases TRAF-2,-5 and-6, which are required for 
activation of TBK1 (Tank binding kinase 1) and the IKK (inhibitor of κB kinase) 
complex(Liu et al, 2013). These kinases promote the activation of NF-kB, IRF3 and IRF7, 
which ultimately leads to production of IFNs, pro-inflammatory cytokines and interferon 
stimulated gens (ISGs) (Figure 3.2a). Interestingly, the ability of MAVS to initiate IFN 
signaling is strictly dependent on its C-terminal transmembrane domain, which shows that 
interaction with RLRs is not sufficient to trigger downstream signaling, but that MAVS 
activation is regulated by receptor recruitment and proper membrane localization(Seth et al, 
2005; Dixit et al, 2010).  
 
3.5.2 Cytosolic DNA sensing: The cGAS/STING signaling axis 
 
The stimulator of IFN genes (STING) hast been known to be involved in cytosolic DNA 
sensing and promotion of downstream signaling(Ishikawa & Barber, 2008; Zhong et al, 
2008; Sun et al, 2009). STING has been proposed to act both, as an adaptor and receptor in 
different scenarios. During viral infections it has been proposed to act as an adaptor for 
potential DNA sensors like IFI16 and DDX41, although the exact mechanisms were 
unclear(Unterholzner et al, 2010; Zhang et al, 2011). Induction of IFN responses upon 
infection with cytosolic bacteria by STING could be well explained, as STING is activated 
by cyclic di-nucleotides (CDNs), which are second-messengers frequently produced in and 
even secreted from bacteria(Burdette et al, 2011; Yin et al, 2012; Ouyang et al, 2012; Huang 
et al, 2012; Shang et al, 2012; Shu et al, 2012). Although CDNs synthesis has been thought 
be a unique feature of bacteria, the mammalian CDNs synthase cGAS (cyclic di-GMP-AMP 
synthase) has been identified(Wu et al, 2013; Sun et al, 2013). Upon binding of cytosolic 
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DNA stretches, cGAS synthesizes cyclic-di-GMP-AMP (cGAMP) from ATP and GTP, 
which acts as a second messenger, binds and activates STING. STING is a localized at the 
ER during steady state and undergoes trafficking to poorly defined vesicles or puncta at the 
Figure 3.2 Nucleic acid sensing in the cytosol 
The RLRs detect pathogen-derived RNA within the cytosol to induce the production of IFN and 
pro-inflammatory cytokines. The TBK1, IKK, and MAVS pathways lead to activation of the 
transcription factors for the induction of IFN and other cytokine genes. MAVS activity is regulated 
by polymerization and signaling from mitochondria results in production of type I and III IFN, 
whereas peroxisomal signaling induces the production only of type III IFN. (b) cGAS detects 
pathogen-derived DNA from within the cytosol and nucleus to induce the production of IFN. In the 
presence of DNA, the enzyme cGAS converts ATP and GTP to the cyclic dinucleotide cGAMP. 
Production of cGAMP induces the activation of STING. TBK1 is recruited to this site of signaling 
to induce the production of type I IFN. (Solid lines indicate signal transduction; dotted lines 
indicate trafficking events.) (Abbreviations cGAMP, cyclic di-GMP/AMP; cGAS, cyclic GMP-
AMP synthase; IKK, IκB kinase; MAVS, mitochondrial antiviral signaling protein; MDA, 
melanoma differentiation gene; RIG-I, retinoic acid–inducible gene I; STING, stimulator of IFN 
gene; TBK, TANK-binding kinase; TRAF, TNF receptor–associated factor). Adapted from 
Brubaker et al., 2015. 
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GOLGI apparatus(Ishikawa & Barber, 2008; Saitoh et al, 2009). This relocation is dependent 
on ATG9a and VPS34, leads to activation of TBK1 and IRF3 and subsequent IFN 
production(Saitoh et al, 2009; Konno et al, 2013)(Figure 3.2b). The cGAS/STING signaling 
axis seems to be the sensor in most scenarios, ranging from recognition of nuclear self-DNA, 
infection with DNA viruses, cytosolic bacteria or engulfment of dead cells (reviewed in 
(Chen et al, 2016a)). 
3.5.3 Canonical inflammasomes 
 
In 2002, Tschopp and co-workers described a high molecular weight complex that is formed 
in the cytosol of stimulated immune cells and that mediates the activation of inflammatory 
caspases, hence termed an inflammasome (Martinon et al, 2002). Since then, the field has 
expanded rapidly and our understanding of activation and regulation of inflammasome 
signaling has increased tremendously. Canonical inflammasomes consist of a PRR, which 
recognizes microbial molecules(Moltke et al, 2013) or other signals altering the homeostasis 
of the cytosol(Liston & Masters, 2017). Upon activation, the receptors oligomerize and 
recruit the adaptor protein ASC (Apoptosis-associated speck-like protein containing a CARD, 
also called PYCARD, because it has a Pyrin domain (PYD) and a Caspase recruitment 
domain (CARD)), which forms a large oligomeric structure, referred to as the ‘ASC Speck’ 
(Broz et al, 2010; Guey et al, 2014). ASC is required to bridge the receptor to pro-caspase-1 
and the formation of the ASC speck is an efficient mechanism for signal amplification to 
enhance caspase-1 activation(Dick et al, 2016). Recruitment of pro-caspase-1 leads to 
proximity induced autoproteolytic cleavage and activation of the caspase. Caspase-1, 
cysteine-specific aspartate directed protease, then induces two main signaling pathways: 1) 
the proteolytic maturation and release of pro-inflammatory cytokines like IL-1β and IL-18 
and 2) the cleavage and activation of gasdermin-D(Kayagaki et al, 2015; Shi et al, 2015a), 
which is capable for permeabilizing cellular membranes through the formation of pores(Liu 
et al, 2016; Sborgi et al, 2016; Aglietti et al, 2016; Chen et al, 2016b; Ding et al, 2016) 
leading to a pro-inflammatory, lytic form of cell death called pyroptosis(Fink & Cookson, 
2005).  
To date, five different receptors which form inflammasomes have been identified. The 
nucleotide binding oligomerization domain (NOD), leucine-rich repeat (LRR)-containing 
protein (NLR) family members NLRP1, NLRP3 and NLRC4, the PYHIN protein AIM2 and 
the protein pyrin (reviewed in(Broz & Dixit, 2016) ). The molecular activation mechanisms 
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of these inflammasomes are fairly well understood and the mechanisms underlying NLRP3, 
NLRC4 and AIM2 activation, which are relevant to my work, are discussed below. 
3.5.3.1 NLRP3 
 
The NLRP3 inflammasome (also known as cryopyrin), responds to a variety of different 
stimuli, among them crystalline substances like monosodium urate (MSU), bacterial pore 
forming toxins (nigericin, gramicidin), extracellular ATP and a variety of viral and bacterial 
pathogens(Latz et al, 2013). Given the diversity of these stimuli, it is likely that all these 
stimuli converge on one common cellular event, to trigger NLRP3 activation. To date, 
several possible triggers, including mitochondrial reactive oxygen species (mtROS) (Groß et 
al, 2016), mitochondrial DNA release(Shimada et al, 2012), lysosomal rupture(Hornung et 
al, 2008) and others have been implicated. It has been convincingly shown by several groups, 
that potassium efflux from the cytosol is one common event for a large variety of 
stimuli(Rühl & Broz, 2015; Muñoz-Planillo et al, 2013; Gross et al, 2012). The hypothesis, 
that potassium efflux is one important step during NLRP3 activation is underpinned by the 
fact, that low potassium medium is capable of activating NLRP3 independently of sodium 
and calcium influx(Muñoz-Planillo et al, 2013) and this activation is not blocked by 
mitochondrial ROS scavengers (S.R. and P.B. unpublished observations). Recently an 
additional regulator of the NLRP3 inflammasome, the NIMA related kinase 7 (NEK7), was 
identified(He et al, 2016; Schmid-Burgk et al, 2015a; Shi et al, 2016). NEK7 directly 
interacts with NLRP3, in manner dependent on potassium efflux to induce its 
oligomerization. Interestingly the catalytic domain of NEK7, but not the catalytic activity is 
required for NLRP3 activation (Figure 3.3c(He et al, 2016).  
While other inflammasomes are mainly involved in host defense against pathogens, several 
NLRP3 gain-of-function mutations(Meng et al, 2009; Brydges et al, 2009) have been 
identified, which lead to auto-inflammatory diseases referred to as Cryopyrin-Associated 
Periodic Syndromes (CAPS). The disease pathology is mainly caused by massive, periodic 
IL-1 production, as treatment with an IL-1R antagonist provides significant improvement in 
mice carrying these mutations(Meng et al, 2009). 
 
3.5.3.2 NAIP-NLRC4 
 
NLRC4 was initially identified due to its homology to apoptotic protease activating factor 1 
(APAF1). It was shown, that bacterial flagellin(Mariathasan et al, 2004; Miao et al, 2006; 
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Franchi et al, 2006) and components of the bacterial Type-3 secretion system (T3SS)(Zhao et 
al, 2011; Miao et al, 2010) activate the NLRC4 inflammasome. Interestingly, NLRC4 is not 
the receptor for these ligands but it uses the NLR family, apoptosis inhibitory proteins 
(NAIPs) as receptors. In murine cells, binding of their cognate ligands by NAIP proteins - the 
T3SS rod is bound by NAIP2, the T3SS needle by NAIP1 and flagellin by NAIP5 and NAIP6 
- allows a conformational change and binding to NLRC4(Zhao et al, 2011; Kofoed & Vance, 
2011). It was always thought that ligand binding happens via the LRR of NLRC4, but instead 
NAIPs bind NLRC4 via the NOD domain(Figure 3.3b)(Tenthorey et al, 2014). Human cells 
only have one NAIP gene, but it was shown recently, that an extended isoform NAIP* is 
expressed in primary human monocyte-derived macrophages, which confers responsiveness 
to Salmonella flagellin(Kortmann et al, 2015). 
 
3.5.3.3 AIM2 
 
The observation that microbial and host derived cytosolic DNA induces caspase-1 activation, 
dependent on ASC, but independent of NLRP3, TLRs or interferons, prompted the 
hypothesis that there must be a dedicated cytosolic DNA receptor leading to inflammasome 
formation(Muruve et al, 2008). Several groups showed that the absent in melanoma 2 
(AIM2), a member of the PYHIN (Pyrin and HIN domain-containing) family is the 
responsible sensor(Hornung et al, 2009; Fernandes-Alnemri et al, 2009; Roberts et al, 2009). 
The N-terminal pyrin domain (PYD) is responsible for recruitment of ASC upon activation 
by DNA stretches, which bind to the C-terminal HIN-200 domain. AIM2 binds DNA via the 
sugar-phosphate backbone, therefore there exists no sequence specificity towards any kind of 
DNA (Hornung et al, 2009; Jin et al, 2012). Generation of Aim2−/− deficient mice confirmed 
the importance of the AIM2 inflammasome in host defense against DNA viruses and, 
surprisingly, against bacterial pathogens like Francisella tularensis subspecies novicida or 
Listeria monocytogenes(Figure 3.3a)(Sauer et al, 2010). AIM2 has been implicated in a 
variety of human diseases among then systemic lupus erythematosus(Dihlmann et al, 2014a; 
Dombrowski et al, 2011; Dihlmann et al, 2014b), Psoriasis(Dombrowski et al, 2011) and the 
development of colorectal cancer(Ponomareva et al, 2013; Wilson et al, 2015; Man et al, 
2015). Interestingly, a recent study showed that pharmacological disruption of the nuclear 
envelope leads to AIM2 dependent inflammasome activation, providing strong evidence that 
in a variety of scenarios, leakage of self-DNA from the nucleus can have detrimental 
consequences(Di Micco et al, 2016). 
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3.5.4 Non-canonical inflammasome 
 
Besides canonical inflammasomes, recently a non-canonical inflammasome pathway has 
been discovered(Kayagaki et al, 2011). Kayagaki et al. found that murine BMDMs infected 
with gram-negative bacteria die by pyroptosis, which is dependent on the presence and 
catalytic activity of caspase-11 and independent of caspase-1(Kayagaki et al, 2011). They 
could show that the Casp1-deficient mice, which were widely used at the time, are actually 
Casp1/Casp11 double deficient mice, due to a passenger mutation originating from 129S 
mice, which only express a truncated and non-functional version of caspase-11(Kayagaki et 
al, 2011). Importantly, caspase-11 is the central mediator of septic shock during injection of 
bacterial Lipopolysaccharide (LPS), a model of endotoxemia. Subsequently it was shown that 
bacterial LPS is the ligand for caspase-11, leading to its activation(Kayagaki et al, 2013; 
Hagar et al, 2013). Another study showed surprisingly that this activation happens via direct 
binding of LPS to the CARD domain of caspase-11 (-4/-5 in humans), therefore establishing 
the model, that caspase-11 is at the same time the receptor and the effector caspase of the 
non-canonical inflammasome pathway(Shi et al, 2014). Caspase-11 is not capable of cleaving 
IL-1β but instead induces potassium efflux to activate NLRP3 in a cell autonomous manner 
to promote cytokine secretion(Figure 3.3d, (Rühl & Broz, 2015; Baker et al, 2015; Schmid-
Burgk et al, 2015b). 
Recently, it was proposed that beyond recognition of LPS through its CARD domain, 
caspase-11 binds endogenous oxidized lipids via its catalytic domain and triggers activation 
of the non-canonical inflammasome pathway. Interestingly this kind of activation only 
triggers IL-1β maturation but not cell death in dendritic cells and induces a state of so-called 
‘DC hyperactivation’. The authors show that the Kd for oxPAPC, the mixture of oxidizes 
phospholipids that binds to the catalytic domain of caspase-11, is 100 fold lower than the Kd 
for LPS, which could explain, why this low level activation only triggers Nlrp3 mediated 
cytokine secretion, without killing dendritic cells(Zanoni et al, 2016). A follow up study 
identified internalization by CD14 mediated endocytosis as a critical step for immune cell 
hyperactivation and two specific phospholipids (PGPC, POVPC) as stimulators of 
hyperactivation in BMDMs(Zanoni et al, 2017). It remains to be determined, if other lipid 
species are capable of activating caspase-11, which could establish a broader role for 
caspase-11 in sensing of pro-inflammatory lipid mediators. 
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Figure 3.3 Canonical inflammasomes 
 
a The AIM2 inflammasome detects the presence of endogenous or exogenous cytosolic DNA 
via its HIN200 domain. Binding of DNA leads to a conformational change and binding of 
ASC via the pyrin domain, which recruits pro-caspase-1. b The NAIP-NLRC4 inflammasome 
recognizes components of the T3SS and flagellin of gram-negative bacteria. Also 
extracellular bacteria can activate this inflammasome as the T3SS accidentally co-translocates 
flagellin molecules upon injection of effectors into the host cytosol or parts of the needles 
disintegrate after injection at the cytosolic side of the PM. NAIPs bind the bacterial proteins 
to activate NLRC4, which in turn exposes its CARD domain. Exposure of the CARD 
domains leads either to direct recruitment of pro-caspase-1(‘death complex’) and activation, 
resulting in cell death with little cytokine maturation or in recruitment of ASC through 
CARD-CARD interaction, which in turn recruits more ASC and pro-caspase-1 which results 
in strong caspase-1 activation, cell death and more IL-1β maturation. c Formation of pores in 
the PM through channel opening (e.g. by extracellular ATP stimulation) or pore forming 
toxins (e.g. nigericin) leads to potassium efflux, which is required for most NLRP3 stimuli. 
For some stimuli, mitochondrial dysfunction and generation of mtROS might be required 
downstream of potassium efflux. Activation of NLRP3 requires recruitment of NEK7 to 
induce oligomerization and subsequent recruitment of ASC and pro-caspase-1. d Cytosolic 
LPS, either delivered artificially or during gram-negative bacterial infection is recognized by 
the CARD of caspase-1, which upon binding to LPS, oligomerizes and gets activated. To date 
it is not clear, if autoproteolytic cleavage is required or sufficient for caspase-11 activation. 
Active caspase-11 is induces potassium efflux in a cell autonomous manner to induce NLRP3 
inflammasome activation. 
 
18Introduction
3.6 Effector functions of inflammasome activation 
 
3.6.1 Cytokine maturation and release 
 
Caspase-1 was initially described as ICE (Interleukin converting enzyme)(Dandekar & 
Argos, 2008), as it processes IL-1β and IL-18 into their mature, bioactive forms. Expression 
of IL-1β and the closely related IL-1α are induced through TLR stimulation, whereas IL-18 is 
expressed constitutively(Gross et al, 2012). As discussed, IL-1β and IL-18 require processing 
by caspase-1 to be active, whereas IL-1α can be processed by caspase-1 but is active without 
processing and is released as an active cytokine also during caspase-1-independent lysis e.g. 
necroptosis(Wallach et al, 2016) or caspase-11-mediated pyroptosis(Kayagaki et al, 2011).  
Besides release of mature cytokines by lysis, several other mechanisms for ‘unconventional 
secretion’ have been implicated (discussed below), however recent studies unraveled that at 
least in BMDMs, pyroptosis constitutes the main release mechanism for mature cytokines 
after caspase-1 activation (Figure 3.4(Shi et al, 2015a). 
 
3.6.2 Pyroptosis 
 
Pyroptosis was first described by Fink and Cookson as a lytic, non-apoptotic caspase-1 
driven cell death, characterized by cell swelling (probably due to membrane pore formation) 
and the subsequent lysis of the cells (Fink & Cookson, 2005). The name originates from the 
Greek ‘pyro’ (fire or fever) and ‘ptosis’ (to fall) indicating the pro-inflammatory nature of 
this cell death(Fink & Cookson, 2005). After years of research, two seminal studies in 2015 
demonstrated that one substrate, gasdermin-D, of both, caspase-1 and caspase-11 is essential 
for induction of pyroptosis. Generation of Gsdmd-deficient cells and mice showed that 
gasdermin-D is essential for pyroptosis and activation of the non-canonical inflammasome 
pathway during LPS transfection and LPS induced septic shock in mice (Figure 3.4(Shi et al, 
2015a; Kayagaki et al, 2015)). Caspase-1 driven pyroptosis depends only at early time points 
on gasdermin-D but prolonged caspase-1 activation results in gasdermin-D independent 
pyroptosis, probably due to activation of caspase-8 in response to ASC speck formation 
(Sagulenko et al, 2013) or cleavage of other cellular substrates by caspase-1 (Kayagaki et al, 
2015; Heilig et al, 2017). 
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Figure 3.4 Effector functions of inflammasome activation 
 
Active caspase-1 and caspase-11 both cleave gasdermin-D into a soluble C-terminal fragment 
(CT) and a cytotoxic, pore forming N-terminal fragment (NT), which translocates to cellular 
membranes to permeabilizes them. Caspase-1 cleaves pro-IL-1β into its mature form, which is 
released partially through gasdermin-D pores. Pore formation leads to water influx, swelling 
of cells and subsequent lysis accompanied by release of cytosolic content. 
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3.7 Gasdermin family of proteins 
 
The gasdermin family of proteins is conserved in vertebrates and composed of four 
paralogues in humans (GSDMA, GSDMB, GSDMC and GSDMD). Mice lack GSDMB but 
have four Gsdmc homologues and three Gsdma homologues. Members of the gasdermin 
family share a distinct N-terminal and a C-terminal region connected by a linker region. This 
feature is shared by the Dfna5 and the Dfnb59 genes, which can be considered to be extended 
family members. The N-termini of all members (except Dfnb59) display similar cytotoxic 
properties to the gasdermin-D N-terminal fragment. 
 
3.7.1 Gasdermin-D 
 
Gasdermin-D is the best studied family member, as its role in pyroptosis induction 
downstream of inflammatory caspase activation has been investigated thoroughly. As 
discussed above, gasdermin-D is a substrate of both caspase-1 and caspase-11 and cleavage 
of gasdermin-D by these caspases at Asp276 is essential for pyroptosis induction (Kayagaki 
et al, 2015; Shi et al, 2015a). The N-terminal fragment is the active part of gasdermin-D, as 
its expression leads to pyroptotic morphology and cell death, whereas the C-terminal 
fragment does not kill cells upon expression. We and several other groups could show that 
the GSDMDNterm translocates to cellular membranes upon cleavage by inflammatory 
caspases, where it forms pores and permeabilizes membranes (Liu et al, 2016; Sborgi et al, 
2016; Aglietti et al, 2016; Chen et al, 2016b; Ding et al, 2016). Formation of these pores 
leads to breakdown of the electrochemical gradient across the PM and water influx due to 
osmotic pressure. The combination of these events ultimately leads to swelling, rupture and 
lysis of the cell. 
It is thought, that the C-terminal fragment acts a solubilization factor or ‘chaperone’ for the 
N-terminal fragment, to prevent cytotoxicity prior to cleavage. This hypothesis is supported 
by the observation, that the cytotoxic activity of the gasdermin-A N-terminus can be inhibited 
by expressing the C-terminal fragment independently(Ding et al, 2016; Shi et al, 2015a). 
Therefore, pore formation by gasdermin-D represents the final step during pyroptosis 
induction by inflammatory caspases. 
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3.7.2 DFNA5/Gasdermin-E 
 
Deafness autosomal dominant 5 (DFNA5), originates from the discovery of the gene, as 
mutations in the Dfna5 gene cause heritable, nonsyndromal deafness, characterized by 
gradual hearing loss, typically starting at high frequency at the age of 15(Bischoff et al, 2004; 
van Laer et al, 1998). Bioinformatic analysis shows, that DFNA5 has putative caspase-3 
cleavage site within the region, connecting the N-terminal and the C-terminal region. It was 
shown that DFNA5 expressing cells undergoing apoptosis, and therefore caspase-3 
activation, rather dye by a necrotic cell death, characterized by cell swelling, rupture and 
lysis, rather than condensation and formation of apoptotic bodies. These findings implicate 
DFNA5 to operate as critical switch between apoptosis and secondary necrosis(Rogers et al, 
2017). A second study could confirm these results, however the authors also went on to 
show, that DFNA5 (or gasdermin-E as they call it) is suppressed in many cancer cells and 
that enforced expression of DFNA5 enhances lytic cell death of cancer cells upon 
chemotherapy drug exposure. Furthermore, chemotherapy induced toxicity and inflammation 
was ablated in DFNA5 deficient animals(Wang et al, 2017). The DFNA5 N-terminal 
fragment, similar to the GSDMDNterm, permeabilizes membranes through the formation of 
pores after cleavage and separation from the C-terminus, explaining the mechanism how 
DFNA5 promotes necrotic cell death after caspase-3 activation. Further research needs to 
determine the physiological role of DFNA5 during apoptosis and its expression and function 
in specific tissues.  
 
3.7.3 Other gasdermin family members 
 
Multiple spontaneous mutations in gasdermin-A3 have been identified to lead to 
hyperkeratosis and spontaneous alopecia(Runkel et al, 2004; Lunny et al, 2005; Tanaka et al, 
2007; Li et al, 2010; Zhou et al, 2012). The disease-causing mutations have been shown to 
disrupt the interaction between the cytotoxic N-terminal domain and the C-terminal part of 
the protein, leading to pore formation and cytotoxicity without cleavage of the linker region 
(10). This explains the inflammation as a depletion of skin bulge stem cells observed in mice 
with Gsdma3 mutations(Zhou et al, 2012; Shi et al, 2015b). SNPs in both, human Gsdma and 
Gsdmb, are associated with asthma in multiple populations(Yu et al, 2011; Wu et al, 2009b; 
Moffatt et al, 2007; 2010). The N-terminal region of gasdermin-B can be cleaved by 
apoptotic caspases, and thus might lead to inactivation of the protein during apoptosis(Chao 
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et al, 2017), however if there is any biological relevance to this observation remains to be 
determined.  
Gasdermin-C is expressed in esophagus, stomach, trachea, spleen intestines, bladder in skin 
{Saeki:ollkdwRF} (Wu et al, 2009a). It has not yet been implicated in any diseases in mice 
or humans. 
DFNB59 is as DFNA5 associated with hearing loss(Delmaghani et al, 2006; Schwander et al, 
2007). It was shown to be essential for proliferation of peroxisomes(Delmaghani et al, 2015), 
but if DFNB59 has a transport function, or also forms pores in peroxisomes needs to be 
determined.  
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3.8 Other modes of regulated cell death 
 
3.8.1 Apoptosis (Figure 3.5) 
 
Apoptotic cell death is either initiated via ligation of death receptors or by engagement of the 
mitochondrial pathway of apoptosis. Activation of either pathway culminates in the 
activation of executor caspases, namely caspase-3, -6 and -7. These executor are synthesized 
as inactive precursors and lack protein-protein interaction domains as their activation is 
achieved through inter-domain cleavage by the initiator caspases-8/-9(Salvesen & Riedl, 
2008). These executioner caspases (especially -3 and -7) are capable of cleaving more than 
1000 substrates(Crawford & Wells, 2011). Cleavage of these substrates activates or represses 
certain cellular signaling pathways leading to the characteristic changes associated with 
apoptosis. These include chromatin condensation (pyknosis), rounding of cells and 
membrane blebbing (Ricci et al, 2004),(Sakahira et al, 1998). The initiator caspases -8 and -9 
are also synthesized as inactive monomers, however they possess additional protein-protein 
interaction domains and get activated through proximity-induced auto-proteolytic 
cleavage(Pop et al, 2007),(Oberst et al, 2010). Which of the initiator caspases is activated in 
response to a certain stimulus is determined by the different pathways of apoptosis, which 
can be engaged. 
The mitochondrial pathway of apoptosis (intrinsic pathway) is the most common mechanism 
of apoptosis in vertebrates. Stimuli, which feed into this pathway include DNA damage, 
growth factor deprivation, ER stress and developmental cues (Bratton & Salvesen, 2010). 
The B-cell lymphoma-2 (Bcl-2) family of proteins is responsible for integration of these 
stimuli as these proteins regulate the critical step of mitochondrial outer membrane 
permeabilization (MOMP), which allows subsequent activation of caspase-9 by the 
apoptosome(Chipuk et al, 2010). The Bcl-2 protein family consists of three broad classes: 
pro-apoptotic effector proteins (Bax and Bak), anti-apoptotic Bcl2 proteins (e.g. Bcl2, Bcl-xl, 
Mcl1) which block apoptosis and BH3-only proteins (e.g. Bid, Bim, Bad and Noxa) which 
repress anti-apoptotic Bcl2 family members. Bax and Bak are in the found in the cytosol in 
healthy cells, however upon activation, or more precisely loss of inhibition by one of the anti-
apoptotic Bcl2 family members(O'Neill et al, 2016), they are capable of permeablizing the 
mitochondrial outer membrane through the formation of large oligomeric pores (Eskes et al, 
2000),(Dewson et al, 2009),(Korsmeyer et al, 2000). 
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This process referred to as MOMP, release cytochrome c as well as the secondary 
mitochondria derived activator of caspases (SMAC) and Omi from the mitochondrial 
intermembrane space. Cytochrome c release is the essential step for the intrinsic apoptotic 
pathway to proceed as, once in the cytosol, it binds to Apaf1 and induces its 
oligomerization(Zou et al, 1997). This allows the formation of an active apoptosome, 
providing an activation platform for caspase-9, which is recruited via its CARD domain and 
gets autoproteolytically activated(Yu et al, 2005),(Yuan et al, 2010). As discussed above, 
activation of caspase-9 leads to processing of executioner caspases, allowing apoptosis to 
proceed. The apoptotic response is potentiated by Smac and Omi which are released from the 
mitochondria during MOMP, as they antagonize the X-linked inhibitor of apoptosis (XIAP). 
In the absence of Smac and Omi XIAP inhibits the catalytic activity of the caspases -3, -7 and 
-9 and mediates ubiquitination of active caspases (Eckelman et al, 2006). 
The extrinsic pathway of apoptosis in turn is initiated by death receptor signaling. Death 
receptors are a subset of the tumor necrosis factor receptor (TFNR) family, including TNFR1, 
Fas and TRAIL R1/2 (Dickens et al, 2012) . They recruit caspase-8 and other signaling 
molecules important for inflammation and cell adhesion by homotypic protein-protein 
interactions mediated by their death domain/s(Newton & Dixit, 2012). Upon activation of 
TRAIL-R or FAS by their ligands, Fas-associated protein with death domain (FADD) is 
recruited, which through exposure of its death effector domain (DED) brings caspase-8 
molecules into close proximity triggering their protease activity. Auto-proteolytic activation 
of caspase-8 promotes apoptosis in some cells (type I cells) by cleaving  and activating 
caspase-3 and -7 however in many cell types (type II cells) the executioner caspases are 
inhibited by XIAPs, which blocks apoptosis(Jost et al, 2009). In these cells cleavage of Bid 
by caspase-8 is required to induce MOMP and therefore release SMAC and Omi, which 
neutralize XIAPs and allows apoptosis to proceed (Dickens et al, 2012).  
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Figure 3.5 Apoptosis 
 
The extrinsic pathway is initiated by ligation of death receptors and leads to activation of caspase-8 
and -10, which in turn activate the executioner caspases 3&7. Caspase -8 and-10 can cleave BID 
into tBID to engage the intrinsic pathway as well. The interactions between Bcl-2 family members 
regulate the critical step of MOMP, which decides if a cell undergoes apoptosis or not. Once 
MOMP is initiated, release of SMAC and cytochrome c lead to inhibition of XIAPs and apoptosome 
assembly respectively. Caspase-9, which is activated within the apoptosome, cleaves caspase-3 and 
-7 to execute apoptosis (adapted from Kalkavan and Green, 2017) 
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3.8.2 Necroptosis (Figure 3.6) 
Signaling downstream of TFNR1 is more complex and can lead to apoptosis, survival or 
necroptosis. TNFR1 recruits Tumor necrosis factor receptor type 1-associated DEATH 
domain protein (TRADD) and other factors to activate NF-kB, which rather culminates in an 
inflammatory response rather than cell death (Newton & Dixit, 2012). One consequence of 
NF-kB activation is the production of cellular FLICE (FADD-like IL-1β-converting 
enzyme)-inhibitory protein (c-FLIP) (Micheau et al, 2001). Though TNFR1 engagement 
leads to caspase-8 activation, by recruitment TRADD, FADD and Receptor interacting kinase 
(RIPK) 1 (also referred to as complex II) (Declercq et al, 2009),(Christofferson & Yuan, 
2010), expression of cFLIP proteins through NF-kB activation however inhibits caspase-8 
mediated apoptosis in most cells. Although in complex with cFLIP caspase-8 is catalytically 
active and apoptosis is not induced. It remains obscure why this is the case, although a 
hypothesis is, that this complex is prone to more rapid degradation (Geserick et al, 
2009).Therefore TNFR1 engagement leads to inflammation and cell survival rather than 
apoptosis in most cells. 
As discussed above, complex II formation in presence of cFLIP proteins does not promote 
apoptosis in response to TNFR1 ligation. Complex II formation leads, beside recruitment of 
RIPK1, to the recruitment of RIPK3, a crucial step for necroptotic cell death to proceed. 
Necroptosis is characterized by a loss of membrane integrity, dissipation of the 
electrochemical gradient across the plasma membrane and release of cytosolic content from 
the cell(Cho et al, 2009),(He et al, 2009),(Zhang et al, 2009). RIPK3 is recruited by RIPK1 
through interaction of their RIP homology interaction motifs (RHIM) domains. In this 
configuration complex II is referred to as the RIPoptosome, and rather induces necrosis than 
apoptosis(Feoktistova et al, 2011),(Tenev et al, 2011). A series of post-translational 
modifications is required for assembly of this signalling platform. De-ubiquitination of 
RIPK1 promotes assembly of the RIPoptosome(Wang et al, 2008),(O’Donnell et al, 
2011),(Moulin et al, 2012). Moreover, the kinase activity of RIPK1 is required for activation 
of RIPK3(Cho et al, 2009),(He et al, 2009),(Zhang et al, 2009). In addition, the caspase-8-
cFLIP heterodimer negatively regulates necroptosis, as RIP1, RIP3 and CYLD (a RIP1 
deubiquitinase, therefore a positive regulator of necroptosis) are cleavage substrates for 
caspase-8(Pop et al, 2011). Consequently, necroptosis in response to TNFR1 ligation only 
progresses if FLIP-caspase-8 activity is blocked. RIP dependent necroptosis can also be 
triggered downstream of TLR3 or TLR4 as these receptors signal through TIR-domain-
containing RHIM-containing adaptor inducing IFN–beta (TRIF)(Imtiyaz et al, 
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2006),(Feoktistova et al, 2011). TRIF recruits RIPK1 and RIPK3 to induce RIP dependent 
necroptosis(Feoktistova et al, 2011). Also, viral infections can induce necroptosis. The RHIM 
containing cytosolic DNA sensor DAI recruits RIP3 through its RHIM domains if activated 
by viral dsDNA(Upton et al, 2010),(Upton et al, 2012),(Cho et al, 2009). Upon activation by 
one of the mechanisms described above, RIPK3 phosphorylates the mixed lineage kinase-
domain like pseudokinase (MLKL)(Quarato et al, 2016), leading to translocation to the 
plasma membrane(Cai et al, 2014),loss of PM asymmetry, collapse of the ionic gradient 
across the PM and ultimately lysis of the cell(Chen et al, 2016b). It has been proposed that 
calcium influx mediated by MLKL through interaction with the non-voltage gated ion 
channel TRPM7 is critical for necroptosis, however depending on the cell type, it seems that 
although calcium influx is reduced, cell death is only modestly impacted (Cai et al, 2014). 
This discrepancy might be explained by the model, that MLKL itself is capable of forming 
pores in membranes (Wang et al, 2014). It remains to be investigated, if both mechanisms 
occur simultaneously or are in any way dependent on each other.  
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Figure 3.6 Necroptosis 
 
Engagement of TNFR leads to complex I assembly and to RIPK1 dependent NF-kB activation and 
gene expression, if RIPK1 is ubiquitinated by cIAP1/2. CYLD leads to de-ubiquitination of 
RIPK1, enabling its interaction with RIPK3 and caspase-8 leading to formation of the 
Ripoptosome or the Necrosome. In the presence of c-FLIP proteins, Ripoptsome mediated 
apoptosis is inhibited, as capase-8 is inhibited by cFLIPLL. However, the caspase-8 cFLIP 
complex is capable of cleaving CYLD as well as RIPK1 and RIPK3, therefore inhibiting MLKL 
activation and necroptosis. Therefore, necroptosis only occurs if caspase-8 is inhibited. 
(adapted from Tummers and Green, 2017) 
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3.9 Plasma membrane repair mechanisms (Figure 3.7) 
 
It has been known for several decades that cells can repair damage inflicted to their plasma 
membrane (PM) by mechanisms strictly dependent on extracellular calcium ions(Andrews et 
al, 2014). Early experiments observed large patches of membranes and vesicles(Miyake & 
McNeil, 1995; Bi et al, 1995), which were recruited to the site of injury, leading to the 
hypothesis that intracellular pieces of membranes fuse at the site of injury to repair the 
PM(McNeil et al, 2000). Yet, how these fusion events occur biophysically and how this leads 
to restoration of PM integrity couldn´t be explained. More recently two non-mutually 
exclusive mechanisms have been investigated to the molecular detail. These mechanisms, 
endocytosis of PM pores and shedding of damaged pieces of membrane, both are dependent 
on calcium influx and are even capable of explaining the repair and removal of stable 
transmembrane pores. 
 
3.9.1 ASM mediated endocytosis of PM pores 
 
The observation that wounding of the PM leads to massive exocytosis (Miyake & McNeil, 
1995; Bi et al, 1995), was initially surprising but could be confirmed in multiple cell types in 
response to different kinds of membrane damage(Forestier et al, 2011; Roy et al, 2004). It 
was initially thought that the membrane patches appearing at the site of injury would serve 
either to ‘clog’ the hole in the PM (McNeil et al, 2000)or they would serve to reduce the 
membrane tension around the site of injury(Togo et al, 2000), which was supported by the 
findings, that lysosomal markers could be observed in punctate patterns at the PM upon 
injury(Reddy et al, 2001). The realization that stable transmembrane pores, like the bacterial 
toxin Streptolysin O (SLO) were removed in a calcium dependent manner prompted a closer 
examination of the mechanistic details(Walev et al, 2001; Morgan & Campbell, 1985). The 
fact that lysosomal hydrolases are secreted in a calcium dependent manner(Tam et al, 2010) 
upon PM injury and the observation that PM injury triggers massive endocytosis of vesicles, 
which look remarkably like endosomes of cells treated with bacterial 
sphingomyelinase(Idone et al, 2008; Zha et al, 1998) provided a first mechanistic explanation 
for removal of PM pores. Sphingomyelin is abundantly found in the PM(Simons & Raposo, 
2009) and sphingomyelinases are capable of generating ceramide from sphingomyelin. 
Ceramide was shown to promote membrane invagination(Holopainen et al, 2000) and was 
implicated in the formation of intraluminal vesicles on multi-vesicular bodies (MVBs), where 
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cytosolic neutral sphingomyelinase is responsible for ceramide generation(Trajkovic et al, 
2008). The lysosomal enzyme acidic sphingomyelinase (ASM) is secreted to the cell surface 
when they are exposed to membrane-damaging stress(Gulbins, 2003; Tam et al, 2010). There 
it acts on the outer leaflet of the PM, generating ceramide-rich micro domains(Schissel et al, 
1998; van BLITTERSWIJK et al, 2003; Grassmé et al, 2002). These micro domains are 
absent during treatment with ASM inhibitors and in cells deficient for ASM during SLO 
treatment(Tam et al, 2010; Babiychuk et al, 2008). Importantly, under these conditions, 
membrane repair is inhibited and cells succumb to otherwise sub-lethal concentrations of 
SLO(Tam et al, 2010). This shows that ASM mediated ceramide generation and subsequent 
endocytosis of PM pores is required for membrane repair during PM pore formation. Once 
internalized by endocytosis, PM pores travel along the endosomal route to be degraded in 
MVBs or lysosomes(Corrotte et al, 2012). 
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3.9.2 ESCRT-III dependent shedding of PM pores 
 
The ESCRT machinery is a multiprotein complex, composed of several parts (ESCRT 0, I, II, 
III). The name, endosomal sorting complex required for transport, originates from its 
discovery in yeast where the ESCRT proteins, just like in all eukaryotic cells, are responsible 
for sorting and trafficking of proteins along the secretory pathway(Katzmann et al, 2002). 
Most prominently, the ESCRT machinery is responsible for formation of intraluminal 
vesicles (ILVs) in multivesicular bodies (MVBs)(Katzmann et al, 2002), as it is the only 
machinery capable of deforming membranes away from the cytosol, leading to generation of 
vesicles at the distal part of a membrane. Over the years, other functions of the ESCRT 
machinery, including cytokinesis(Carlton & Martin-Serrano, 2007; Morita et al, 2007), a role 
for the budding of several enveloped viruses (Morita & Sundquist, 2004) and a function for 
restoration of nuclear envelope restoration have been implicated(Raab et al, 2016; Denais et 
al, 2016). More recently, it has been shown convincingly by several groups that the ESCRT-
III machinery has a function in PM repair(Jimenez et al, 2014; Scheffer et al, 2014). These 
studies could demonstrate that several components of the ESCRT machinery are enriched in 
membrane fractions of cells treated with the calcium ionophore ionomyin. Validation 
experiments showed that this recruitment is not only dependent on calcium influx, but is 
observed if the PM is damaged by different means. Laser wounding, detergent treatment, 
bacterial pore forming toxins and perforin treatment all induced clustering of the ESCRT-III 
component CHMP4 at the PM. Both groups showed that other ESCRT-III components are 
recruited as well during micro-laser wounding and that most components of the ESCRT 0, I, 
and II machineries are dispensable (except ALIX and ALG-2) for PM repair. Consequently, 
inhibition of ESCRT-III activity by either knock-down or expression of dominant-negative 
proteins inhibited membrane repair and lead to enhanced cell death during laser wounding, as 
damaged pieces of membrane could not be removed by ectocytosis (Jimenez et al, 2014; 
Scheffer et al, 2014). 
A recent study demonstrated that beyond repairing laser inflicted PM damage the ESCRT-III 
machinery also negatively controls necroptotic cell death. As discussed above, necroptosis 
involves pore formation at the PM by MLKL, leading to collapse of the ionic gradient across 
the PM and ultimately lysis of cells. The study could show that the ESCRT-III machinery is 
activated during necroptosis and recruited to MLKL positive parts of the PM, where it sheds 
‘bubbles’ of membrane up to 0.5 µm in size. Inhibition of the ESCRT-III machinery resulted 
in enhanced cell death during necroptosis and prevented ‘resuscitation’ of cells. Resuscitation 
32Introduction
is a phenomenon, where cells which have received a necroptotic stimulus (have exposed PS 
at the PM and are therefore Annexin-V positive) can come back to life if the stimulus is 
removed. Interestingly, premature death of cells during necroptosis leads to reduced cytokine 
secretion and T-cell cross-priming as stimulated cells have too little time to engage NF-κB 
dependent signaling and cytokine production. This study for the first time implicated a role 
for membrane repair mechanism in the regulation of cellular death programs, showing an 
interesting connection between cellular survival and cell death pathways(Gong et al, 2017). 
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Figure 3.7 Plasma membrane repair mechanisms 
 
Damage or pore formation at the PM (middle) leads to calcium influx, which is essential for 
triggering both described membrane repair mechanisms. ASM dependent endocytosis (left 
part) is initiated by rapid secretion of ASM to the supernatant of cells, from secretory 
lysosomes. ASM hydrolyses sphingomyelin to ceramide around the site of exocytosis, leading 
to ceramide driven invagination of the damaged area of the membrane. Pores are sequestered 
within endosomes and travel to MVBs to be degraded. ESCRT dependent ectocytosis (right 
part) is initiated by activation of ALG-2 through calcium flux, which is turn recruits ALIX 
(ALG-2 interacting protein X). Components of the ESCRT-III machinery are consecutively 
recruited, leading to shedding of PM pores within ectosomes to restore PM integrity 
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3.10 Aim of the thesis 
During my PhD I was always intrigued by the simplicity of the non-canonical inflammasome 
pathway and how it works to protect the host from gram-negative pathogens. As the 
mechanisms downstream of caspase-11 activation were not well understood, my work 
focused on understanding these signaling events. I wanted to understand how caspase-11 acts 
to promote NLRP3 activation, executes pyroptosis through gasdermin-D and how the cell is 
capable of regulating pyroptosis downstream of caspase-11 activation. I also tried to identify 
unknown components of the non-canonical pathway by performing an unbiased forward 
genetic screen. Overall I aimed to improve our understanding of the signaling events elicited 
by activation of caspase-11 through intracellular LPS. 
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Caspase-11 activates a canonical NLRP3 inﬂammasome
by promoting K+ efﬂux
Sebastian Ru¨hl and Petr Broz
Focal Area Infection Biology, Biozentrum, University of Basel, Basel, Switzerland
Recognition of microbe-associated molecular patterns or endogenous danger signals by
a subset of cytosolic PRRs results in the assembly of multiprotein signaling complexes,
the so-called inﬂammasomes. Canonical inﬂammasomes are assembled by NOD-like
receptor (NLR) or PYHIN family members and activate caspase-1, which promotes the
induction of pyroptosis and the release of mature interleukin-1β/-18. Recently, a non-
canonical inﬂammasome pathway was discovered that results in caspase-11 activation
in response to bacterial lipopolysaccharide (LPS) in the cytosol. Interestingly, caspase-
11 induces pyroptosis by itself, but requires NLRP3, the inﬂammasome adapter ASC, and
caspase-1 to promote cytokine secretion. Here, we have studied the mechanism by which
caspase-11 controls IL-1β secretion. Investigating NLRP3/ASC complex formation, we ﬁnd
that caspase-11 functions upstream of a canonical NLRP3 inﬂammasome. The activation
of NLRP3 by caspase-11 during LPS transfection is a cell-intrinsic process and is inde-
pendent of the release of danger signals. Furthermore, we show that active caspase-11
leads to a drop of intracellular potassium levels, which is necessary to activate NLRP3.
Our study, therefore, sheds new light on the mechanism of noncanonical inﬂammasome
signaling.
Keywords: Caspase-11  Inﬂammasome  Interleukin-1 beta (IL-1β)  Lipopolysaccharide 
NLRP3  Potassium efﬂux  Pyroptosis
See accompanying articles by Masters and colleagues and Hornung and colleagues.
See accompanying Commentary by Rivers-Auty and Brough.
 Additional supporting information may be found in the online version of this article at thepublisher’s web-site
Introduction
Inﬂammasomes are multiprotein complexes assembled by cytoso-
lic PRRs from the NOD-like receptor (NLR) and PYHIN protein
family upon recognition of microbe-associated molecular patterns
(MAMPs) or danger signals [1]. Ligand recognition results in
receptor activation and recruitment of the adaptor ASC, which
rapidly oligomerizes to form the so-called ASC speck. The ASC
speck serves as an activation platform for the cysteine protease
Correspondence: Dr. Petr Broz
e-mail: petr.broz@unibas.ch
caspase-1 [2] that processes the cytokines IL-1β and IL-18 to
their mature form and promotes pyroptosis, a lytic form of cell
death [1]. Besides their role in host defense [1], inﬂammasomes
attract interest since deregulation of inﬂammasome signaling is
also linked to a number of hereditary and acquired inﬂammatory
diseases [3].
Inﬂammasome receptors, such as NLRs and PYHINs, contain
several functional domains that are thought to be involved in lig-
and recognition. Direct binding of the ligand has been demon-
strated for AIM2, which binds double-stranded DNA [4], and
for the NAIP proteins, which bind ﬂagellin and type 3 secretion
systems subunits [1]. However, for most other inﬂammasomes
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it remains unclear how the stimulus is recognized. This is
particularly true for the NLRP3 inﬂammasome that is activated
by a variety of structurally and chemically distinct stimuli, rang-
ing from pathogens and pore-forming toxin to crystalline particles
and UV irradiation [5]. These results suggest that some signal/s
common to all of these activators must be recognized. Currently,
these common denominators are thought to be K+ efﬂux [6, 7],
lysosomal damage and the release of Cathepsins [8, 9], mitochon-
drial ROS production and the release of oxidized mitochondrial
DNA [10, 11]. Nevertheless, despite these advances it remains
unclear if and how these events are causally linked.
Investigating the response of murine macrophages to
lipopolysaccharide (LPS) and cholera toxin B, as well as other bac-
terial inﬂammasome activators, Kayagaki et al. recently discovered
a noncanonical inﬂammasome pathway that relies on caspase-11
[12]. Subsequent studies reported that this pathway was activated
by Gram-negative, but not by Gram-positive, bacteria, indicating
a requirement for a conserved factor from Gram-negative bacte-
ria [13, 14]. Consistently, it was later shown that Gram-negative
bacterial LPS delivered to the cytosol by transfection or electropo-
ration is sufﬁcient to induce caspase-11 activation [15, 16]. While
it was initially assumed that a cytosolic LPS receptor activates
caspase-11, it was recently shown that caspase-11 as well as its
human homologs caspase-4/5 recognize LPS directly via the CARD
domain [17]. Another particularity of the noncanonical inﬂamma-
some pathway is that caspase-11 is able to induce a lytic cell death
similarly to caspase-1, however, cannot by itself trigger IL-1β/-
18 release [12]. To promote cytokine secretion, caspase-11 abso-
lutely requires components of the NLRP3 inﬂammasome—namely
NLRP3, ASC, and pro-caspase-1 [12]. However, how caspase-
11 is linked to NLRP3 activation in this noncanonical inﬂamma-
some pathway remains unclear. While some results suggest that
caspase-11 forms a complex together with NLRP3/ASC and pro-
caspase-1 [12, 14], others indicate that caspase-11 is upstream of
NLRP3 activation [13]. Here, we have addressed the link between
caspase-11 and NLRP3 activation upon LPS transfection. Our
results showed that caspase-11 acts indeed upstream of NLRP3
activation and controlled the assembly of NLRP3–ASC complexes
(ASC specks). This process was induced on a cell-autonomous level
and was independent of a released/secreted activator of NLRP3.
Further investigations showed that caspase-11 activation led to a
drop in intracellular K+ concentrations and that this served as a
trigger of canonical NLRP3 activation.
Results
NLRP3 activation by caspase-11 is a cell-autonomous
process
Caspase-11 activation following LPS transfection induces a lytic
type of cell death (measured by the release of lactate dehydro-
genase (LDH)), which is mostly independent of known inﬂam-
masome components (Fig. 1A) [12, 15]. Interestingly, however,
caspase-1 activation and the secretion ofmature, processed IL-1β/-
18 upon LPS transfection are absolutely dependent on NLRP3,
ASC, and pro-caspase-1 (Fig. 1B and F) [12, 15], indicating
the existence of a noncanonical pathway of NLRP3 activation
that involves caspase-11. In contrast to this pathway, treat-
ment with the canonical NLRP3 stimulus nigericin resulted in
comparable levels of cell death and cytokine production in WT
and Casp11-deﬁcient cells, but not in Nlrp3-deﬁcient cells (Fig. 1F,
Supporting Information Fig. 1A and B). Based on similar ﬁnd-
ings, previous publications suggested that during LPS transfec-
tion caspase-11 is either part of a noncanonical NLRP3 complex
[12, 14] or acts upstream of NLRP3 activation [13]. In order to
determine if caspase-11 is required for the formation of NLRP3–
ASC complexes, we assayed ASC oligomerization and ASC speck
formation in PAM3CSK4-primed WT, Nlrp3−/−, and Casp11−/−
BM-derived macrophages (BMDMs) following LPS transfection.
Importantly, ASC specks form even in the absence of inﬂamma-
tory caspases [2] and provide a robust measure of inﬂammasome
complex formation. While WT cells formed detectable ASC specks
(>60%) at 16 h post transfection, the rate of ASC speck formation
in Nlrp3−/− and Casp11−/− cells was below 5% (Fig. 1C and D).
Consistent with reduced ASC speck formation, knockout of Nlrp3
or Casp11 abrogated ASC oligomerization as determined by the
disappearance of ASC oligomers in DSS-cross-linked nonsoluble
fractions of LPS-transfected cells (Fig. 1E). Again canonical inﬂam-
masome activation by nigericin induced a comparable response
in WT and Casp-11-deﬁcient macrophages (Fig. 1E, Supporting
Information Fig. 1C and D). In conclusion, these results argue for
a model in which active caspase-11 is upstream of a canonical
NLRP3 inﬂammasome and against the existence a noncanonical
NLRP3 complex.
The NLRP3 inﬂammasome responds to a variety of chemically
and structurally diverse stimuli, among them are released danger
signals such as extracellular ATP [1]. To address if caspase-11-
induced host-cell lysis results in the release of cytosolic content
and the activation of NLRP3 in neighboring cells, we assayed
inﬂammasome activation in the presence of osmoprotectants.
PAM3CSK4-primed WT, Nlrp3−/−, and Casp11−/− BMDMs were
transfected with LPS and 50 mM of the osmoprotectant glycine
was added 1 h post LPS transfection. Extracellular glycine effec-
tively blocked release of cytosolic content in WT and Nlrp3−/−
BMDMs as assayed by the release of LDH (Fig. 1A) or the dan-
ger signal HMGB1 (Fig. 1F). Addition of glycine, however, did
not result in reduced levels of NLRP3 activation, as IL-1β release
remained unchanged (Fig. 1B and F), indicating that lysis and
the release of cytosolic contents were not a trigger of NLRP3 acti-
vation. Consistently, glycine treatment did also not block NLRP3–
ASC complex assembly as ASC speck formation and ASC oligomer-
ization remained unchanged (Fig. 1C–E). Interestingly, glycine
treatment reduced the release of caspase-1 p10 and NLRP3, prob-
ably due to reduced release of NLRP3–ASC specks from lytic cells
(Fig. 1F).
Since cells containing active caspase-11 might also release
or secrete danger signals independently of lysis, we used cocul-
ture experiments to determine if caspase-11-mediated NLRP3
activation is a cell-intrinsic process. We cocultured unlabeled
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Figure 1. Caspase-11 activates a canonical NLRP3 inﬂammasome on a cell-autonomous level independently of the release of danger signals.
(A–F) Pam3CSK4-primed BMDMs from WT, Nlrp3–/–, and Casp11–/–mice were transfected with LPS for 16 h in the presence or absence of glycine,
or treated with nigericin for 1 h. (A and B) Cell death was quantiﬁed by measuring LDH release, IL-1β release was measured by ELISA. Graphs
show average (±SD) of quadruplicate wells and are representative of at least three independent experiments. (C and D) Immunoﬂuorescence
analysis and quantiﬁcation of ASC speck formation. (E) ASC oligomerization after DSS cross-linking was analyzed by Western blot. LPS TF, LPS
transfection. (F) Western blot analysis for the release of processed caspase-1 p10, IL-1β, HMGB-1, and NLRP3 (alpha tubulin as loading control). (G)
Experimental scheme for coculture experiments. (H and I) Immunoﬂuorescence analysis and quantiﬁcation of ASC speck formation in cocultured
Pam3CSK4-primed WT/WT, Asc–/–/Casp11–/–, and WT/Casp11–/– BMDMs (ratio 3:1 unlabeled/labeled) transfected with LPS for 16 h. (A, B, D, and I)
Data are shown as mean ± SD (n = 4 replicates) and are pooled from three independent experiments. (E and F) Western blots are representative
of three independent experiments. (C and H) Magniﬁcation 63×, scale bars 10 μm. Images are representative of three independent experiments.
*p < 0.05; Student’s t-test; ND, not detectable.
WT or Asc-deﬁcient BMDMs with CFSE-labeled WT (control)
or Casp11-deﬁcient cells at different ratios (3:1 and 2:1), acti-
vated caspase-11 by LPS transfection, and quantiﬁed the rate of
NLRP3–ASC speck formation as a readout for NLRP3 activation
in respective cell populations (Fig. 1G). If a factor released from
caspase-11-proﬁcient cells is sufﬁcient to trigger NLRP3 activation
upon LPS transfection, we expected to see formation of ASC specks
in cocultured Casp11-deﬁcient cells. Analysis of ASC speck forma-
tion in the labeled and unlabeled populations showed that caspase-
11-deﬁcient BMDMs were not able to initiate ASC speck forma-
tion and consequently had not activated NLRP3, when cocultured
with either WT or Asc−/− BMDMs transfected with LPS (Fig. 1H
and I, Supporting Information Fig. 2). In conclusion, our results
demonstrated that active caspase-11 triggers a canonical NLRP3
pathway in a cell-intrinsic manner, independent of the release of
danger signals or cytokines from adjacent cells.
Involvement of mitochondria in NLRP3 activation
by caspase-11
Since canonical NLRP3 activation has been linked tomitochondrial
ROS production and ROS scavengers are known to reduce NLRP3
inﬂammasome activation [11], we next investigated if mito-
chondrial ROS generation was required for caspase-11-mediated
NLRP3 activation. Pretreatment of BMDMs with the ROS scav-
enger N-acetyl-cysteine (NAC, Sigma-Aldrich) before LPS transfec-
tion or nigericin stimulation resulted in a signiﬁcant reduction of
reduction in IL-1β release (Fig. 2A). Consistently, NAC reduced cell
death in nigericin-treated cells. However, NAC also reduced cell
death levels in LPS-transfected cells indicating that NAC interferes
with caspase-11 activation or that ROS is required for caspase-11-
induced cell death (Fig. 2A). To speciﬁcally monitor the produc-
tion of mitochondrial ROS, we used MitoSOX, a mitochondrial
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Figure 2. Involvement of mitochondria in noncanonical NLRP3 activation. (A) LDH and IL-1β release from PAM3CSK4-primed WT BMDMs trans-
fected with LPS for 4 h or stimulated with nigericin for 1 h in Opti-MEM with or without 10 mM NAC. (B) Flow cytometry analysis of mitochondrial
ROS levels in PAM3CSK4-primed WT BMDMs transfected with LPS for 4 h or transfected with deoxy-adenosine:deoxy-thymidinde (0.3 μg/2.5 ×
104 cells) to stimulate caspase-1-induced mitochondrial ROS via the AIM2 inﬂammasome for 3 h in Opti-MEM with or without 10 mM NAC. Live
cells were analyzed for MitoSOX staining by ﬂow cytometry (as shown in F). Bars represent the fold change in MFI compared to nonstimulated
controls. (C and D) LDH and IL-1β release and ﬂow cytometry analysis of mitochondrial ROS levels (as described in F) in PAM3CSK4-primed WT
BMDMs transfected with LPS for 4 h or stimulated with nigericin for 0.5 h in Opti-MEM with or without 1 mM MitoTEMPO. (E) LDH and IL-1β release
from PAM3CSK4-primed WT BMDMs infected with log-phase S. typhimurium (MOI 25) for 1 h in Opti-MEM with or without 1 mM MitoTEMPO (x-axis
indicates hours of MitoTEMPO incubation). (F) Staining procedure and gating scheme for MitoSOX analysis. ND, not detectable. All data show
average (±SD) of triplicate wells representative of at least two independent experiments. *p < 0.05, Student’s t-test.
ROS indicator. Consistent with reduced inﬂammasome activation,
NAC reduced caspase-11-induced mitochondrial ROS (Fig. 2B)
but NAC could not reduce mitochondrial ROS that was induced
during AIM2 inﬂammasome activation by deoxy adenosine:deoxy
thymidinde transfection. These data questioned the ability of NAC
to speciﬁcally reduce mitochondrial ROS (Fig. 2B) and suggested
that NAC might have unspeciﬁc effects on caspase activation.
In order to solve this discrepancy between NLRP3-induced IL-1β
production and mitochondrial ROS levels, we decided to use the
ROS scavenger MitoTEMPO (Sigma-Aldrich), which should specif-
ically target mitochondria. IL-1β secretion upon LPS transfection
was signiﬁcantly reduced in the presence of MitoTEMPO; how-
ever, nigericin induced IL-1β production as well as cell death
levels for both stimuli were unaffected (Fig. 2C). Furthermore,
analysis of mitochondrial ROS levels showed no difference for
WT macrophages stimulated in presence of MitoTEMPO or a
vehicle control indicating that MitoTEMPO might unspeciﬁcally
reduce NLRP3-induced IL-1β production during LPS transfection
(Fig. 2D). Interestingly, when analyzing the effect of MitoTEMPO
on the NLRC4 inﬂammasome, which is directly activated by ﬂag-
ellin or components of type 3 secretion systems [1], we also
noticed that increasing incubation times in medium contain-
ing MitoTEMPO diminished cell death and IL-1β production,
indicative of off-target effects on caspase-1 activation or IL-
1β secretion (Fig. 2E). We concluded that due to off-target
effects ROS scavengers cannot be used to study the involve-
ment of mitochondria in caspase-11-driven NLRP3 activation,
yet we cannot exclude a possible involvement of mitochondrial
ROS or other factors of mitochondrial physiology such as the
release of oxidized mitochondrial DNA or the perturbation of the
mitochondrial membrane potential in caspase-11-induced NLRP3
activation.
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Figure 3. K+ efﬂux is sufﬁcient to stimulate NLRP3 inﬂammasome activation. (A–D) BMDMs from WT and Nlrp3–/– mice were primed with LPS
for 3 h and incubated in Buffer A (see Materials and Methods). (A) IL-1β release was measured by ELISA. (B) Caspase-1 processing was analyzed by
Western blot. Pro-caspase-1 and GAPDH are shown as loading controls. (C) ASC oligomerization (after DSS cross-linking). (B and C) Western blots
are representative of three independent experiments. (D) Immunoﬂuorescence analysis and percentage of ASC speck formation upon incubation
in potassium-free medium. Magniﬁcation 63×; scale bars 10 μM (E) Schematic representation of the PBFI staining procedure and subsequent
ﬂow cytometry analysis. (F) PBFI staining intensity of L/Dnegative Casp1–/–/Casp11–/– BMDMs determined by ﬂow cytometry following incubation
in potassium-free medium. (G) PBFI staining intensity of L/Dnegative WT and Nlrp3-deﬁcient BMDMs, as determined by ﬂow cytometry following
priming with Pam3CSK4 and treatment with nigericin for indicated times. (A, D, F, and G) Graphs show average (±SD) and data are representative
of at least two independent experiments. *p < 0.05, Student’s t-test; ND, not detectable.
K+ efﬂux is sufﬁcient to activate NLRP3
Recent work suggested that K+ efﬂux is a common event dur-
ing the activation of the canonical NLRP3 pathway by a num-
ber of different stimuli [7]. In agreement with these data, we
found that incubation of cells in K+-free medium was sufﬁcient
to induce caspase-1 processing and the release of mature IL-1β
and from WT cells, but not from Nlrp3-deﬁcient cells (Fig. 3A
and B). Furthermore, incubation in K+-free medium was also suf-
ﬁcient to drive assembly of the NLRP3 inﬂammasome as deter-
mined by quantiﬁcation of ASC speck formation (Fig. 3D) and
ASC oligomerization (Fig. 3C). We next validated that incuba-
tion in K+-free medium indeed resulted in K+-efﬂux from BMDMs
using the cell-permeable, ﬂuorescent indicator PBFI-AM, which
binds to K+. BMDMs were incubated in K+-free medium, labeled
with PBFI-AM and subjected to ﬂow cytometry based analysis for
PBFI intensity [18] (Fig. 3E). To reduce the possibility that active
caspase-1 triggers cell death and subsequent loss of intracellular
K+, we used Casp1−/−/Casp11−/− BMDMs for this analysis and
added a near-infrared live–dead marker (L/D, Life Technologies)
to distinguish between live and dead cells (Fig. 3E). Incubation of
Casp1−/−/Casp11−/− BMDMs with K+-free medium resulted in a
signiﬁcant decrease of PBFI mean ﬂuorescence intensity (MFI) in
the L/Dnegative population (Fig 3F). These results indicated that K+-
free medium was sufﬁcient to initiate a measurable drop in intra-
cellular K+ concentrations, in line with published results obtained
by ICP-OES (inductively coupled plasma-optical emission spec-
trometry) [7]. To validate our method, we next compared K+
efﬂux from WT and Nlrp3−/− BMDMs treated with the canonical
NLRP3 activator nigericin. Similarly to K+-free medium, nigericin
treatment resulted in a decrease of PBFI-MFI in the L/Dnegative pop-
ulation in WT and Nlrp3-deﬁcient cells (Fig. 3G). Similar results
were obtained by using PI to separate live and dead cells (Sup-
porting Information Fig. 3). Taken together, these results showed
C© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu
41Results
2932 Sebastian Ru¨hl and Petr Broz Eur. J. Immunol. 2015. 45: 2927–2936
Figure 4. Caspase-11-induced K+ efﬂux is essential for NLRP3 activation. (A) WT, Nlrp3-deﬁcient, or Casp11-deﬁcient cells were primed with
PAM3CSK4 overnight and transfected with LPS for the indicated timepoints. PBFI staining was performed as described above and analyzed by
ﬂow cytometry. Quadrant blots show PBFI versus PI staining over time. (B and C) PAM3CSK4-primed WT BMDMs were transfected for 6 h with
LPS, stimulated with nigericin, or infected with log-phase S. typhimurium for 1 h in Buffer A supplemented with the indicated KCl concentrations
(see Materials and Methods). (B) Cell death was quantiﬁed by measuring LDH release, IL-1β release was measured by ELISA. (C) Pam3CSK4-primed
WT BMDMs were left unstimulated or transfected for 6 h with LPS in Buffer A in the presence of KCl and NaCl. (Left panel) Immunoﬂuorescence
analysis and (right panel) quantiﬁcation of ASC speck formation. Magniﬁcation 63×, scale bars 10 μM. (A and B) Data are show as mean ± SD of
triplicate wells and are representative of three independent experiments. (C) Graphs show data pooled from three independent experiments. ND,
not detectable; *p < 0.05; Student’s t-test.
that PBFI-AM ﬂuorescence measured by ﬂow cytometry provides
a good measure of intracellular K+ content and substantiated
observations showing that K+ efﬂux is sufﬁcient to trigger NLRP3
inﬂammasome assembly [7].
Active caspase-11 triggers K+ efﬂux, which is
essential for NLRP3 activation
Since our data indicated that K+ efﬂux is sufﬁcient to drive NLRP3
assembly, we tested if caspase-11 elicits a drop of intracellular K+
levels that would activate NLRP3 in a cell-autonomous manner.
PAM3CSK4-primed WT, Nlrp3−/−, and Casp11−/− BMDMs were
transfected with LPS for different timepoints, labeled with PBFI-
AM and PI as described above and their intracellular PBFI staining
was quantiﬁed by ﬂow cytometry. Analysis of the quadrant blots
over time showed that in the majority of cells acquired PI staining
very quickly (starting at 60 min) leading to the appearance of
a PBFIhigh PIhigh population of cells (Fig. 4A). This population
then proceeded to loose PBFI staining leading to its disappearance
at later timepoints (120 min) and the appearance of a PBFIlow
PIhigh population (Fig. 4A), which represents the ﬁnal state of
cells following caspase-11 activation. These results suggest that
caspase-11-induced membrane permeabilization occurred prior to
K+ efﬂux (as measured by PBFI staining), and that this population
quickly proceeded to become PBFIlow probably by complete loss
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of membrane integrity and the subsequent loss of K+ ions or the
PBFI dye itself. Yet, it remained unclear if after K+ loss these
PBFIhigh PIhigh cells were activating NLRP3 and forming ASC specks
(Fig. 4A).
To assess if this caspase-11-induced drop of intracellular K+
levels was necessary for NLRP3 activation after intracellular
delivery of LPS, we next transfected WT BMDMs with LPS in
either regular medium or medium with increasing K+ concen-
trations. As described previously, we isoosmotically substituted
NaCl with KCl in these media [7]. Increasing extracellular K+
concentrations did not result in reduced levels of cell death in
LPS-transfected BMDMs as assayed by the release of LDH and the
danger signal HMGB1 (Fig. 4B, Supporting Information Fig. 4A).
In contrast, extracellular K+ signiﬁcant decreased IL-1β release
and caspase-1 processing in a concentration-dependent manner
(Fig. 4B, Supporting Information Fig. 4A). Consistent with reduced
levels of NLRP3 activity, high extracellular K+ levels resulted in
reduced levels of ASC speck formation and ASC oligomerization in
LPS-transfected WT BMDMs (Fig. 4C, Supporting Information
Fig. 4B). As a control, we also analyzed the effects of increased
extracellular K+ on the canonical NLRP3 and NLRC4 inﬂamma-
somes. In contrast to the noncanonical pathway, we observed a
reduction in both cell death and cytokine release in WT BMDMs
treated with nigericin in presence of increasing concentrations
of extracellular K+. Furthermore, ASC oligomerization, caspase-1
processing, and HMGB1 release upon nigericin treatment were
reduced as well (Fig. 4B, Supporting Information Fig. 4A and
B). This is consistent with the notion that K+ efﬂux is upstream
of NLRP3 and thus high extracellular K+ blocks both cell death
and IL-1β release. As expected, NLRC4 inﬂammasome activation
by Salmonella typhimurium infection was not affected by high
extracellular KCl concentrations (Fig. 4B, Supporting Information
Fig. 4A and B). In conclusion, our data demonstrate that caspase-
11 activation by LPS transfection leads to a drop of intracellular
K+ levels, which is dispensable for the induction of cell death,
but required for NLRP3 activation, thus highlighting two separate
pathways downstream of cytosolic LPS.
Discussion
The exact cellular events involved in the activation of the NLRP3
inﬂammasome are still poorly understood [1]. Lysosomal dam-
age, K+ efﬂux, ROS, and mitochondrial DNA have been brought
forward, but if and how these events are causally connected is
unclear. The ﬁndings that caspase-11-mediated cytokine produc-
tion requires the NLRP3 inﬂammasome has led to speculations
that yet another, noncanonical NLRP3 inﬂammasome exists. The
data presented here argue that the noncanonical inﬂammasome
pathway does not involve a noncanonical NLRP3 inﬂammasome
associated with or containing caspase-11, but that rather caspase-
11 is upstream of NLRP3 activation. Of note, our data demon-
strate that this pathway does not involve a released factor, but
proceeds cell autonomously, thus excluding the possibility that
NLRP3 senses caspase-11-induced pyroptosis in neighboring cells.
Interestingly, we could show that the key event during caspase-11-
triggered NLRP3 activation is K+ efﬂux, while the involvement of
mitochondrial ROS production could not be deﬁnitely determined
due to off-target effects of ROS scavengers. In agreement with pre-
vious ﬁndings by Munoz-Planillo et al. [7], we show that K+ efﬂux
induced by K+-freemedium is sufﬁcient to induce NLRP3 assembly
and activation. It remains, however, unclear how active caspase-
11 promotes a drop in intracellular K+ levels—that is, what target
proteins need to be cleaved by caspase-11 to trigger K+ efﬂux or
if caspase-11 permeabilizes the membrane directly. Notably, our
results indicate that during cytosolic LPS delivery, active caspase-
11 leads to massive membrane permeabilization in a majority of
cells, which can be measured by PI inﬂux and which could at the
same time lead to loss of K+ from the cell. Yet it could not be
directly assessed if these cells also activate NLRP3 before lyzing
completely. Given the large number of these cells in the total pop-
ulation, it however seems probable that although these cells have
become PIpositive, they are still proﬁcient in activating the NLRP3
inﬂammasome upon membrane permeabilization and loss of K+.
Interestingly, this it would indicate that “cell death” as measured
bymembrane permeabilization does not exclude cellular processes
such as NLRP3 activation from happening. Further work such live-
cell imaging of LPS-transfected cells and additional studies aimed
at identifying caspase-11 target proteins might therefore not only
broaden our understanding of how caspases induce lytic cell death
and what happens to cells after pyroptosis, but also identify pro-
teins involved in regulating K+ levels or membrane permeability.
Materials and methods
Mice
Casp1−/−Casp11−/− (caspase-1-KO), Asc−/−, Casp11−/−, and
Nlrp3−/− mice have been described [6, 12]. Mice were bred in
the animal facility of the University of Basel. All animal exper-
iments were approved (license 2535, Kantonales Veterina¨ramt
Basel-Stadt) and were performed according to local guidelines
(Tierschutz-Verordnung, Basel-Stadt) and the Swiss animal pro-
tection law (Tierschutz-Gesetz).
Cell culture and stimulation
BMDMs were differentiated and cultured as previously described
in [2]. Cells were seeded in assay medium (DMEM, 10% FCS, 10%
3T3 conditioned MCSF medium, 10 mM HEPES, 1x NEAA) 1 day
prior to stimulation at a density of 2.5 × 104 cells per well in 96-
well plates. Cells were primed for 4 h with 1 μg/mL Pam3CSK4 in
Opti-MEM. LPS/FuGeneHD complexes were prepared by mixing
100 μL Opti-MEM with 2 μg of ultrapure LPS O111:B4 (Invivo-
gen) and 0.5 μL of FugeneHD (Promega) per well to be trans-
fected. The transfection mixture was vortexed brieﬂy, incubated
for 15 min at room temperature and added dropwise to the cells.
For osmoprotection experiments treatment, glycine was added to
a ﬁnal concentration of 50 mM at 1 h post transfection. Controls
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were treated with an equal volume of PBS. For nigericin stimu-
lation and S. typhimurium infection, cells were primed for 16 h
with Pam3CSK4 (1 μg/mL) and stimulated with 20 μM nigericin
or infected with log-phase S. typhimurium (MOI 25) as described
previously [2] in Opti-MEM for 1 h.
Cytokine and LDH release measurement
IL-1β was measured by ELISA (eBioscience). LDH was measured
using LDH Cytotoxicity Detection Kit (Clontech). To normalize for
spontaneous lysis, the percentage of LDH release was calculated
as follows: (LDH infected – LDH uninfected)/(LDH total lysis –
LDH uninfected) × 100.
PI inﬂux measurement
Following stimulation/infection of BMDMs, 10× PI was added
to 3.9 μM ﬁnal concentration and the plate was incubated for
15 min at 37°C 5% CO2. A total of 100% lysis controls were
obtained by addition of Saponin (0.04% ﬁnal concentration).
Plates was transferred on ice until measurement on a synergy
H1 plate reader (biotek, Ex 485/Em 580, bottom read).
CFSE labeling and coculture
BMDMs were harvested and labeled with 5 μM CFSE (Abcam)
in PBS for 12 min at room temperature in the dark. CFSE was
quenched by addition of assay medium. Cells were pelleted,
counted, and mixed with unlabeled cells at the indicated ratios
before stimulation.
ASC speck immunoﬂuorescence
BMDMs were plated at 1.5 × 105 cells per well in 24-well plates
on sterile glass coverslips and treated as outlined in the ﬁgure leg-
end. Coverslips were stained and mounted as done previously [2]
using rat-anti-ASC antibodies (1:1000, Genentech) and Alexa-568
conjugated anti-rat-antibodies (1:500, goat anti-rat Alexa 568,
Life Technologies, A11077). Slides were analyzed on a LSM700-
Upright confocal microscope. Images were analyzed with Image-J;
ASC specks and cells per ﬁeld of view were counted manually. Per
experiment four images (at least 100 cells per condition) from two
coverslips were quantiﬁed.
ASC oligomerization
BMDMs were seeded 1.1 × 106 cells per well in 6-well plates
and grown for at least 48 h. Afterward stimulation, puriﬁcation,
and cross-linking of ASC pyroptosomes were done as described
elsewhere [7]
Western blotting
Immunoblots were done according to standard protocols. Pri-
mary antibodies were as follows: rabbit-anti-caspase-1 p10 (SCBT
sc-514, 1:1000), rabbit-anti-HMGB-1 (Genetex, GTX-101277,
1:3000), goat-anti-IL-1β (R&D AF-401-NA, 1:2000), rabbit-anti-
alpha-tubulin (abcam ab-4074-100, 1:1000), mouse-anti-NLRP3
(Enzo Life Sciences ALX-804-880-C100, 1:3000), anti ASC (Adi-
pogen AG-25B-0006, 1:1000), anti-GAPDH (SCBT SC-365062,
1:500). Secondary antibodies were as follows: goat-anti-rabbit-
HRP (Invitrogen G21234), rabbit-anti-mouse-HRP (Invitrogen
816720), rabbit-anti-goat (Invitrogen 811620).
MitoSOX staining
BMDMs were seeded at 0.25 × 106 cells per well in 24-well plates
and allowed to adhere overnight. After stimulation, cells were
washed once with warm PBS and stained with 300 μL of assay
medium containing MitoSOX reagent (5 μM) for 15 minutes at
37°C, 5% CO2. After labeling, the plate was transferred on ice,
cells were washed with ice-cold PBS, and stained using the near-
infrared L/D marker (1:1000) in PBS for 20 min on ice in the
dark. Cells were washed twice, detached with a cells scraper, and
transferred to FACS tubes in 300 μL PBS containing 2% FCS and 1
mM EDTA. L/D negative cells were analyzed for MitoSOX staining
on a BD Canto II Flow Cytometer. At least 3000 live cells were
acquired.
Stimulation for treatment with inhibitors
For treatment with NAC and MitoTEMPO, cells were primed
overnight with Pam3CSK4 and preincubated with the inhibitor
in twice the ﬁnal concentration in 100 μL (PI/LDH/ELISA) or
200 μL (MitoSOX) of Opti-MEM for 30 min, prior to stimulation,
if not indicated differently in the ﬁgure legends. Stimuli were
added in 100 and 200 μL to yield a ﬁnal concentration of 1×
inhibitor and 1× stimulus, respectively.
Incubation in K+-free medium
Cells were primed with 300 ng/mL LPS O55:B5 for 3 h and sub-
sequently washed three times with Buffer A (4.2 mM Na2CO3,
0.8mMNa2HPO4, 1.3mMCaCl2, 0.5mMMgCl2, 10mMD-glucose
monohydrate, pH 7.4) supplemented with 137 mM NaCl and
5 mM choline chloride. Nonstimulated controls were washed with
Buffer A supplemented with 137 mM and 5 mM KCl. Cells were
incubated for indicated times in respective buffers and inﬂamma-
some activation was determined as described above or K+ concen-
trations were determined as described below.
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Stimulation in high-K+ medium
Prior to stimulation, cells were washed once with Buffer A (see
above) supplemented with 137 mM NaCl and 5 mM KCl. Buffer A
with 2× ion concentrations was added to respective wells—that is,
supplemented with 274 mM NaCl and 10 mM KCl, 259 mM NaCl
and 25 mM KCl, 234 mM NaCl and 50 mM KCl, 184 mM NaCl and
100 mM KCl. The stimulus was added in an equal volume of plain
Buffer A to yield a ﬁnal 1× concentration of respective ions and
stimuli.
Intracellular K+ measurements
Intracellular K+ measurements were performed essentially as
described [19]. BMDMs were seeded at a density of 0.2 × 106
per well of a 24-well plate and stimulated as described in the
respective ﬁgure legend. After stimulation at 37°C 5% CO2, the
medium was removed until 270 μL were left and 30 μL of 10×
staining solution (100 μM PBFI-AM, 25 mM Probenecid, 0.4% v/v
Pluronic-123) was added per well and the plate was incubated for
45 min at room temperature in the dark. The plate was transferred
on ice and washed once with ice-cold PBS, cells were stained with
1× PI (3.9 μM ﬁnal) for 5 min on ice and lifted with a cell scraper
and transferred to 5 mL FACS tube (BD) in 0.5 mL PBS, 2% FCS,
1 mM Probenecid. Cells were analyzed for PBFI ﬂuorescence on a
Fortessa Flow Cytometer (BD).
Statistical analysis
Statistical data analysis was done using Prism 5.0a (GraphPad
Software). To evaluate the differences between two groups the
Student’s t-test was used.
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GSDMD membrane pore formation constitutes the
mechanism of pyroptotic cell death
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Abstract
Pyroptosis is a lytic type of cell death that is initiated by inflamma-
tory caspases. These caspases are activated within multi-protein
inflammasome complexes that assemble in response to pathogens
and endogenous danger signals. Pyroptotic cell death has been
proposed to proceed via the formation of a plasma membrane
pore, but the underlying molecular mechanism has remained
unclear. Recently, gasdermin D (GSDMD), a member of the ill-
characterized gasdermin protein family, was identified as a caspase
substrate and an essential mediator of pyroptosis. GSDMD is thus a
candidate for pyroptotic pore formation. Here, we characterize
GSDMD function in live cells and in vitro. We show that the N-
terminal fragment of caspase-1-cleaved GSDMD rapidly targets the
membrane fraction of macrophages and that it induces the forma-
tion of a plasma membrane pore. In vitro, the N-terminal fragment
of caspase-1-cleaved recombinant GSDMD tightly binds liposomes
and forms large permeability pores. Visualization of liposome-
inserted GSDMD at nanometer resolution by cryo-electron and
atomic force microscopy shows circular pores with variable ring
diameters around 20 nm. Overall, these data demonstrate that
GSDMD is the direct and final executor of pyroptotic cell death.
Keywords atomic force microscopy; cell death; gasdermin; inflammasomes;
inflammation; pyroptosis
Subject Categories Autophagy & Cell Death; Immunology
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Introduction
Inflammatory caspases (caspase-1, human caspase-4, human
caspase-5, and murine caspase-11) are a group of cysteine-
dependent aspartate-directed proteases that is essential for host
innate immune defense. Caspase-1 is activated within large multi-
protein complexes termed inflammasomes, which are assembled by
the protein pyrin or members of the NOD-like receptor (NLR) and
PYHIN protein families (Latz et al, 2013; von Moltke et al, 2013).
These proteins act as cytosolic pattern-recognition receptors (PRRs)
and detect a variety of pathogen-associated molecular patterns
(PAMPs) or endogenous danger signals (DAMPs). In contrast, the
bacterial cell wall component lipopolysaccharide (LPS), one of the
strongest immune-system activators, leads to the assembly of “non-
canonical” inflammasomes through activation of caspase-4,
caspase-5 or caspase-11 (Kayagaki et al, 2011, 2013; Hagar et al,
2013; Shi et al, 2014).
The downstream signaling pathways that follow the activation of
inflammatory caspases and how the active caspases initiate these
events are still poorly understood (Lamkanfi, 2011). Initial work has
identified the pro-inflammatory cytokine interleukin (IL)-1b as a key
substrate of caspase-1 (Thornberry et al, 1992). Subsequently, it
was found that caspase-1, as well as caspase-11 and its human
orthologs caspase-4 and caspase-5, induces a novel programmed cell
death pathway that is characterized by cell swelling, lysis, and the
release of cytoplasmic content (Fink & Cookson, 2007; Kayagaki
et al, 2011; Shi et al, 2014), presumably as a result of the formation
of membrane pores (Fink et al, 2008). Since this type of cell death is
morphologically distinct from apoptosis and intrinsically pro-
inflammatory, it was named pyroptosis, from the Greek pyro (fire or
fever) and ptosis (to fall) (Bergsbaken et al, 2009). The physiologi-
cal function of pyroptosis is thought to be the prevention of intra-
cellular pathogen replication and to re-expose pathogens to
extracellular killing mechanisms (Miao et al, 2010).
Several landmark studies have recently identified GSDMD (gas-
dermin D), a member of the gasdermin protein family, as an essen-
tial mediator of pyroptosis in human and murine cells (He et al,
2015; Kayagaki et al, 2015; Shi et al, 2015). GSDMD is required for
pyroptosis induction after canonical and non-canonical inflamma-
some activation and is processed by caspase-1, caspase-11, caspase-4,
and caspase-5, but not by apoptotic caspases. The N-terminal frag-
ment of GSDMD (GSDMDNterm) was found sufficient to induce cell
death with the morphological features of pyroptosis (Kayagaki et al,
2015; Shi et al, 2015), and overexpression of the C-terminal domain
GSDMDCterm was found to block GSDMDNterm-dependent cell death
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(Shi et al, 2015). These results gave rise to the hypothesis that
caspase-dependent cleavage releases the N-terminal domain from an
inhibitory interaction with the C-terminus, allowing GSDMDNterm to
induce cell death by a yet undefined mechanism. Since pyroptosis
had long been speculated to involve the formation of a plasma
membrane pore, immediate destruction of the electrochemical gradi-
ent, and subsequent osmotic lysis of the host cell (Lamkanfi, 2011),
it is likely that GSDMDNterm either promotes the formation of this
pore or itself has pore-forming activity (Broz, 2015). Here, we inves-
tigate the functional role of GSDMDNterm in live cells and in vitro.
We demonstrate that after cleavage by caspase-1, GSDMDNterm
targets cellular membranes and that it induces the formation of a
large permeability pore in the plasma membrane. In vitro experi-
ments with purified recombinant GSDMD show that GSDMDNterm
forms large pores in liposomes. We visualize these with cryo-
electron and atomic force microscopy. Overall, these results close
the gaps in the pyroptotic signaling pathway by providing the proof
that GSDMD is the final and direct executor of pyroptotic cell death.
Results
The N-terminal GSDMD fragment induces the formation of a
large plasma membrane pore
Pyroptotic cell death involves the formation of a plasma membrane
pore, cell swelling, and rupture of the plasma membrane. To investi-
gate whether GSDMD, a recently identified mediator of pyroptosis,
mediates pore formation directly, we developed a doxycycline-
inducible system to express the N-terminal fragment (GSDMDNterm)
of mouse GSDMD in HEK293T cells. Doxycycline treatment caused
cell death in HEK293T cells harboring the GSDMDNterm-expressing
plasmid, but not in cells harboring a vector control, in a concentra-
tion-dependent manner (Fig 1A). To characterize whether
GSDMDNterm expression induced a lytic type of cell death, character-
istic for pyroptosis, we next measured the amount of LDH (lactate
dehydrogenase) release after doxycycline-induced expression of the
GSDMDNterm (Fig 1B). Increasing levels of GSDMDNterm expression
resulted in increased levels of LDH release, indicating that ectopic
expression of the GSDMDNterm induced death through cell lysis.
Microscopy analysis showed that GSDMDNterm-induced death had the
morphological features of pyroptosis, that is, cell swelling and nuclear
condensation. To estimate the size of the GSDMDNterm-induced
plasma membrane pore, we next employed an osmoprotection assay
based on the addition of polyethylene glycols (PEGs) of increasing
molecular weight. Addition of these high-molecular polymers can
prevent water influx through pores and the resulting swelling and
osmotic lysis, if the molecular diameter of the agent is larger than
the diameter of the pore (Appendix Fig S1A). We induced
GSDMDNterm expression by doxycycline addition in HEK293T cells
in the presence of PEGs and measured LDH release as a readout for
osmotic lysis and propidium iodide (PI) staining as a measure of
plasma membrane pore formation (Fig 1C and D). Only the largest
sized agent, PEG3000, was able to reduce LDH release partially,
while smaller PEGs did not reduce cell lysis. Importantly, PEG3000
did not prevent PI influx, indicating that it does not block the pore
directly, but functions as an osmoprotectant. PEGs in the range of
600–3,000 Da did not induce significant levels of cell death when
added to cells (Appendix Fig S1B), but larger PEGs could not be
used, since they proved to be cytotoxic.
Infection of primary murine bone marrow-derived macrophages
(BMDMs) with Salmonella enterica serovar Typhimurium
(S. typhimurium) activates the NLRC4 inflammasome (Mariathasan
et al, 2004) and results in caspase-1- and GSDMD-dependent pyrop-
tosis and cytokine release (Appendix Fig S1C and D). To estimate
the size of the GSDMD-dependent plasma membrane pore in
BMDMs, we measured cell lysis as a function of time in the presence
of PEGs of increasing size (Fig 1E and F). Consistent with the
osmoprotection experiment done in HEK293T cells, we observed
that only PEG3000 had a small protective effect, while all smaller
PEGs did not prevent pyroptosis. PI influx was not affected by any
of the osmoprotectants. IL-1b release was also partially affected by
PEG treatment (Appendix Fig S1E); consistent with the observation
that pyroptosis is required for efficient release of the mature
cytokine in BMDMs (Shi et al, 2015). Overall, these experiments
suggest that GSDMD-dependent pyroptosis involves the formation
of a plasma membrane pore with an inner diameter of over 3.5 nm,
the estimated molecular size of PEG3000 (Scherrer & Gerhardt,
1971).
The N-terminal GSDMD fragment targets cellular membranes
GSDMDNterm might itself form a pore in the plasma membrane or
alternatively initiate other events that result in pore formation
(Broz, 2015). To define the fate of GSDMDNterm after caspase-1-
dependent cleavage of GSDMD, we followed caspase-1 activation,
GSDMD processing, and cell death over time in immortalized
wild-type macrophages infected with S. typhimurium (Fig 2A,
Appendix Fig S2A). The processed caspase-1 p20 fragment, an indi-
cator of caspase-1 activation, appeared within 20 min after infection
in the supernatant of macrophages. GSDMD processing correlated
with caspase-1 activation and was detectable in the cell lysate as
well as in the cell supernatant. LDH release was also detectable at
the same time points (Fig 1F and Appendix Fig S1C). Based on
these data, we decided to determine the subcellular localization of
full-length GSDMD and GSDMDNterm in either uninfected cells or in
cells infected with S. typhimurium for 10 and 20 min. Cells were
harvested at each of these time points and subjected to subcellular
fractionation as outlined (Fig 2B). GSDMD full length was exclu-
sively found in the cytosolic fraction (S150) in uninfected cells
(Fig 2C and Appendix Fig S2B), in line with the notion that it is a
soluble, cytosolic protein. After infection, full-length GSDMD, but
very little GSDMDNterm was detected in the S150 fraction. Instead,
the majority of GSDMDNterm was found in the P150 fraction and in
the P10 fraction, correlating with the presence of the plasma
membrane marker Na+K+ ATPase. The Na+K+ ATPase was also
strongly present in the P10, presumably since it is secreted via the
ER/Golgi pathway. The mitochondrial marker VDAC, a porin of
the outer mitochondrial membrane, did not correlate with the
GSDMDNterm and was mainly found in the P0.7 and P10 fractions,
but not in the P150 fraction. Overall, these results suggest that the
GSDMDNterm targets membranes after caspase-1-mediated cleavage.
To characterize the interaction, we isolated plasma membrane frac-
tions of BMDMs after S. typhimurium infection and subjected them
to different treatments (Fig 2D). Conditions known to release
membrane-associated proteins or destabilize protein–protein
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interactions (Gatfield & Pieters, 2000), such as high salt (1 M NaCl)
and sodium carbonate (pH 11) did not solubilize GSDMDNterm.
Extraction of the plasma membrane with 0.02% digitonin, a
cholesterol-sequestering detergent, did not solubilize GSDMDNterm
either. Only the disruption of the membrane with low concentra-
tions of the detergent SDS (0.1%) was able to fully solubilize
GSDMDNterm. Consistently, extraction of BMDMs membranes with
1% Triton was also able to partly solubilize GSDMDNterm
A B
C D
E F
Figure 1. GSDMDNterm induces the formation of a large plasma membrane pore.
A Cell viability as assessed by GFP expression in HEK293T cells transfected with the pRetroX TetOne3G-eGFP plasmid only (vector) or pRetroX TetOne3G-eGFP
harboring the N-terminal fragment of GSDMD. Cells were treated with the indicated concentrations of doxycycline 24 h post-transfection, and the percentage of
GFP-positive cells was determined 16 h later by flow cytometry.
B LDH release from HEK293T cells transfected with the pRetroX TetOne3G-eGFP plasmid only (vector) or pRetroX TetOne3G-eGFP harboring the N-terminal fragment
of GSDMD. At 24 h post-transfection, cells were treated with the indicated concentrations of doxycycline for 8 h and the percentage of LDH release was
determined. Graphs show mean and s.d. of quadruplicate wells.
C, D PI staining of and LDH release from HEK293T cells transfected with pRetroX TetOne3G-eGFP harboring the N-terminal fragment of GSDMD in the presence of
osmoprotectants. At 24 h post-transfection, PEGs of the indicated molecular weights were added to a final concentration of 30 mM, cells were treated with
250 ng ml1 doxycycline for 8 h, and the level of PI staining (C) or LDH release (D) was determined.
E, F PI staining of and LDH release from LPS-primed primary BMDMs infected with log-phase S. typhimurium for the indicated time points in the presence of PEGs of
the indicated molecular weight (numbers on the x-axis, 30 mM final concentration).
Data information: Graphs show mean and s.d. of quadruplicate wells (B–F) or the mean and s.d. of duplicate wells (A). *P < 0.05 as determined by Student’s t-test. Data
are representative of at least three independent experiments.
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(Appendix Fig S2C). Thus, GSDMDNterm integrates into cellular
membranes in a cholesterol-independent manner, and this integra-
tion is associated with formation of a pore and cell lysis.
The N-terminal fragment of GSDMD associates to
liposomes in vitro
These findings encouraged us to attempt the reconstitution of a
possible pore-forming function of GSDMDNterm in vitro. We estab-
lished recombinant expression for full-length human GSDMD in
E. coli BL21(DE3) expression cells. The protein expressed well with
yields of 1.5 mg l1 cell culture. Notably, following the same proto-
col, GSDMDNterm did not express in E. coli BL21(DE3) cells to
detectable levels by SDS–PAGE, in agreement with the hypothesis
that the protein might have a toxic effect on the host cells. Full-
length GSDMD was isolated and purified to homogeneity
(Appendix Fig S3A). It elutes as a monodisperse, homogeneous
elution peak from size exclusion chromatography, at the position of
the expected monomeric species. Thermal denaturation showed a
melting point of 43°C, indicating that the protein is folded and can
be thermally denatured. Upon incubation with different human
caspases, we confirmed that recombinant GSDMD is cleaved by
caspase-1, but not by the apoptotic caspase-3 or caspase-8 (Shi et al,
2015). Recombinant GSDMD is thus a functional substrate of its
native enzyme. Then, we characterized the time dependence of
GSDMD cleavage (Fig 3A). About 5 nM of caspase-1 cleaves more
than 50% of 2 lM of GSDMD in 40 min. GSDMD cleavage by
caspase-1 results in a 30-kDa N-terminal (GSDMDNterm) and a
22-kDa C-terminal (GSDMDCterm) fragment. In aqueous solution in
the absence of a lipidic phase, GSDMDNterm is not soluble and forms
aggregates, as demonstrated in a cross-linking experiment (Fig 3B).
After cleavage, the N-terminus is highly cross-linked by DSS (disuc-
cinimidyl suberate), while the 22-kDa GSDMDCterm remains soluble.
To determine whether the poorly soluble GSDMDNterm associates
with lipids, GSDMD was incubated in the presence or absence of
active caspase-1 with unilamellar liposomes made of either 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC) or from E. coli
polar lipid extract. Ultracentrifugation allowed for separation of the
A C
B D
Figure 2. GSDMDNterm localizes to cellular membranes after inflammasome activation.
A Immunoblot analysis of cleaved GSDMD in culture supernatants and full-length GSDMD, cleaved GSDMD and a-tubulin in the cell lysates of immortalized LPS-
primed WT macrophages left uninfected (NS) or infected for 10–40 min with log-phase S. typhimurium (MOI = 50).
B Schematic representation of the subcellular fractionation shown in (C).
C Fractionation and immunoblot analysis for GSDMD, Na+K+ ATPase, VDAC (voltage-dependent anion channel), HDAC1 (histone deacetylase 1), and GAPDH
(glycerinaldehyd-3-phosphate dehydrogenase) of WT macrophages infected for 10 and 20 min with log-phase S. typhimurium (MOI = 50). Fractionation was carried
out as described in the Materials and Methods section, and equivalent amount of protein was loaded per lane.
D Extraction of cleaved GSDMD from isolated membranes of WT macrophages infected for 10 min with log-phase S. typhimurium (MOI = 50). Extraction was carried in
variable conditions as described in the Materials and Methods section.
Source data are available online for this figure.
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liposomes from the soluble fraction. Whereas full-length GSDMD
did not associate with either the DMPC or the E. coli polar extract
liposomes, the GSDMDNterm fully associated with either of the two
membrane mimetics. GSDMDCterm did not associate with the lipo-
somes (Fig 3C). Therefore, the soluble GSDMDCterm domain is
acting in full-length GSDMD not only as an inhibitor of GSDMDNterm
but also as a solubility tag for the intrinsically insoluble and lipo-
philic GSDMDNterm, preventing it from aggregation and membrane
association. Once cleaved, GSDMDNterm associates strongly to
available membranes. DMPC liposomes are made from a chemically
pure compound, showing that membrane association by
GSDMDNterm does not require any specific receptors in the
membrane.
The N-terminal fragment of GSDMD forms pores in liposomes
Next, we asked whether liposome-associated GSDMDNterm forms
transmembrane pores. Liposomes filled with a self-quenching
concentration of the fluorophore 6-carboxyfluorescein were incubated
with recombinant full-length GSDMD in the presence or absence of
active caspase-1 (Fig 4). Release of the fluorophore from the lipo-
some interior results in a strong reduction in the concentration-
dependent self-quenching effect and consequently in an increase of
the overall fluorescence signal, as demonstrated by chemical
rupture of the liposomes with the detergent Triton X in a control
experiment (Appendix Fig S5). Neither caspase-1 nor full-length
GSDMD alone was able to release dye from the liposomes, but in
the presence of both GSDMD and caspase-1, dye release was
observed, indicating the formation of permeability pores with open
diameters of at least the molecular size of 6-carboxyfluorescein
(1 nm). The dye release reaction from liposomes includes at least
three kinetic steps: the first step is the proteolytic cleavage of
GSDMD by caspase-1, the second step is the membrane associa-
tion, and the third step is pore formation of GSDMDNterm. Whereas
the first step follows classical Michaelis–Menten kinetics, the reac-
tion mechanisms of the second and third steps may include addi-
tional oligomerization steps with non-trivial concentration
dependence. In an attempt to visualize the concentration depen-
dence of the overall reaction, we measured the kinetics of dye
release as a function of GSDMD concentration at a constant
caspase-1 concentration of 5 nM (Fig 4A). At a GSDMD concentra-
tion of 520 nM, the dye release is very efficient so that in 20 min,
already more than 90% of the total fluorescence signal is observed.
With decreasing GSDMD concentration, the overall reaction rate
decreases, but the overall dye release nonetheless reaches 100%,
showing that sufficient GSDMD is available to permeate all lipo-
somes. This conclusion breaks down at a GSDMD concentration of
65 nM, where only about 50% of the liposomes are permeated at
late time points.
We then measured the kinetics of dye release as a function of the
caspase-1 concentration in the range 1.2–15 nM, while keeping the
GSDMD concentration constant at 130 nM (Fig 4B). In this experi-
ment, by decreasing the concentration of caspase-1, we expect a
reduction of the availability of cleaved GSDMDNterm by the initial
protease cleavage step, and consequently, we observe a deceleration
of the dye release reaction. The total amount of GSDMD is always
sufficient to permeate all liposomes in the setup, and consequently,
we observe 100% dye release levels in all measurements.
A B C
Figure 3. GSDMDNterm targets liposomes after caspase-1 cleavage.
A Human GSDMD at a concentration of 2 lM was incubated at room temperature with 5 nM caspase-1. The protein was cleaved in a time-dependent manner into two
bands of 31 kDa (GSDMDNterm) and 22 kDa (GSDMDCterm).
B Cross-linking experiment of full-length and cleaved GSDMD. GSDMD at a concentration of 2 lM was incubated at room temperature with 5 nM caspase-1. After
enzymatic cleavage, GSDMDNterm is highly cross-linked by DSS, resulting in the gel-impenetrating species highlighted by the arrow. GSDMDCterm is not cross-linked.
C GSDMD at a concentration of 1 lM was incubated at room temperature with 5 nM caspase-1 and liposomes composed of 4 mM DMPC or polar lipid extract derived
from E. coli. After 2 h, the lipid fraction (L) was separated from the supernatant (S) by ultracentrifugation at 4°C for 1 h at 120,000 g.
Source data are available online for this figure.
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Importantly, GSDMD did not only permeate liposomes made of
bacterial lipid extract (Fig 4A and B), but similarly also liposomes
from a eukaryotic source (Fig 4C). In a next experiment, we
examined the functionality of the I105N mutant of GSDMD. This
mutant had played a key role in the discovery of GSDMD, since it
had previously been identified as a loss-of-function mutant in mouse
models (Kayagaki et al, 2015). We generated the analogous
mutation I104N in GSDMD and expressed and purified the mutant
protein with the same biochemical protocols as the wild-type
protein. GSDMDI104N is cleaved by caspase-1 with kinetics
A B C
D E F
G H I
Figure 4. GSDMDNterm causes liposome permeability by pore formation.
A–I Dye release time courses from liposomes as a percentage of maximal release. (A) Five different reactions, where 5 nM caspase-1 and 400 lM 6-carboxyfluorescein-
loaded liposomes prepared with E. coli polar lipids were incubated with GSDMD concentrations of (nM): 520, 260, 130, 100, 65 (colored dark to light orange). The
time point of 20 min is highlighted by a vertical dashed line. (B) Five different reactions, where 130 nM of GSDMD and 400 lM 6-carboxyfluorescein-loaded
liposomes prepared with E. coli extract polar lipid, were incubated with caspase-1 concentration of (nM): 15, 8, 5, 2.5, 1.2 (colored dark to light blue). The time point
of 20 min is highlighted by a vertical dashed line. (C) Three different reactions, where 5 nM caspase-1 and 400 lM 6-carboxyfluorescein-loaded liposomes prepared
with porcine brain total lipid extract, were incubated with GSDMD concentrations of (nM): 520, 260, 100 (colored dark to light green). (D) Dye release at 20-min
reaction as a function of GSDMD (dark orange) and caspase-1 (dark blue) concentrations. Error bars for three independent experiments are shown. (E) Two different
sets of reactions, where wild-type GSDMD (dark to light orange) and the mutant GSDMDI104N (dark to light blue) were independently incubated at the
concentrations of 260, 130, and 65 nM with 5 nM caspase-1 and 400 lM 6-carboxyfluorescein-loaded liposomes. The time point of 60 min is highlighted by a
vertical dashed line. (F) Dye release at 60 min of reaction as a function of GSDMD wild-type (dark orange) and GSDMDI104N (dark blue) concentration. Error bars for
three independent experiments are shown. (G–I) Dye release from 400 lM liposomes loaded with the 6-carboxyfluorescein derivates FD-20, FD-40, and FD-150,
with variable Stokes diameters, as indicated. 130 nM of GSDMD and 5 nM caspase-1 were incubated with the liposomes. For each experiment, a representative
from three independent experiments is shown. The corresponding raw data are shown in Appendix Figure S5.
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indistinguishable from wild-type GSDMD (Appendix Fig S4A and
B). In the dye release assay, at high protein concentrations,
GSDMDI104N is able to form functional pores with only minor
differences to the wild-type protein. At reduced proteins concentra-
tions, however, it showed reduced activity compared to the
wild-type protein (Fig 4E and F). Consistent with these data and
previously published work (Kayagaki et al, 2015), we found that
GSDMDI104N could also induce cell death of HEK293T cells when
expressed by a doxycycline-inducible promoter, although signifi-
cantly less than the WT protein (Appendix Fig S4D). Similarly,
expression of the I104N mutant of human GSDMD in immortalized
Gsdmd-deficient mouse macrophages partially restored pyroptosis
after Salmonella infection when compared to wild-type human
GSDMD (Appendix Fig S4C). The quantitative differences observed
here may well translate into an effective loss-of-function effect in
whole animals, and our experiments thus confirm the functional
deficiency of the mouse I105N mutant. As an additional control
experiment, we verified that uncleaved GSDMD full length does not
form pores in liposomes (Appendix Fig S5E and F). Next, we
addressed the size of the GSDMD pore in liposomes by using
carbohydrate-conjugated fluorophores as markers. These fluo-
rophores have differently long carbohydrate chains attached, resulting
in different overall Stokes radii. We selected three different fluo-
rophores with Stokes radii of 33, 45, and 85 A˚, but all of them were
still released by the GSDMD pore (Fig 4G–I). This suggests that the
pyroptosis pore formed by GSDMDNterm can reach diameters of at
least 15 nm, in full agreement with the cellular experiments.
Visualization of GSDMD pores
We employed two methods to resolve pores of GSDMDNterm in lipo-
somes at nanometer resolution. Cryo-electron micrographs of
untreated liposomes show intact spherical shapes (Appendix
Fig S6A). Also the incubation with full-length GSDMD in the
absence of caspase-1 did not result in visual distortions of the lipo-
somes (Appendix Fig S6B). However, upon addition of caspase-1
and subsequent incubation, large ruptures of the liposome structure
were observed. In these preparations, the liposome surface features
numerous large rings of dense material with inner diameters of
20 nm (Fig 5A–D and Appendix Fig S6C–E). These rings are
formed by GSDMDNterm and although the liposomes appear
completely covered by the assemblies, from the available contrast of
the micrographs, it remains inconclusive, whether these rings are
lipid-filled protrusions or actual transmembrane pores. The lack of
contrast also did not allow for a clear identification of the different
shapes of GSDMD oligomers. To characterize the assembly of the
transmembrane pores convincingly, we thus imaged GSDMD oligo-
mers and pore formation on liposomes by atomic force microscopy
(AFM). In an initial control experiment, we adsorbed either GSDMD
alone, or caspase-1 alone, or GSDMD and caspase-1 together to
freshly cleaved mica, which we used as sample support in our AFM
studies (Appendix Fig S7A–D). GSDMD and caspase-1 readily
adsorbed to the negatively charged hydrophilic mica surface as
monomers or small oligomers, but did not assemble into arcs or
rings. After this, we incubated liposomes composed of E. coli polar
lipids with GSDMD and caspase-1 for 90 min at 37°C and adsorbed
the sample onto freshly cleaved mica. The AFM topographs
recorded in buffer solution showed that upon adsorption to mica,
the liposomes opened as single-layered membrane patches
(Appendix Fig S7E). At higher resolution, the topographs showed
GSDMD bound to the lipid membranes and forming arc-, slit- and
ring-shaped oligomers (Fig 6A–E and Appendix Fig S7F). The height
profile around the arc-, slit- and ring-like oligomers indicates that
they protruded 4.3  0.3 nm (average  s.d.; n = 218) from the
lipid surface and that each of them could form pores through
the lipid membrane (Fig 6F and G). Occasionally, arcs and slits
combined into ring-shaped structures, which were not yet perfectly
circular and only partially associated with the formation of
membrane pores. Several pore-forming toxins (PFTs) have shown
the ability to bind to lipid membranes as oligomers forming arcs or
slits that can dynamically rearrange on the membrane surface to
form larger pores (Leung et al, 2014; Sonnen et al, 2014; Mulvihill
et al, 2015; Podobnik et al, 2015). In agreement with this observa-
tion, GSDMD arcs and slits were found that presumably fused into
perfect ring-shaped GSDMDNterm oligomers of variable diameters,
with an average value of 21 nm (Fig 6F–H). These AFM topographs
thus clearly show a structural variability of the GSDMDNterm
assembly, which is, however, determined to eventually lead to the
assembly of ring-like structures. These ring-like structures corre-
spond to the pyroptotic membrane pores.
A B C D
Figure 5. Visualization of GSDMDNterm pores in liposomes by cryo-electron microscopy.
A–C Cryo-electron micrographs of GSDMDNterm pores in E. coli polar lipid liposomes. The micrographs were acquired at protein/lipid molar ratios of 1/1,000, 1/500, and
1/100, respectively. Black arrows indicate ring-shaped structures corresponding to oligomeric GSDMDNterm pore forms. Scale bars = 80 nm.
D Proteoliposome with protein/lipid molar ratio of 1/100 at higher magnification. Black arrows indicate ring-shaped structures corresponding to oligomeric
GSDMDNterm pore forms. Scale bar = 80 nm.
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Discussion
Pyroptotic death is a defining feature of canonical and non-
canonical inflammasome engagement and the final step associated
with the activation of human and mouse caspase-1, but also mouse
caspase-11 and human caspase-4/-5. Although the morphological
features of pyroptotic cell death indicated the formation of a plasma
membrane pore and subsequent lysis of the cell (Lamkanfi, 2011),
the molecules involved in pyroptosis induction had remained
elusive. The recent identification of GSDMD as an essential mediator
of pyroptosis significantly expanded our understanding of pyroptotic
cell death (He et al, 2015; Kayagaki et al, 2015; Shi et al, 2015), but
A
F G H
B C
D E
Figure 6. Characterization of GSDMDNterm pores by atomic force microscopy.
A AFM topograph of GSDMDNterm bound to lipid membranes of E. coli polar lipids. Overview topograph showing arc-, slit-, and ring-like GSDMD oligomers. Scale bar
corresponds to 100 nm.
B–E High-resolution AFM topographs and height profiles of GSDMDNterm oligomers (red curves). Height profiles were measured along the red lines in the topographs.
Dashed zero lines (0 nm) indicate the surface of the lipid membrane; heights of < 4 nm indicate that the oligomers formed transmembrane pores. Topographs
were taken in buffer solution (150 NaCl, 20 mM Hepes, pH 7.8) at room temperature. The experiment was reproduced at least three times using independent
liposome and GSDMD preparations. Scale bars of topographs correspond to 50 nm and of height profiles 10 nm. The full color range of the AFM topographs
corresponds to a vertical scale (height) of 20 nm.
F–H Analysis of GSDMDNterm oligomers bound to lipid membranes of E. coli polar lipids. (F) GSDMDNterm oligomers assembled into arcs, slits, and rings leading to
transmembrane (TM) pores or not transmembrane aggregate (n = 218). (G) Height of GSDMDNterm oligomers protruding from the lipid membrane. Bars represent
mean, and error bars represent s.e.m. (n = 218). (H) Distribution of the diameters of rings formed by GSDMDNterm oligomers. The average distribution was
21.2  5.6 nm (n = 164; average  s.d.), and the bin size was 3 nm.
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whether after cleavage by caspases GSDMD executes pyroptosis
directly, or by initiating other signaling events remained unclear. In
this work, we have shown that the N-terminal fragment of GSDMD,
GSDMDNterm, can form pores with average diameters of 21 nm in
artificial liposomes, as well as large pores in the plasma membrane
of cells (Figs 5 and 6). GSDMD oligomers were found to form
pre-pore states consisting of arcs, slits, and rings. Each of these
oligomeric states had a certain probability to also show a pore state,
among which the GSDMD rings with their variable diameter
formed the largest transmembrane pores. The variable pore size
suggests that GSDMD possesses an intrinsic high structural vari-
ability and that GSDMD arcs and slits represent intermediates that
presumably may fuse toward the ring-shaped structures, similar to
observations for several other pore-forming toxins (PFTs) that
dynamically rearrange on the membrane surface (Leung et al,
2014; Sonnen et al, 2014; Mulvihill et al, 2015; Podobnik et al,
2015). Importantly, our in vitro assays show that the formation of
the GSDMD pore does not require other proteins as co-factors or
membrane receptors, demonstrating that GSDMDNterm is the sole
and final executor of pyroptotic cell death (Fig 7). While this
manuscript was in revision, other reports have been published that
confirm our findings that the N-terminal fragment of GSDMD
causes pyroptosis through the formation of a plasma membrane
pore and that demonstrate that the N-terminal domains of other
gasdermin family members share this pore-forming activity
(Aglietti et al, 2016; Ding et al, 2016).
The placement and function of GSDMD in the canonical and
non-canonical inflammasome pathway strongly resembles the
placement and function of Bax (Bcl-2-associated X protein) in the
apoptotic cell death pathways (Youle & Strasser, 2008). Bax is the
final executor of apoptosis and forms a large pore in the mitochon-
drial outer membrane. Interestingly, whereas both proteins form
large permeability pores in their respective target membranes, their
mechanism of activation is entirely different. Whereas GSDMD is
activated by proteolytic cleavage, Bax is activated by interactions
within the Bcl-2 family of proteins (Gavathiotis et al, 2008; Czabotar
et al, 2013). A strong difference can also be expected for the atomic
structure of the two proteins. Bax features a bundle of nine a-helices
(Suzuki et al, 2000), thereby burying the two presumed pore-forming
helices in its central core. The prediction of secondary structure
elements shows that GSDMDNterm consists mainly of b-strand
secondary structure, whereas the soluble GSDMDCterm consists of
a-helical secondary structure (Appendix Fig S8). Thus, while Bax
resembles the bacterial pore-forming colicins, structural studies of the
membrane-inserted form of GSDMD will be of highest interest.
Another functionally related pathway is necroptotic cell death,
which is for instance initiated by TNF (tumor necrosis factor)-a or
the engagement of Toll-like receptor (TLRs) in absence of caspase-8
activity (Pasparakis & Vandenabeele, 2015). Necroptosis involves
the formation of the necrosome, a complex consisting of RIP (recep-
tor serine–threonine–protein kinase)1, RIP3 and MLKL (mixed
lineage kinase domain-like) and similarly to pyroptosis it is charac-
terized by cell lysis (Pasparakis & Vandenabeele, 2015). Recent
work has demonstrated that recruitment of MLKL to RIP3 and MLKL
phosphorylation results in the conformational change that leads to
the exposure of its four-helix bundle domain (FHBD) and oligomer-
ization of MLKL (Murphy et al, 2013). Binding of the FHBD to
negatively charged phosphatidylinositol phosphates has been
proposed to recruit MLKL to the plasma membrane allowing it to
directly permeabilize the membrane by forming a pore (Dondelinger
et al, 2014; Su et al, 2014; Wang et al, 2014). Alternatively, it has
been also proposed that plasma membrane-bound MLKL recruits Ca2+
or Na+ ion channels to permeabilize the membrane (Cai et al, 2014;
Chen et al, 2014). Thus, although the steps leading up to necroptosis
are markedly different from pyroptosis, the execution of both types of
lytic cell death involves the formation of plasma membrane pores.
The fact that GSDMD targets membranes after cleavage by
caspases and forms permeability pores also sheds some light on the
function of the regulatory C-terminal domain. Cleavage of GSDMD
by inflammatory caspases results in the release of the GSDMD
C-terminal fragment (Kayagaki et al, 2015; Shi et al, 2015), but
overexpression of GSDMDCterm, which was found to bind
GSDMDNterm, results in the inhibition of cell death (Shi et al, 2015).
This gave rise to a model in which cleavage releases an intramolecu-
lar autoinhibition exerted by GSDMDCterm on the GSDMDNterm, thus
preventing GSDMDNterm to unleash its cytotoxic activity. Interest-
ingly, we have observed that GSDMDCterm is a soluble protein, while
GSDMDNterm is insoluble and aggregates, when GSDMD is cleaved
in the absence of a target membrane (Fig 3). This result supports a
slightly different model in which GSDMDCterm does not only act as
an inhibitory domain, but simultaneously also as a solubility tag for
the N-terminal domain, maybe by shielding certain hydrophobic or
amphipathic segments required for membrane insertion. Based on
these functions, the alternative names pore-forming domain (PFD)
and solubilizing inhibitory domain (SID) appear well suited for the
GSDMDNterm and GSDMDCterm, respectively.
Figure 7. Model for GSDMD-mediated pyroptotic cell death.
Canonical inflammasomes act as sensors for a variety of pathogens and cellular
insults. Assembly of these types of inflammasomes involves multimerization of
the receptor (purple), which initiates filament formation of the adaptor protein
ASC (green). ASC filaments act as activation platforms for caspase-1 (blue). In the
noncanonical pathway, LPS is directly bound by caspase-11 (yellow), resulting in
its activation. Caspase-1 processes interleukin IL-1b (red). Both caspase-1 and
caspase-11 process GSDMD (orange), which results in release of the GSDMDNterm
fragment. GSDMDNterm forms a large pore in the plasma membrane. Pore
formation results in rapid loss of membrane integrity, the dissipation of the
electrochemical gradient, and ultimately in cell death.
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The identification of GSDMD as an essential mediator of pyropto-
sis has shed light on the possible functions of other gasdermin
family members in programmed cell death. All gasdermins
(GSDMA, GSDMB, GSDMC, and GSDMD in humans; GSDMA1-3,
GSDMC1-4, and GSDMD in mice) are composed of a distinct
N-terminal and C-terminal domain (Tanaka et al, 2013), a feature
shared by the extended gasdermin family members DFNA5 and
DFNB59 (deafness, autosomal-dominant 5/autosomal-recessive 59).
Several lines of evidence suggest that the N-terminal domain of
other gasdermin family members is intrinsically cytotoxic (Saeki
et al, 2007; Op de Beeck et al, 2011; Shi et al, 2015). Given the func-
tional and sequence similarity between gasdermin N-terminal
domains, it is not surprising that all gasdermins induce membrane
permeability pores and subsequent cell death (Ding et al, 2016).
Structural studies of GSDMD and other gasdermin family members
in their full-length and membrane inserted forms as well as the
stoichiometry of these pores will thus remain of high interest.
Furthermore, it remains to be shown whether several gasdermins
might cooperate in pore formation, given that caspase-1-dependent
cell death does not solely rely on GSDMD (Kayagaki et al, 2015).
Finally, to fully understand this emerging group of cell death effec-
tors, it will be necessary to define how other gasdermin family
members are activated and to identify the physiological context in
which they induce cell death.
Materials and Methods
Cell culture and reagents
HEK293T were maintained in DMEM (Sigma), 10% FCS (Amimed),
1% penicillin/streptomycin (Amimed) and split, when they reached
90% confluency. Immortalized macrophages were obtained from R.
Vance (UC Berkeley) and cultured in DMEM, 10% FCS, 1%
PenStrep, 10 mM HEPES (Amimed), 1% non-essential amino acids
(NEAA, Amimed). Polyethylenimine was from Polysciences Inc,
LDH detection kit from Takara, IL-1b ELISA from eBiosciences, near
IR live/dead marker from Thermo Scientific, propidium iodide from
Santa Cruz Biotechnology, PEGs of different sizes from Merck.
pRetroX TetONE3G-Puro was obtained from Clontech. The puro-
mycin resistance cassette was replaced by an EGFP by standard
cloning procedures yielding pRetroX TetONE-eGFP. GSDMDNterm
was amplified from murine cDNA and cloned into pRetroX
TetONE-eGFP by standard cloning procedures. Anti-GSDMD and
anti-GAPDH antibodies were from SCBT (both used at 1:250), anti-
caspase-1 p20 from Adipogen (used at 1:4,000), anti-alpha tubulin
from Abcam (used at 1:2,500), anti-VDAC, anti-HDAC1, and anti-
Na+/K+ ATPase antibodies were from Cell Signaling Technologies
(all at 1:1,000). HEK293T cells were seeded in 96-well plates (30,000
cells per well) 1 day prior to transfection. Cells were subsequently
transfected with 300 ng of plasmid DNA and 3× (wt/vol) linear PEI
(polyethylenimine). Twenty-four post-transfection cells were treated
as indicated in the respective figures.
Generation of stable cell lines
For complementation of GsdmdKO cell lines (Dick et al, 2016),
human Gsdmd was amplified from HeLa cell cDNA (Clontech) and
cloned into pLJM1 (addgene #19319) where the puromycin resis-
tance cassette was replaced with a hygromycin resistance cassette.
The I104N mutant was generated using the Q5 site-directed mutage-
nesis kit (NEB). To produce lentiviral particles, 1 × 106 HEK239T
cells were transfected with the 2 lg lentiviral plasmid, 2 lg psPax2,
and 0.4 lg VSV-G for 6 hrs. Medium was exchanged, and lentiviral
particles were collected 24 h later. Gsdmd-deficient immortalized
macrophages were spin-infected with these particles, and trans-
duced cells were selected with Hygromycin (500 lg/ml, invivogen)
for 7 days. Selected cells were used for experiments.
Macrophage infection
Immortalized macrophages were seeded the day before the experi-
ment (30,000 cells per well of a 96-well plate, 1.5 × 106 cells per
well of a 6-well plate). S. typhimurium (SL1344) was grown
overnight in Luria broth (LB) medium. On the day of experiment,
bacteria were subcultured 1:40 in LB and grown for 4 h to logarith-
mic phase to induce SPI-1 expression. Cells were washed once with
PBS and infected at an MOI of 50 with S. typhimurium diluted in
OptiMEM. LDH and IL-1b release was determined as described in
the respective manufacturer’s instructions. Cell lysates and super-
natants were prepared for Western blot and analyzed by SDS–PAGE
as described previously (Broz et al, 2012).
Subcellular fractionation and membrane extraction
About 1.5 × 107 million immortalized macrophages were seeded in
10-cm tissue culture-treated dishes the day before the experiment.
The next day, cells were left either uninfected or infected with log-
phase S. Typhimurium at a MOI of 50 for 10 and 20 min at 37°C. Cells
were washed three times with homogenization buffer (10 mM Tris,
10 mM acetic acid, 1 mM EDTA, 7.5 mM MgCl2, 250 mM sucrose),
scraped, and homogenized using a syringe equipped with a 25G
needle (30 strokes) (Total lysate). Samples were centrifuged for
700 g for 5 min; supernatants were transferred to a new tube and
centrifuged the same way again. Combined pellets yielded the P0.7
fraction, while the remaining supernatant yielded the S0.7 fraction.
Pellets were washed twice with homogenization buffer and lysed in
RIPA buffer. Supernatants (S0.7) were centrifuged 10,000 g for
15 min; supernatant was transferred to new tube and centrifuged the
same way again. Pellets (P10) were combined, washed twice with
homogenization buffer, and resuspended in SOL buffer (50 mM
Tris–HCl pH 6.8, 1 mM EDTA, 1% Triton X-100). Supernatants (S10)
were centrifuged at 150,000 g for 30 min; supernatant was trans-
ferred to a new tube and centrifuged the same way again. Pellets
were combined, washed again twice, and resuspended in SOL buffer
(P150). The supernatants were analyzed as S150. Protein concentra-
tion of every sample was determined by BCA, and equal amounts
were analyzed by SDS–PAGE. For extraction of membrane fractions,
cells were infected for 15 min with log-phase S. typhimurium,
homogenized as described above, and membrane preparation and
extraction were performed as described in Gatfield and Pieters (2000).
Cloning, expression, and purification of GSDMD and caspases
cDNA coding for the full-length human GSDMD was cloned with an
N-terminal His6-SUMO-tag into a pET28a vector under control of a
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T7 promoter. Single amino acid point mutation I104N was generated
by QuickChange site-directed mutagenesis kit (Stratagene). All plas-
mids were verified by DNA sequencing. The protein construct was
transformed in BL21 (DE3) E. coli strains, and the protein was
expressed by growing the cultures at 37°C to an OD600 of 0.7 and by
inducing with 0.5 mM IPTG overnight at 18°C. The cells were
harvested by centrifugation and the pellet was resuspended in
20 mM Tris buffer pH 7.5, 50 mM NaCl, 5 mM imidazole, 20 mM
MgCl2, 10 mM KCl, 0.5 mM TCEP, 0.1 mM protease inhibitor, and
DNase I. The resuspended cells were disrupted by high-pressure
microfluidization and centrifuged at 30,000 g at 4°C for 45 min.
The supernatant was incubated for 2 h at room temperature with
pre-equilibrated Ni-NTA affinity resin (Thermo Scientific) and then
passed through a column for gravity flow purification. The column
was washed with 20 column volumes of resuspension buffer
containing 15 mM imidazole, and the fusion protein was eluted
with 3 column volumes of the same buffer with 250 mM imidazole.
SUMO-tag cleavage was achieved by addition of ULP1 protease to
the solution and subsequent dialysis overnight at 4°C against 20 mM
Tris buffer pH 7.5, 50 mM NaCl, 0.5 mM TCEP. GSDMD was eluted
from a second round of purification through pre-equilibrated
Ni-NTA affinity resin. The protein was further purified by Hi-trapQ
ion-exchange and a Superdex 75 gel filtration column (GE Health-
care) pre-equilibrated with 20 mM Tris buffer pH 7.5, 50 mM NaCl,
0.5 mM TCEP. Purified GSDMD was frozen in small aliquots in
liquid N2. Human caspase-1, caspase-3, and caspase-8 were cloned
into pET22 expression vectors, expressed as inclusion bodies in
E. coli, and refolded as previously described (Ramage et al, 1995).
Briefly, inclusion bodies were solubilized in 8M urea, and protein
was refolded by rapid dilution; during which the enzymes auto-
activated. A gel filtration column was run to purify the final product,
and the concentration of active enzyme determined by active site
titration.
Liposome preparation
The polar lipid extract derived from E. coli, total lipid extract
derived from porcine brain, and DMPC were purchased from Avanti
Polar Lipids, Inc. (Alabaster AL, USA). Chloroform lipid solutions at
a concentration of 25 mg ml1 were gently dried in a glass tube into
a thin film under nitrogen flow and placed under vacuum overnight
to further evaporate any residual solvent. The lipid layers were that
rehydrated in 1 ml of 50 mM HEPES buffer, 150 mM NaCl, pH 7.5
under continuous shaking at 50°C for 2 h. The lipid dispersions
were subjected to 10 freeze–thaw cycles, and the resultant lipo-
somes were extruded 20 times through 100-nm polycarbonate
membranes to form large unilamellar vesicles (LUV). The mean
size diameter of the liposomes was verified by dynamic light scatter-
ing (DLS). To prepare dye-filled LUVs, the dry lipid film was
hydrated with 0.5 ml of 50 mM HEPES buffer, 50 mM NaCl,
70 mM 6-carboxyfluorescein, 5 mM TCEP, pH 7.5) or by adding
100 mg ml1 of fluorescein isothiocyanate dextran FD-20, FD-40,
and FD-150. For the 6-carboxyfluorescein containing liposome, the
removal of extra-vesicular dye was achieved by a purification step
through a PD-10 column (GE Healthcare) pre-equilibrated with
50 mM HEPES buffer, 150 mM NaCl, 5 mM TCEP pH 7.5. The
FD-20, FD-40, and FD-150 dye-filled liposomes were washed twice by
ultracentrifugation at 4°C for 20 min at 100,000 g and then
resuspended in 0.5 ml of the same isotonic solution. All liposomes
were stored at 4°C and used within 24 h.
Liposome leakage assay
Membrane leakage experiments were performed using 6-carboxy-
fluorescein, FD-20, FD-40, and FD-150-filled liposomes composed of
polar lipid extract derived from E. coli and total lipid extract derived
from porcine brain. The samples were initially prepared by diluting
40 mM total lipid concentration in 100 ll solution of 50 mM HEPES
buffer, 150 mM NaCl, 5 mM TCEP, pH 7.5 supplemented with dif-
ferent aliquots of a 2.6 lM GSDMD stock solution. The NaCl
concentration in the reaction buffer outside the LUV was optimized
to preserve caspase-1 activity and to minimize the dye release due
to the osmotic pressure exerted by the dye on the membrane
bilayer. To initiate the cleavage of GSDMD and the consequent pore
formation reaction, different amounts of caspase-1 from a 12 lM
stock solution were added to 100 ll of premixed LUV–GSDMD solu-
tion. The membrane leakage was detected by measuring the time-
course increase in fluorescence resulting from the dye dilution and
subsequent dequenching upon membrane pore formation. The
experiments were carried out in a Corning 384-well non-binding
surface plate, and the fluorescence was continuously recorded for
2 h at 10-s intervals using a Biotek Synergy 2 plate reader with
excitation and emission wavelengths at 492 and 520 nm,
respectively. At each time point, the percentage of dye release was
calculated as:
Dye release ¼ ðI  I0Þ=ðImax  I0Þ
where I is the emission intensity of the sample, I0 is the emission
intensity from an experiment with the liposome solution only (neg-
ative control), and Imax is the emission intensity from an experiment
with added Triton X-100 to the liposome solution (positive control).
Gel-shift assays
Recombinant GSDMD was incubated with different caspases for the
indicated time period in a reaction vessel in caspase activity buffer
of 100 mM Hepes, pH 7.4, 0.5 mM EDTA, 50 mM NaCl, 0.1%
CHAPS, 0.005% Novexin, and 5 mM TCEP. Final concentrations
were 5 nM enzyme, 2 lM GSDMD. Reactions were quenched with
6xSDS loading buffer and analyzed by SDS–PAGE. For cross-linking
experiments, 2 mM DSS (ThermoFisher) were added to the reaction,
and protein was cross-linked for 30 min before quenching the
reaction.
Thermofluor assay
To monitor GSDMD thermal stability, the protein was incubated
with the fluorescent dye Sypro orange and the thermal shift assay
was conducted in the CFX96 Real Time Detection System (Bio-
Rad, Hercules, CA). Solutions of 2 ll of 2 lM GSDMD, 8 ll of
5× Sypro orange, 10 ll solution of screened condition were loaded
to a 96-well plate. The plate was heated from 10 to 90°C with a
heating rate of 0.5°C min1. The fluorescence intensity was
measured with excitation and emission wave lengths of 490 and
530 nm, respectively.
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Cryo-electron microscopy (cryo-EM)
Cryo-EM was used to visualize GSDMD-mediated pore on liposome
surfaces. The samples were prepared by 2-h incubation of freshly
prepared liposome (2 mM lipids) with 2.6 lM of GSDMD in the pres-
ence and the absence of catalytic amounts of caspase-1. All samples
were adsorbed for 10 s on glow-discharged thin carbon film-coated
300-mesh lacey EM grids, blotted for 2 s, and plunge frozen in
liquid ethane using a FEI Vitrobot MK4 (Vitrobot, Maastricht Instru-
ments). Cryo-EM micrographs were acquired with a Philips
CM200FEG transmission electron microscope operated at 200 kV
and a nominal magnification of 66,000×. Images were recorded with
a TVIPS F416 CMOS camera.
Liposome Preparation for atomic force microscopy (AFM)
Unilamellar liposomes were prepared at room temperature (23°C)
by hydration of lipid films and extrusion through polycarbonate
filters with 0.1-lm pore diameter (Nucleopore Polycarbonate,
Whatman) according to the method described by Avanti Polar
Lipids (www.avantilipids.com). The E. coli polar lipids and the
extruding equipment used for liposome preparation were purchased
from Avanti Polar Lipids. The liposomes were stored at 80°C in
buffer solution (150 mM NaCl, 20 mM Hepes, pH 7.25). After incu-
bation with 1 lM mM GSDMD and 0.2 lM caspase-1 for 90 min at
37°C in buffer solution (50 mM NaCl, 100 mM Hepes, 5 mM TCEP,
pH 7.4), the liposomes were adsorbed onto freshly cleaved mica in
buffer solution (50 mM NaCl, 20 mM Hepes, pH 7.4) (Muller et al,
1997). After an adsorption time of 30 min, the sample was washed
several times with the AFM imaging buffer (150 mM NaCl, 20 mM
Hepes, pH 7.8) to remove weakly adsorbed protein. Buffer solutions
were freshly made using nanopure water (18.2 MΩ cm1) and pro-
analysis (> 98.5%) purity grade reagents from Sigma-Aldrich and
Merck. Each experimental condition characterized by AFM was
reproduced at least three times. Liposomes made from E. coli polar
lipids incubated in buffer solution but in the absence of GSDMD
showed no arc-, slit- or ring-like structures when imaged by AFM
(Mulvihill et al, 2015).
AFM
Force–distance curve-based AFM (FD-based AFM) (Dufrene et al,
2013) was performed using a Nanoscope Multimode 8 (Bruker,
Santa Barbara, USA) operated in the PeakForce Tapping mode. The
AFM was equipped with a 120-lm piezoelectric scanner and fluid
cell. AFM cantilevers used (BioLever mini BL-AC40, Olympus
Corporation, Tokyo, Japan) had a nominal spring constant of
0.1 N m1, a resonance frequency of 110 kHz in liquid and sharp-
ened silicon tip with a nominal radius of 8–10 nm. The FD-based
AFM topographs were recorded in AFM imaging buffer (150 mM
NaCl, 20 mM Hepes, pH 7.8) and at room temperature as described
(Pfreundschuh et al, 2014). The maximum force applied to image
the samples was 70 pN, and the oscillation frequency and oscilla-
tion amplitude of the cantilever were set to 2 kHz and 40 nm,
respectively. The AFM was placed inside a home-built temperature
controlled acoustic isolation box. For data analysis, we took unpro-
cessed AFM topographs. Diameters of ring-like GSDMD oligomers
were measured from the highest protruding rim. Heights of GSDMD
arcs, slits, and rings were measured from their highest protruding
feature relative to the surface of the lipid membrane. GSDMD oligo-
mers were classified to having formed transmembrane pores if the
inside of the pore was at least 3.5 nm deeper compared to the
surface of the surrounding lipid membrane.
Expanded View for this article is available online.
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4.3 Research Article III: ESCRT dependent membrane repair negatively regulates 
pyroptosis downstream of GSDMD activation 
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Abstract  
Gasdermin-D is a new pore forming protein that is proteolytic processed and actiavted by 
inflammatory caspases. These caspases, caspase-1/11 in mice and caspase-1/-4/-5 in humans, 
are activated within canonical or non-canonical inflammasomes upon detection of host- or 
pathogen derived danger signals. Gasdermin-D pores target the cellular plasma membrane, 
disrupt the electrochemical gradient and thereby induce a lytic, inflammatory type of cell 
death referred to as pyroptosis, which involves the release of cytosolic content and pro-
inflammatory cytokines like IL-1b and IL-18. Here we find that calcium influx through 
Gasdermin-D pores serves a signal for cells to repair damaged membrane areas and therefore 
delay or even prevent pyroptosis. We show that sensing of intracellular calcium ions is 
necessary for recruitment of the ESCRT-III machinery to the plasma membrane during 
pyroptosis. Inhibition of the ESCRT-III machinery strongly enhances pyroptosis in both 
human and murine cells and it enhances cytokine secretion in response to canonical and non-
canonical inflammasome activators. Our results therefore not only attribute an anti-
inflammatory role to membrane repair by the ESCRT-III system but also provide insight in 
general survival mechanisms during pyroptosis.  
Main text  
Introduction  
Pyroptosis is a necrotic type of cell death initiated by inflammatory caspases (1). These 
caspases are activated within macromolecular signalling complexes known as 
inflammasomes (2). Canonical inflammasomes activate caspase-1 in both human and mouse 
cells and are assembled by cytoplasmic sensors - Pyrin and members of the PYHIN or the 
NLR (NOD-like receptor) family - that detect diverse pathogen- and host-derived danger 
signals. A ‘non-canonical inflammasome’ has been identified as well and shown to be 
assembled by the binding of the bacterial cell-wall component lipopolysaccharide (LPS) to 
caspase-4, -5 in humans or caspase-11 in mice (2). All inflammatory caspases share the 
ability to induce pyroptotic cell death. Caspase-1 however is unique as it can also process the 
pro-forms of interleukin (IL)-1b and IL-18 into their mature, bioactive forms.  
Pyroptosis is characterised by a rounding of the nucleus, membrane blebbing and ballooning, 
cell swelling and ultimately results in cell lysis and the release of cytoplasmic content (3-5). 
Two landmark studies recently identified Gasdermin D (GSDMD), a member of the ill-
characterized gasdermin protein family, as the sole executor of pyroptosis (6, 7). GSDMD is 
a 53 kDa protein that contains distinct N- and C-terminal domains connected by a linker. 
Inflammatory caspases cleave GSDMD at a conserved cleavage site within this linker, thus 
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liberating the N-terminal domain (GSDMDNT) from an inhibitory interaction with the C-
term (GSDMDCT), and allowing the N-terminal part to induce pyroptosis (6, 7). Studies by 
us and others showed that GSDMDNT targets cellular membranes, among them the plasma  
membrane, and that it forms large pores with an internal diameter of 10-16 nm in liposomal 
membranes (8-11). Permeabilization of the plasma membrane by GSDMDNT pores 
dissipates the electrochemical gradient across the membrane (5), leading to the inability to 
maintain osmotic balance and to stabilize cell volume. This ultimately causes uncontrolled 
water influx, swelling and cell lysis. These findings however also raise the question if 
activation of inflammatory caspases always results in cell death or if cells feature 
mechanisms by which they can completely prevent or at least delay cell death. Indeed, 
several groups have reported that caspase-1 activation can result in pyroptosis- independent 
cytokine release, depending on stimulus or cell type (12-15).  
Interestingly, damage of the plasma membrane does not necessarily result in death in all 
cases and muscle fibers for example repair large mechanical injuries in their plasma 
membrane in a Ca2+ dependent manner(16-18). Early studies postulated that this involves the 
fusion of large intracellular membrane patches to the site of injury, yet how these fusion 
events can mechanistically restore a functional lipid bi-layer could not be explained (19, 20). 
Later studies showed that stable trans- membrane pores, as assembled by bacterial pore 
forming toxins (PFTs) like Streptolysin O (SLO), are removed in a Ca2+-dependent manner, 
and proposed two mutually non-exclusive models. One mechanism involves the exocytosis of 
lysosomal acidic sphingomyelinase (ASM) at the site of injury, resulting in plasma 
membrane remodelling and subsequent endocytosis of damaged membrane parts (21). The 
other mechanism involves the shedding of damaged plasma membrane parts in form of 
ectosomes that are formed by the ESCRT machinery(22, 23). Both mechanisms are 
dependent on Ca2+ influx at the site of injury, confirming early observations that membrane 
repair by many cell types is dependent on extracellular calcium(24). ESCRT-mediated 
plasma membrane repair was mainly characterized in response to laser-induced damage, but 
recently Gong et al. demonstrated that the ESCRT machinery prevents premature cell death 
during necroptosis, therefore allowing the cells to produce more pro-inflammatory cytokines 
and signal to neighbouring cells(25).  
In this study, we investigated if pyroptosis is an unavoidable consequence of inflammasome 
activation, or if cells have the ability to delay or prevent pyroptosis. We find that upon non-
canonical inflammasome activation a sub-population of cells resists pyroptosis, and that this 
requires the detection of Ca2+ influx. Furthermore, pyroptosis induction leads to the 
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translocation of the ESCRT machinery to the plasma-membrane in a Ca2+-dependent 
manner, where the ESCRT components partially co- localize with GSDMDNT. Inactivation 
of the ESCRT machinery by expression of dominant-negative proteins resulted in highly 
enhanced pyroptotic cell death and cytokine release in a number of different cell types and in 
response to activators of both the canonical and non-canonical inflammasomes. Titration of 
inflammasome stimuli showed that an active ESCRT machinery was necessary for survival at 
sublytic levels of inflammasome activation. In conclusion, our findings indicate that 
membrane repair by the ESCRT machinery represents a universal mechanism how cells limit 
or even prevent cell death in response to inflammasome activation.  
Results 	
Ca2+ chelation enhances cell death after non-canonical inflammasome activation In 
most cell types the activation of canonical or non-canonical inflammasomes results in 
incomplete lethality. Yet if the surviving cells fail to receive the stimulus or actively avoid 
cell death has not been examined so far. To investigate this question, we transfected primed 
bone marrow-derived macrophages (BMDMs) with LPS and monitored the disruption of the 
electrochemical gradient using the Ca2+ probe Fluo-8 and loss of membrane integrity (e.g. 
lysis) by propidium iodide (PI) staining in real-time. As expected we found that within 120 
minutes post LPS transfection up to 50% of cells displayed strong PI staining (Fig. 1A). 
Single cell analysis showed that PI influx was preceded by a marked increase in Fluo-8 signal 
intensity that peaked immediately before cells lost membrane integrity and became PIhigh 
(Fig. 1B-C, Movie 1). Macrophages from Casp11-/- or Gsdmd-/- mice did not show an 
increase in Fluo-8 levels, nor did they acquire PI staining (Fig. 1C, S1A, Movie 1), 
confirming that the Ca2+ and PI influx was dependent on activation of the non-canonical 
pathway and the pyroptosis executor GSDMD. When examining the 40-50% cells that did 
not exhibiting strong Ca2+ influx (Fluo-8 increase) (Fig. 1A), we unexpectedly found that 
these cells also displayed a gradual increase in intracellular PI staining (Fig. 1D and S1B). 
The intensity of this PI signal was much lower than what could be observed in cells that 
completely lost membrane integrity, and only reached 1/10 of the signal 1.5 hours post LPS 
transfection. This low-level PI influx was however not due to plasma membrane leakage of 
PI into the cells, since it required stimulation by LPS transfection (Fig. 1D) (see Material and 
Methods section for calculation details), and was not observed in LPS transfected Casp11-/- 
or Gsdmd-/- cells (Fig. 1C and S1B). Altogether this analysis indicated that, depending on 
time point and amount of transfected LPS, GSDMDNT-induced pore formation leads to rapid 
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rise in intracellular Ca2+ concentrations in a majority of BMDMs, indicating a loss of the 
electrochemical gradient shorty before complete rupture of the plasma membrane. However, 
these data also show that a sizeable subset of LPS transfected BMDMs can by some means 
restore membrane integrity after GSDMD activation, thus acquiring PI staining gradually 
without apparent loss of the electrochemical gradient.  
Since Ca2+ signalling controls cellular membrane repair mechanisms (16), we hypothesized 
that Ca2+ influx through the GSDMD pore serves indicates membrane permeabilization and 
that this initiates the repair of the affected plasma membrane area. Treatment with BAPTA-
AM, a chelator of intracellular Ca2+ ions, has been widely used to study Ca2+-dependent 
membrane repair (21, 24). BMDMs were therefore pre-loaded with BAPTA-AM and 
transfected with LPS to test how the sensing of intracellular Ca2+ affects the level or speed 
of pyroptosis induction. BAPTA treatment increased the level of Lactate Dehydrogenase (a 
measure of cell death/lysis) release from LPS transfected WT BMDMs in a dose- dependent 
manner (Fig. 1E). Importantly, BAPTA treatment did not result in spontaneous LDH release, 
since LDH levels were not significantly altered in Casp11–/– BMDMs (Fig. 1E), thus 
confirming that the observed increase in cell death was specific to detecting Ca2+ influx. 
Ca2+ chelation robustly increased and accelerated cell death over a range of transfected LPS 
concentrations as shown by titration experiments (Fig. S1C). The most striking effects of 
BAPTA treatment were observed at very low levels  
of LPS transfection, as cells transfected in medium were able to cope with caspase-11 
activation and did not release LDH, while cells unable to detect Ca2+ influx failed to survive 
sub-lytic inflammasome activation and showed significant levels of cell death (Fig. S1C). 
Since Ca2+ chelation could increase the activity of the non-canonical inflammasome pathway 
by either enhancing the levels of LPS transfection, caspase-11 oligomerization or caspase-11 
activity, we assessed the level of GSDMD processing as a proxy for altered levels of non-
canonical inflammasome activation. Immortalized BMDMs expressing HA-tagged mouse 
GSDMD were transfected with different amounts of LPS in the presence or absence of 
BAPTA-AM, and the generation of the N-terminal p30 GSDMD fragment was assayed by 
immunoblotting. BAPTA treatment did not enhance GSDMD processing (Fig. 1F), 
suggesting that Ca2+ chelation did not modulate the assembly of the non-canonical 
inflammasome or caspase-11 activation, but acted downstream of GSDMD activation.  
We next asked if the non-canonical inflammasome in human cells responds similarly to 
chelation of intracellular Ca2+ by examining HeLa cells infected with ΔsifA S. enterica 
serovar Typhimurium (S. typhimurium). Deficiency in the effector SifA results in an instable 
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Salmonella containing vacuole and entry of the bacteria into the cytosol, where LPS is 
detected by caspase-4 (NLRC4 is not present in HeLa cells)(26, 27). We observed a similar 
increase in LDH release upon treatment with BAPTA-AM compared to cells infected in 
medium (Fig. 1G), confirming the data obtained with primary mouse BMDMs. Ca2+ 
chelation did also not increase the levels of GSDMD processing in HeLa cells expressing 
FLAG-tagged human GSDMD (Fig. 1H). Overall, these findings suggested that chelating 
intracellular Ca2+ ions does not affect inflammasome assembly, caspase activation or 
GSDMD processing per se, but specifically enhances the levels of cell lysis, most likely by 
masking the signal (Ca2+ influx) necessary to initiate the repair of GSDMD-damaged plasma 
membrane regions.  
 
ESCRT components translocate to the plasma membrane during pyroptosis  
Ca2+ influx engages membrane repair programs, among them the shedding of damaged 
membrane areas in form of ectosomes that are formed with help of the ESCRT machinery 
(22, 23). To investigate if the ESCRT machinery is activated during upon pyroptosis 
induction, we made use of HeLa cells stably expressing near endogenous levels of CHMP4-
GFP (28). Uninfected cells showed homogenous distribution of CHMP4-GFP in the 
cytoplasm and the nucleus, whereas upon activation of the non- canonical inflammasome by 
ΔsifA S. typhimurium infection, CHMP4-GFP formed multiple distinct puncta at the cell 
periphery, presumably at the plasma membrane (Fig. 2A, arrowheads). Similar puncta could 
also be observed in cells treated with pore forming toxin perforin (Fig. 2A), which has been 
shown to form pores in the plasma membrane (24). Furthermore, expression of GSDMDNT 
was sufficient to induce CHMP4-GFP puncta formation, supporting the notion that CHMP4-
GFP aggregation was triggered by plasma membrane damage (Fig. 2A).  
To confirm that CHMP4-GFP translocated to the plasma membrane upon GSDMD pore 
formation, we used the lipophilic probe FM 4-64FX that exhibits low fluorescence in water 
but fluoresces intensely upon binding the outer leaflet of the plasma membrane. Upon 
induction of GSDMDNT expression  
CHMP4-GFP puncta localized with FM4-64FX stained membrane regions (Fig. 2B), 
confirming that during pyroptosis the ESCRT machinery is activated and localizes to the 
plasma membrane. Live cell microscopy of CHMP4-GFP puncta in cells induced for 
GSDMDNT expression further showed that CHMP4-GFP was dynamic, quickly assembling 
and disassembling at the cell periphery before cells lost membrane integrity (Fig. 2C, Movie 
2). Interestingly, we also observed that in pyroptotic CHMP4-GFP HeLa cells the cytosolic 
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GFP signal was lost while peripheral GFP puncta were retained, suggesting that CHMP4-
GFP complexes remain strongly associated with the plasma membrane after cell death (Fig 
2D).  
The translocation of ESCRTIII components to the plasma membrane in response to laser-
induced damage or MLKL-induced damage requires the detection of Ca2+ influx into the 
cytosol and is effectively blocked by incubation in Ca2+ free medium or chelators like EDTA 
or BAPTA-AM (22, 25). We therefore assessed next if chelation of Ca2+ ions affects the 
number of CHMP4-GFP speckles after pyroptosis induction. HeLa CHMP4-GFP cells stably 
transduced with Dox-inducible GSDMDNT-mCherry, were pre- treated using medium, 
medium supplemented with BAPTA-AM or Ca2+-free medium (containing 2 mM EDTA). 
Cells were then either left untreated (control) or treated with Dox to induce GSDMDNT 
expression and subsequent pyroptosis, before quantifying the number of CHMP4-GFP specks 
by microscopy. Treatment with BAPTA-AM or incubation in Ca2+-free medium did not 
affect CHMP4-GFP localization in control cells, but significantly reduced the percentage of 
cells displaying CHMP4-GFP speckles after GSDMDNT induction (Fig. 2E-F). This finding 
demonstrated that detection of Ca2+ influx in response to GSDMD pore formation is 
necessary for the translocation of CHMP4-GFP and presumably other ESCRTIII components 
to the plasma membrane and suggested that the increase in cell death upon Ca2+ chelation 
(Fig. 1, S1) is linked to an inability to engage ESCRT-mediated membrane repair.  
While clathrin, COPI and COPII coat promote the budding and pinching-off of vesicles 
towards the cytosol, the ESCRT machinery is the only mechanism known so far that allows 
vesicles to bud and pinch-off away from the cytosol (29, 30). This feature is necessary for 
example to form multi-vesicular bodies (MVBs), to release ectosomes or as part of viral 
budding, which incidentally involves the hijacking of the ESCRT machinery by the virus 
(31). In the context of ESCRT-mediated membrane repair these buds are thought to contain 
damaged plasma membrane areas. During necroptosis, which is delayed by ESCRT-mediated 
membrane repair, Annexin-V-positive bubbles appear at the plasma membrane(25), which 
might be ESCRT-induced structures, although their size (up to 500 nm in diameter) is larger 
than what has been reported for viral buds (approx. 100 nm in diameter). Examination of LPS 
transfected iBMDMs by electron microscopy revealed multiple vesicles budding off from the 
plasma membrane towards the extracellular space (Fig. 2G), while no such features could be 
found in untreated cells (Fig. S2B). These vesicles ranged in size between 50 and 100 nm 
often had a distinct neck region, reminiscent of ESCRT-induced HIV buds(31). In 
conclusion, our results showed that during GSDMDNT-induced pyroptosis cells respond by 
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initiating the formation of ectosomes and the recruitment of the ESCRT machinery to the 
plasma membrane, and that ESCRT recruitment requires  
Ca2+ signalling. Thus, they support the notion that ESCRT-mediated membrane repair is 
engaged in response to GSDMD pore formation at the plasma membrane.  
 
Expression of dominant-negative ESCRT-III components enhances pyroptosis  
The ESCRT-III machinery is essential for cellular homeostasis (29, 32), and consequently 
knock-out or prolonged knock-down results in toxicity, for example due to uncontrolled basal 
levels of necroptosis(25). Previous studies have however shown that expression of dominant 
negative ESCRT- III proteins, such as truncated CHMP3 that lacks the regulatory C-terminal 
domain (CHMP31-179) or ATP-binding deficient VPS4a (VPS4aE228Q) leads to 
deregulated activation and impaired recycling of other ESCRT components, therefore 
effectively depleting the cytosolic pool of functional ESCRT components (22). To assess if 
an ESCRT-dependent membrane repair program regulates pyroptosis, we stably transduced 
HeLa cells with Dox-inducible wildtype human ESCRT-III proteins (CHMP3WT or 
VPS4aWT) or the respective dominant-negative versions (CHMP31-179 or VPS4aE228Q) 
(Fig. S3A). To assess the toxicity of these proteins we induced their expression for up to 24 
hours. Immunoblot analysis showed that following Dox treatment WT and dominant-negative 
VPS4a and CHMP3 were expressed to comparable levels at all time points examined (Fig. 
S3B). Expression of VPS4aWT or CHMP3WT did not affect cell viability during the period 
examined, while both VPS4aE228Q or CHMP31-179 induced moderate cell death after 20 
hours (Fig. S3C). This cell death, which is most likely caused by necroptosis (25), was even 
more prominent at 24 hours post induction (Fig. S3C). We therefore restricted the following 
experiments to the early period post induction (i.e. all experiments were terminated not later 
than 15 hours post Dox treatment) during which expression of dominant-negative proteins 
did not lead to increased frequency of dead cells nor changes in cell density or cell 
morphology, compared to cells expressing the WT protein. We next tested if induction of 
dominant-negative ESCRTIII components inactivates the ESCRT machinery. Induction of 
HA-tagged WT and dominant- negative VPS4a for 6 hours showed that while VPS4aWT 
localized evenly throughout the cytoplasm, VPS4aE228Q aggregated inside the cell (Fig. 
3A). A similar pattern was observed with CHMP31-179, but required induction for 12 hours 
(Fig. 3A). These findings were in line with published observations (33, 34), and indicated 
that the dominant-negative proteins arrested the disassembly of the ESCRT machinery and 
thus depleted the cells of active ESCRT components.  
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We then assessed how depletion of active ESCRT components affected pyroptosis after non- 
canonical inflammasome activation in human and mouse cells. Expression of wildtype and 
dominant- negative VPS4a or CHMP3 was induced in the HeLa cells prior to infection with 
ΔsifA S. typhimurium to activate the non-canonical inflammasome. Consistent with an 
important role of the ESCRT machinery in controlling pyroptotic cell death in human cells, 
we observed that cell death was strongly enhanced in cells expressing either VPS4E228Q or 
CHMP31-179 compared to WT controls, independently of the multiplicity of infection (MOI) 
(Fig 3B). Immunoblotting for GSDMD processing demonstrated that inactivation of the 
ESCRT machinery through VPS4E228Q and CHMP31-179 expression did not change 
GSDMD processing even though it strongly enhanced cell death, suggesting that the ESCRT 
mediated  
membrane repair acts downstream of caspase-4 and GSDMD activation (Fig 3C). As cells of 
the myeloid lineage respond to pathogen infection by activation of inflammasome, we tested 
if ESCRT dependent membrane repair has a role during pyroptosis in mouse macrophages by 
generating immortalized BMDMs stably transduced with Dox-inducible human VPS4WT or 
VPS4E228Q. The transgenic iBMDM lines were simultaneously treated for 6 hours with LPS 
to induce caspase-11 expression and doxycycline to induce expression of wildtype or 
dominant-negative VPS4a before transfection of LPS. Consistent with the results obtained in 
HeLa cells, we found that the wildtype protein localized evenly throughout cells, whereas the 
dominant-negative VPS4a clustered in iBMDMs (Fig. S3D). LPS transfection of these lines 
showed that expression of VPS4aE228Q more than doubled the levels of membrane 
permeabilization as judged by PI staining (Fig. 3D-E) as well as LDH release (Fig. 3F) 
compared to iBMDMs expressing VPS4aWT. These increased levels of cell death required 
the activation of the non-canonical inflammasome and GSDMD, as Casp11-/- or Gsdmd-/- 
iBMDMs expressing VPS4aWT or VPS4aE228Q only displayed basal levels of cell death 
when transfected with LPS (Fig. 3G). Immunoblots confirmed equal expression levels of 
VPS4aWT or VPS4aE228Q in all genotypes  
(Fig. 3H). Next, we asked how ESCRT-III-mediated inhibition of cell death impacts on the 
release of mature  
IL-1 cytokines. Since GSDMD pore formation and subsequent efflux of K+ is necessary to 
activate NLRP3 and caspase-1 in the non-canonical pathway (35), ESCRT inactivation could 
enhance cytokine release by enhancing the degree of K+ efflux due to prolonged GSDMD 
pore formation. Alternatively, accelerated cell lysis as a result of ESCRT inactivation could 
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also limit the time available for NLRP3 activation and IL-1b maturation and thus reduce the 
amount of mature cytokine that are released from dying cells. LPS-primed immortalized 
BMDMs expressing VPS4aE228Q or VPS4aWT were thus transfected with LPS and 
supernatants analysed for the release of mature IL-1b by ELISA. Significantly higher levels 
of mature IL-1b were found in the supernatants of VPS4aE228Q expressing BMDMs 
compared to VPS4aWT expressing controls (Fig. 3I), which was entirely dependent on the 
presence of caspase-11 and GSDMD (Fig. 3J). These findings are consistent with a model in 
which enhanced or prolonged GSDMD pore formation triggers increased K+ efflux and thus 
increased NLRP3 inflammasome activation, which was confirmed by the enhanced levels of 
processed, activated caspase-1 that were found in cells expressing VPS4aE228Q (Fig. 3K). 
Furthermore, inhibition of NLRP3 by MCC950 treatment or high extracellular K+ inhibited 
IL-1b release in cells expressing wild-type or dominant-negative VPS4a (Fig. 3L, S3E). 
Immunoblotting revealed, that GSDMD processing was slightly enhanced in cells expressing 
VPS4aE228Q compared to iBMDMs expressing VPS4aWT (Fig. 3M). We postulated that 
this increase of GSDMD processing could be a consequence of enhanced NLRP3 
inflammasome activation (Fig. 3J-L), and thus caspase-1-dependent. Consistent with this 
hypothesis, we found that GSDMD processing was unchanged between VPS4aE228Q and 
VPS4aWT expressing iBMDMs in the presence of MCC950 (Fig. 3M), confirming that in 
the non-canonical pathway ESCRT mediated regulation of pyroptosis is downstream of 
caspase-11 activation and GSDMD processing. Taken together these data show that 
inactivating the ESCRT machinery strongly enhances pyroptotic  
cell death in human and mouse cells following non-canonical inflammasome activation, thus 
suggesting that ESCRT-dependent membrane repair is a conserved mechanism that 
counteracts cell death by reducing plasma membrane damage caused by GSDMD pore 
formation.  
 
ESCRT controls cell death after canonical inflammasome activation  
Given the strong effects of ESCRT inhibition of pyroptosis induced by the non-canonical 
inflammasome, we asked if cell death triggered by the canonical inflammasome pathway, 
which involves the activation of caspase-1 in human and mouse cells, is also negatively 
regulated by ESCRT-mediated membrane repair. We first examined the effect of Ca2+ 
chelation on pyroptosis induction after activation of the AIM2 inflammasome. Mouse 
BMDMs were primed, treated with BAPTA-AM and transfected with different 
concentrations of poly(dA:dT) (synthetic DNA), an AIM2 ligand. As observed for LPS 
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transfection (Fig. 1), intracellular Ca2+ chelation also significantly increased pyroptosis after 
AIM2 inflammasome activation (Fig. 4A). BAPTA treatment did not lead to spontaneous cell 
death, since BMDMs deficient in Asc, a critical adaptor protein of canonical inflammasomes, 
showed only basal levels of pyroptosis. Assessing caspase-1 activation by immunoblotting 
revealed that the generation of the caspase-1 p20 subunit was not enhanced by Ca2+ 
chelation, suggesting that BAPTA treatment did not enhance steps upstream of caspase-1 
activation (Fig. 4B). These experiments (Fig. 4B) were conducted in BMDMs deficient in 
Nlrp3 to exclude effects of secondary NLRP3 activation via GSDMD pore induced 
potassium efflux, and importantly, enhancement of cell death by calcium depletion was 
independent of NLRP3 (Fig S4A). Given the effects of Ca2+ sensing on canonical 
inflammasome activation, we next examined the effects of depleting the ESCRT machinery 
on cell death induction. Immortalized macrophages stably transduced with Dox-inducible 
VPS4aWT or VPS4aE228Q were treated with Dox to induce protein expression, primed and 
infected with different MOIs of log-phase S. typhimurium to activate the canonical NLRC4 
inflammasome (36). Consistent with our previous findings, we observed an enhancement of 
cell death in cells expressing dominant-negative VPS4a despite unaltered levels of ASC 
speck formation or caspase-1 and GSDMD processing (Fig. 4C-D and Fig. S4B). This cell 
death was specific to the activation of the NLRC4 inflammasome, since it was not observed 
in Gsdmd-/- BMDMs (Fig. S4C). Increased cell death as a consequence of ESCRT 
inactivation also led to a slight increase in the release of mature IL-1b (Fig. 4C), suggesting 
that ESCRT-mediated membrane repair negatively regulates the levels of cytokines that are 
released in a GSDMD-dependent manner.  
Although our experiments suggested that ESCRT-mediated membrane repair restricts 
caspase-1- induced cell death, the effects were much smaller compared to non-canonical 
inflammasome activation. A possible explanation could be that oligomerization of the 
receptors and the adaptor ASC, which have been proposed to amplify the signal generated by 
few active receptors (37, 38), produces too much active caspase-1 within a short period of 
time thereby quickly overwhelming membrane repair mechanisms. To investigate this 
possibility, we created HEK293T cells stably transduced with chemically dimerizable 
caspase-1 (DmrB-Casp1 HEK293T). Addition of B/B homodimerizer allows to induce the 
oligomerization of DmrB and thus the activation of caspase-1 in a controlled manner and  
without the need for receptor or adaptor proteins. DmrB-Casp1 HEK293T were co-
transfected with human GSDMD and Dox-inducible constructs for wildtype and dominant-
negative CHMP3/VPS4a proteins, respectively, and protein expression was induced with 
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Dox for 16 hours. Remarkably and unlike to what we had observed in HeLa cells, none of the 
dominant-negative proteins induced changes in cell appearance or induced cell death after 16 
hours of expression in HEK 293T cells, most likely because of absence of a functional 
RIPK3/MLKL signalling axis(39) (Fig. S4D). We next examined the effects of ESCRT 
inactivation on caspase-1-induced pyroptosis by measuring PI influx over a period of 1.5 
hours post B/B homodimerizer addition. PI influx increased faster in cells expressing 
dominant- negative ESCRT proteins compared to cells expressing wild-type ESCRT proteins 
(Fig. S4E), confirming that the ESCRT machinery restricts pyroptosis after caspase-1 
activation. Nevertheless, even cells with an active membrane repair reached high levels of 
cell death after 2.5 hours, indicating that even chemically activated caspase-1 eventually 
overwhelms membrane repair mechanisms.  
Treatment with washout compound allows to quickly disrupt B/B homodimerizer-induced 
DmrB oligomers and might thus allow to terminate DmrB-Casp-1 activity and create a 
limited amount of GSDMD pores. To test this, we activated DmrB-caspase-1 by B/B 
homodimerizer addition for 30 minutes in GSDMD expressing DmrB-Casp-1 HEK293T 
cells, before addition of a 50-fold excess of washout compound. Disruption of caspase-1 
activity by washout compound treatment resulted in a significant reduction of cell death 
levels, while PI levels in cells that were only treated with B/B homodimerizer continued to 
rise (Fig. 4E). While washout compound treatment decreased cell death levels in cells 
expressing VPS4aWT and VPS4aE228Q, it however also strongly enhanced the difference in 
cell death levels between cells expressing VPS4aWT and VPS4aE228Q, indicating that an 
active ESCRT machinery plays a more important role in conditions where caspase-1 is 
activated at low level or for a limited time (compare Fig 4E to Fig. S4E). Titration of the B/B 
homodimerizer followed by washout treatment revealed that across a variety of 
concentrations, disruption of the ESCRT machinery by expression of dominant-negative 
proteins enhanced cell death strongly (Fig 4F, Fig. S4F), while processing of GSDMD by 
caspase-1 was not altered by expression of dominant-negative proteins compared to their 
wildtype counterparts (Fig 4G). Importantly, inhibition of ESCRT activity only enhanced cell 
death in Dmrb-Casp-1 HEK293T cells only when GSDMD was expressed, confirming that 
ESCRT-mediated membrane repair negatively regulates GSDMD-induced pyroptosis (Fig. 
S4G).  
To confirm the impact of ESCRT-mediated membrane repair on cytokine secretion in DmrB-
Casp1 HEK293T cells, we stably transduced these cells with pro-IL-1b (DmrB-Casp1 pro-
IL-1b HEK293T). These cells were then transfected with Dox-inducible GSDMD and 
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dominant-negative CHMP3 and VPS4a respectively. Stimulation of these cells with B/B 
homodimerizer followed by treatment with washout compound resulted in the release of 
mature IL-1b, which was significantly higher in cells expressing CHMP31-179 or 
VPS4aE228Q (Fig 4H and 4I). Enhanced levels of IL-1b release correlated with enhanced 
cell death, consistent with the essential role of GSDMD pores in IL-1b release (Heilig et al. 
unpublished data, (40). Overall these experiments show that ESCRT mediated membrane 
repair not only dampens GSDMD pore mediated cell death but at the same time negatively 
affects IL-1b secretion  
following canonical and non-canonical inflammasome activation, in a variety of cell lines and 
systems.  
Discussion  
Since the 1950 it has been known that various cells feature the ability to rapidly reseal 
damaged plasma membrane areas by mechanisms that strictly depends on the detection of 
Ca2+ influx. How membrane repair is initiated and executed has however only emerged 
recently, and two mutually non-exclusive mechanisms have been identified, relying either on 
lysosome exocytosis of ASM followed by internalization of damaged membrane regions or 
the removal of damaged membrane in form of ectosomes generated by the ESCRT 
machinery. While early reports suggested that such membrane repair is mainly regulating 
plasma membrane damage as a result of PFT or mechanical damage, it has now become 
evident that the ESCRT machinery also regulates host-signalling pathways, for example by 
enhancing survival of cells undergoing necroptosis and therefore increasing the potential to 
signal to neighbouring cells (25).  
We now demonstrate that a Ca2+-dependent membrane repair by the ESCRT system 
negatively regulates GSDMD-induced pyroptosis in human and mouse cells, and in response 
to a variety of activators. We propose that the function of ESCRT in the context of pyroptosis 
is to remove GSDMD pores from the plasma membrane by removing permeabilized areas in 
form of ectosomes. We can however not exclude that another function of the ESCRT 
complex, for example in vesicular trafficking, restricts pyroptosis as well, nor do our findings 
exclude the possibility that other parallel mechanisms restrict pyroptotic cell death. ESCRT 
inhibition enhances IL-1b release after both canonical and non- canonical inflammasome 
activation and allows cell survival at sub-lytic levels of inflammasome stimulation, 
suggesting that membrane repair might be essential to protect the organism against low level 
spontaneous or uncontrolled inflammasome activation that could result in systemic 
inflammation. Unfortunately, due to the essential nature of the ESCRT machinery deletion of 
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ESCRT-III components are lethal, thus making it impossible to investigate the role of 
membrane repair in vivo.  
Our results demonstrate the importance of calcium mediated membrane repair downstream of 
inflammasome assembly, caspase activation and GSDMD processing. It is however well 
established that membrane damage through pore forming toxins is an upstream signal that 
drives NLRP3 inflammasome assembly (41). Thus, it will be interesting to determine if and 
how membrane repair programs regulate NLRP3 activation triggered by pore forming toxins 
or during pathogen infection. recently it has also been demonstrated that disruption of the 
nuclear envelope results in release of DNA into the cytosol and the activation of the AIM2 
inflammasome (42). As the ESCRT machinery mediates resealing of the nuclear envelope 
during upon mechanical stress (43, 44) or during the reformation of the nuclear envelop 
during telophase, it will be interesting to examine if inactivation of ESCRT-III results in 
higher levels of AIM2 activity during these events.  
The release or secretion of mature IL-1b has debated for decades and several mechanisms 
were proposed. release within ectosomes or exosomes has been proposed to be one 
mechanism for how  
IL-1b leaves the cells (45), and indeed several publications have reported that pyroptotic cells 
release microvesicles (46-48), even though the nature and source of these vesicles was 
unknown. Our findings thus provide an explanation why microvesicle shedding can be 
observed during inflammasome activation and implicate the ESCRT machinery in this 
process. It will be interesting to investigate if microvesicles released from pyroptotic cells 
contain mature GSDMD and possibly other factors know to be release during pyroptosis. 
Moreover, the function of these vesicles prior to pyroptosis or for cell to cell communication 
or as means of communication to more distant sites in the host remains to be elucidated.  
Our findings could also have important implications for the mechanism of IL-1b release 
itself. While IL- 1b release has been shown to be GSDMD-dependent in macrophages and 
other cell types (6, 7), we have observed that GSDMD-dependent IL-1b release also happens 
if lysis is blocked (Heilig and Broz, EJI, in press) (40). While it is possible that IL-1b is 
released directly through the GSDMD pore under these circumstances, an alternative 
explanation would be that GSDMD pore formation triggers ESCRT activity that continuously 
releases IL-1b packed in ectosomes. Such a mechanism might also be mediating IL-1b 
release at sublytic levels of inflammasome activation (see Fig. 4) or in several systems that 
have been reported to result in cell death-independent IL-1b release, among these neutrophils 
(13), OxPAPC-treated DCs (12) and NAG-elicited activation of the NLRP3 inflammasome 
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(14). If lL-1b release in these systems requires GSDMD and the ESCRT machinery, and if it 
proceed through microvesicle shedding should be subject of further research.  
Our results provide a conceptual insight into how the different cell types mentioned above 
resist pyroptosis and that regulation of inflammasome signalling is not necessarily dependent 
on expression and activation of components of the inflammasome but on the integration of 
inflammasome pathways with different host signalling pathways. These pathways may confer 
permanent resistance or transient persistence of cells against GSDMD mediated pyroptosis. It 
is important to note that plasma membrane repair in particular does not exclusively rely on 
the ESCRT system but can be mediated by ASM mediated endocytosis of pores. Both 
pathways are not mutually exclusive, however if they are connected yet needs to be 
determined. In addition, it was reported that caspase-1 activity induces the activation Sterol 
Regulatory Element Binding Proteins (SREBPs) (49), which can promote cell survival upon 
toxin challenge possibly by facilitating membrane repair. Therefore, further research is 
necessary to define membrane repair programs, cell type specific differences and if the 
engagement of the different programs changes the fate of cells subjected to inflammasome 
activation.  
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Figure 1. GSDMD-mediated calcium flux negatively regulates pyroptosis 
A. Percentage of LPS-primed wildtype BMDMs displaying high PI levels after transfection 
with the indicated amount of LPS for 2 hours. Three fields of view were analyzed and PIhigh 
cells enumerated manually. B. Live cell imaging of Ca2+ influx (Fluo-8) and membrane 
permeabilization (PI) in LPS-primed wildtype BMDMs after transfection of LPS. Scale bars 
are 5 µm. C. Single cell analysis of Ca2+ (Fluo-8) and PI influx in LPS-primed wildtype and 
Casp11-/- BMDMs either not stimulated or transfected with LPS. Graphs show data from 3 
representative cells out of at least 30 analyzed per condition. D. PI influx in wildtype and 
Casp11-/- BMDMs not undergoing pyroptosis. Graphs show data from 6 representative cells 
out of at least 30 analyzed per condition. E. LDH release from untreated or BAPTA-AM 
treated wildtype and Casp11-/- BMDMs 2 hours after LPS transfection. F. Immunoblots for 
GSDMD processing in combined lysates and supernatants of LPS-primed immortalized 
BMDMs (expressing HA-tagged mGSDMD) after transfection with the indicated amounts of 
LPS in the presence or absence of BAPTA-AM. GAPDH serves as loading control. G. LDH 
release from BAPTA-AM treated HeLa cells (expressing Flag-hGSDMD-V5) 5 hours post 
infection with different multiplicities of infection (MOI) of ∆sifA S. typhimurium. H. 
Immunoblots for GSDMD processing in combined lysates and supernatants of BAPTA-AM 
treated HeLa cells (expressing Flag-hGSDMD-V5) 5 hours post infection with ∆sifA S. 
typhimurium at the indicated MOIs. Statistical analysis was done using unpaired student’s t-
test, * p<0.05, **p<0.01, ***p<0.001. Results shown in A-H are representative of at least 
three independent experiments. Time is shown in hh:mm:ss. 
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Figure 2. The ESCRT machinery translocates to the plasma membrane during 
pyroptosis 
A. Microscopy images of CHMP4-GFP HeLa cells treated with medium only, perforin (200 
µg/ml, 45 minutes) or infected with ∆sifA S. typhimurium (MOI 100, 5 hours), or CHMP4-
GFP HeLa cells stably transduced with Dox-inducible GSDMDNT-mCherry treated with Dox 
(1 µg/ml, 4 hours). Cells were fixed and analyzed by microscopy. B. Microscopy images of 
CHMP4-GFP HeLa cells stably transduced with Dox-inducible GSDMDNT-mCherry 4.5 
hours after Dox treatment. Cells were stained with FM4-64FX, fixed and analyzed by 
confocal microscopy. Inset shows co-localization CHMP4-GFP and FM4-64FX at the plasma 
membrane. C-D. Still images from time lapse movies of pyroptosis in CHMP4-GFP HeLa 
cells stably transduced with Dox-inducible GSDMDNT-mCherry after Dox treatment. White 
arrows show peripheral ESCRT aggregates. Imaging was performed in the presence of PI to 
assess membrane integrity. Time is shown in mm:ss. Scale bars are 5 µm. E-F. Microscopy 
images and quantification of cells showing CHMP4 speckles. CHMP4-GFP HeLa cells stably 
transduced with Dox-inducible GSDMDNT-mCherry were treated with 1 µg/ml Doxycycline 
for 4.5 hours in the presence of medium, 6 µM BAPTA-AM or 2 mM EDTA, fixed and 
analyzed by confocal microscopy. At least 100 cells per condition were analyzed for CHMP4 
speckle formation. G. Electron microscopy of LPS-primed immortalized wildtype BMDMs, 
transfected with LPS for 1.5 hours. Insets show membrane buds emerging from the plasma 
membrane. Scale bar in left image is 1 µm, scale bars in insets corresponds to 100 nm. Result 
shown in A-G are representative of at least three independent experiments 
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Figure 3 The ESCRT system negatively regulates gasdermin-D mediated pyroptosis 
A. Subcellular distribution of wild-type and dominant-negative CHMP3 and VPS4a. HeLa
cells stably transduced with HA-tagged Dox-inducible CHMP3 or VPS4 constructs were
treated with 1 µg ml-1 Dox for 6 hours (VPS4aWT and VPS4aE228Q) or 12 hours (CHMP3WT
and CHMP31-179), fixed and stained for the HA-tag. Scale bar corresponds to 5 µm. B-C.
LDH release (B) and GSDMD processing (C) after infection with varying MOI of ∆sifA S.
typhimurium in HeLa cells stably transduced with HA-tagged Dox-inducible CHMP3 or
VPS4 constructs. Protein expression was induced with 0.5 µg ml-1 Dox for 12 hours.
GSDMD processing was analyzed in combined lysate and supernatant samples by
immunoblotting. D-E. Immortalized wildtype BMDMs stably transduced with indicated Dox-
inducible VPS4a constructs were primed with LPS (250 ng ml-1) and Dox (1 µg ml-1) for 4
and 6 hours and transfected with 5 µg ultrapure LPS /106 cells. PI staining was imaged (D)
and counted (E) at 2 hours post transfection. F and I. LDH and IL-1b release from LPS-
primed immortalized BMDMs stably transduced with indicated Dox-inducible VPS4
constructs after transfection with indicated amounts of LPS. G and J. LDH and IL-1b release
from LPS-primed immortalized wildtype, Casp11-/- or Gsdmd-/- BMDMs expressing the
respective Dox-inducible VPS4a constructs after transfection with LPS for 2 hours. H.
Lysates of wildtype, Casp11-/- or Gsdmd-/- BMDMs from (G) were analyzed for expression
of VPS4a proteins. K. Immunoblots from VPS4a transgenic immortalized macrophages
treated as in D. Actin serves as loading control L. LDH and IL-1b release from LPS-primed
immortalized BMDMs stably transduced with indicated Dox-inducible VPS4a constructs
after transfection with indicated amounts of LPS in medium or medium supplemented with
2.5 µM MCC950. M. Immunoblots of combined lysate and supernatant samples from LPS-
primed immortalized BMDMs stably transduced with indicated Dox-inducible VPS4a
constructs after transfection with indicated amounts of LPS in medium or medium
supplemented with 2.5 µM MCC950. Statistical analysis was done using unpaired student’s t-
test, *p<0.05, **p<0.01, ***p<0.001. Results shown in A-M are representative of at least
three independent experiments.
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Figure 4. ESCRT negatively regulates pyroptosis and cytokines downstream of 
canonical inflammasomes. 
A. LDH release from untreated or BAPTA-AM treated wildtype and Asc-/- BMDMs 2 hours
after poly(dA:dT) transfection (500ng/5x104 cells). B. Immunoblots for pro-caspase-1 and
caspase-1 p20 on combined supernatant and lysates samples of untreated or BAPTA-AM
treated Nlrp3-deficient BMDMs 2 hours after poly(dA:dT) transfection. GAPDH serves as
loading control. C. LDH and IL-1b release from immortalized wild-type BMDMs stably
transduced with indicated Dox-inducible VPS4a constructs after infection with different MOI
of S. typhimurium for 1 hour. D. Immunoblots for caspase-1 and GSDMD on combined
supernatant and lysates samples from immortalized wild-type BMDMs stably transduced
with indicated Dox-inducible VPS4a constructs after infection with different MOI of S.
typhimurium for 1 hour. Actin serves as loading control. E. Time course of PI influx in
DmrB-Casp1 HEK293T cells transfected with FLAG-hGSDMD-V5 and Dox-inducible
VPS4a constructs (1:3). Cells were treated with 1 µg ml-1 doxycycline to induce ESCRT
protein expression. Caspase-1 activation was induced by addition of 25 nM B/B
homodimerizer (B/B HD) followed by addition of washout compound (1.25 µM final
concentration or medium only) at 30 minutes. F. DmrB-Casp1 HEK293T were transfected as
in E, treated with the indicated concentrations of B/B HD for 30 minutes and followed by
washout compound at 50-fold excess. LDH release was analyzed 2 hours post stimulation.
Immunoblots show equal expression levels of CHMP3 proteins. G. Immunoblots for full-
length GSDMD and processed GSDMDCT in combined supernatant and lysates from DmrB-
Casp1 HEK293T cells treated for 60 minutes with 50 nM B/B homodimerizer (F). Actin
serves as loading control. H-I. LDH and IL-1b release from DmrB-Casp1 pro-IL-1b
HEK293T double transgenic cells transfected with FLAG-hGSDMD-V5 and Dox-inducible
ESCRT constructs (1:3). Cells were treated with the indicated concentrations of B/B
homodimerizer for 30 minutes and followed by washout compound at 50-fold excess. LDH
and IL-1b release were measured at 90 minutes post treatment. Statistical significance was
determined using unpaired student’s t-test, * p<0.05, **p<0.01, ***p<0.001. Each result is
representative of at least three independent experiments
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Figure S1 (related to Figure 1) 
A. Single cell analysis of Ca2+ (Fluo-8) and PI influx in LPS-primed wildtype and Gsdmd-/- 
BMDMs left unstimulated or transfected with LPS. Graphs show data from 3 representative 
cells out of at least 30 analyzed per condition. B. PI influx in wildtype and Gsdmd-/- BMDMs 
not undergoing pyroptosis. Graphs show data from 8 representative cells out of at least 30 
analyzed per condition. C. Time course analysis of LDH release from untreated or BAPTA-
AM treated wildtype BMDMs transfected with the indicated amounts of LPS. Results shown 
in A-C are representative of three independent experiments 
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Figure S2 (related to Figure 2) 
A. Electron microscopy of LPS-primed immortalized wildtype BMDMs. Scale bar
corresponds to 3 µm. Result shown are representative of at least three independent
experiments.
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Figure S3 (related to Figure 3) 
A. Schematic outline of pRetroX-Tet-One plasmids used for Dox-induced expression of HA-
tagged wild-type and dominant negative human CHMP3 and VPS4a, used in Figures 3, 4, S3 
and S4. B. Time course of protein expression of HA-tagged CHMP3WT, CHMP31-179, 
VPS4aWT or VPS4aE228Q in HeLa cells with HA-tagged Dox-inducible VPS4 or CHMP3 
constructs after Dox treatment. Immunoblots show anti-HA and anti-actin (loading control). 
C. Cell viability measurement of HeLa stably transduced with Dox-inducible constructs for 
CHMP3WT, CHMP31-179, VPS4aWT or VPS4aE228Q after Dox treatment for up to 25 hours. 
Cells were stained with a live/dead marker and cell death was quantified by flow cytometry 
analysis. D. Subcellular distribution of wild-type and dominant-negative VPS4a. 
Immortalized WT BMDMs stably transduced with HA-tagged Dox-inducible VPS4 
constructs were treated with 1 µg ml-1 Dox for 6 hours, fixed and stained for the HA-tag. 
Scale bar corresponds to 5 µm. E. LDH and IL-1b release from LPS-primed immortalized 
BMDMs stably transduced with indicated Dox-inducible VPS4 constructs after transfection 
with indicated amounts of LPS in medium or medium supplemented with 55 mM KCl. 
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Figure S4 (related to Figure 4) 
A LDH release 2 hours post stimulation of Nlrp3-deficient BMDMs transfected with the 
indicated amounts of poly(dA:dT) per 5x104 cells in medium or in the presence of 3.3 µM 
BAPTA-AM B. VPS4a WT or E228Q expressing iBMDMs were primed with doxycycline 
and LPS for 6 and 4 hours and infected with S. typhimurium (MOI 10) for 1 hour. ASC 
specks were enumerated manually after immunofluorescence C. LDH release from 
immortalized wild-type or Gsdmd-/- BMDMs stably transduced with indicated Dox-inducible 
VPS4 constructs after infection with S. typhimurium (MOI 5) for 1 hour. D. PI levels in 
DmrB-Casp1 HEK293T cells transfected with Dox-inducible ESCRT constructs at 16 hours 
post Dox treatment. E. Time course of PI influx in DmrB-Casp1 HEK293T cells transfected 
with FLAG-hGSDMD-V5 and Dox-inducible ESCRT constructs (1:3). Cells were treated 
with 1 µg/ml doxycycline to induce ESCRT protein expression. Caspase-1 activation was 
induced by addition of 25 nM B/B homodimerizer (B/B HD and washout compound was 
added to a final concentration of 1.25 µM after 30 minutes. PI influx was measured on a 
multiplate reader. F. DrmB-Casp1 HEK293T were transfected as in 4C, treated with the 
indicated concentrations of B/B HD for 30 minutes and followed by washout compound at 
50-fold excess. LDH release was analyzed 1.5 hours post stimulation. Immunoblots show
equal expression levels of VPS4a proteins. G. LDH release from DmrB-Casp1 HEK293T
cells transfected with Luciferase or FLAG-hGSDMD-V5, and Dox-inducible ESCRT
constructs (1:3). Cells were treated as in Fig 4D. Statistical significance was determined
using unpaired student’s t-test, * p<0.05, **p<0.01, ***p<0.001. Each result is representative
of at least three independent experiments
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The innate immune system detects invading pathogens through 
membrane-bound and cytosolic pattern-recognition receptors, 
which recognize microbe- and damage-associated molecular pat-
terns and induce conserved signaling pathways. Nucleic acids and 
their derivatives are detected by RIG-I-like receptors, cGAS, DAI and 
RNA polymerases, which results in the induction of type I interferons 
via the signaling molecule STING and the kinase TBK1 (refs. 1–3). 
Cytosolic microbial and host DNA also induces inflammasome forma-
tion through AIM2, a member of the PYHIN family of receptors4–7. 
AIM2 binds double-stranded DNA through its HIN-200 domain8 
and recruits the inflammasome adaptor ASC. ASC rapidly oligomer-
izes to form a macromolecular inflammasome complex known as an 
‘ASC speck’, which activates caspase-1. Active caspase-1 promotes 
the maturation and release of the pro-inflammatory cytokines 
interleukin 1? (IL-1?) and IL-18. In addition, it induces pyroptosis, 
a lytic form of cell death that restricts pathogen replication. The 
AIM2 inflammasome mediates the recognition of DNA viruses as 
well as that of various Gram-negative and Gram-positive cytosolic 
bacteria, such as Listeria monocytogenes, Legionella pneumophila, 
Mycobacterium species and Francisella tularensis subspecies novicida 
(F. novicida)8–14. Notably, several studies have shown that activation 
of AIM2 by these bacteria requires bacteriolysis and the subse-
quent release of bacterial chromosomal DNA into the cytosol10,12,15. 
However, whether the bacteriolysis is accidental or is an active, 
host-directed mechanism has remained unclear.
The activation of AIM2 via the transfection of synthetic DNA 
or during infection with a DNA virus is independent of signaling 
via Toll-like receptors or interferons9,13,16. In contrast, the 
activation of AIM2 during infection with F. novicida requires the 
production of type I interferons, which are induced as a result 
of the recognition of an as-yet-undefined F. novicida–derived 
nucleic acid ligand in the cytosol9,10,17–20. Consistent with that, 
the activation of AIM2 inflammasomes in F. novicida–infected 
cells requires signaling through STING and the transcription 
factor IRF3 (refs. 9,10,17). It has been speculated that interferon 
signaling is necessary to increase cellular AIM2 for the detection 
of F. novicida DNA9, yet interferon-mediated induction of AIM2 is 
contested, and even small amounts of transfected DNA efficiently 
trigger activation of AIM2 in an interferon-independent manner9. 
Therefore, it is likely that one or several interferon-inducible 
factor(s) is (are) required for efficient activation of AIM2 during 
bacterial infection.
Type I and type II interferons are potent cytokines that exert 
anti-microbial effects through the induction of a broad transcrip-
tional program involving ~2,000 genes, the so-called ‘interferon-
stimulated genes’ (ISGs), many of which remain uncharacterized. 
1Focal Area Infection Biology, Biozentrum, University of Basel, Basel, Switzerland. 2Centre International de Recherche en Infectiologie, Inserm U1111, CNRS UMR 
5308, Université Claude Bernard Lyon-1, Ecole Normale Supérieure, Lyon, France. 3Structure Fédérative de Recherche Biosciences, UMS344/US8, Inserm, CNRS, 
Université Claude Bernard Lyon-1, Ecole Normale Supérieure, Lyon, France. 4Institute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-University 
Duesseldorf, Duesseldorf, Germany. 5Department of Microbiology and Immunology, Osaka University, Osaka, Japan. 6These authors contributed equally to this work. 
Correspondence should be addressed to T.H. (thomas.henry@inserm.fr) or P.B. (petr.broz@unibas.ch).
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Guanylate-binding proteins promote activation 
of the AIM2 inflammasome during infection with 
Francisella novicida
Etienne Meunier1,6, Pierre Wallet2,6, Roland F Dreier1, Stéphanie Costanzo2, Leonie Anton1, Sebastian Rühl1, 
Sébastien Dussurgey3, Mathias S Dick1, Anne Kistner1, Mélanie Rigard2, Daniel Degrandi4, Klaus Pfeffer4, 
Masahiro Yamamoto5, Thomas Henry2 & Petr Broz1
The AIM2 inflammasome detects double-stranded DNA in the cytosol and induces caspase-1-dependent pyroptosis as well as 
release of the inflammatory cytokines interleukin 1? (IL-1?) and IL-18. AIM2 is critical for host defense against DNA viruses  
and bacteria that replicate in the cytosol, such as Francisella tularensis subspecies novicida (F. novicida). The activation of 
AIM2 by F. novicida requires bacteriolysis, yet whether this process is accidental or is a host-driven immunological mechanism 
has remained unclear. By screening nearly 500 interferon-stimulated genes (ISGs) through the use of small interfering RNA 
(siRNA), we identified guanylate-binding proteins GBP2 and GBP5 as key activators of AIM2 during infection with F. novicida. 
We confirmed their prominent role in vitro and in a mouse model of tularemia. Mechanistically, these two GBPs targeted cytosolic 
F. novicida and promoted bacteriolysis. Thus, in addition to their role in host defense against vacuolar pathogens, GBPs also
facilitate the presentation of ligands by directly attacking cytosolic bacteria.
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Prominent among the products of these ISGs are several families of 
interferon-inducible GTPases, such as the 47-kilodalton immunity- 
related GTPases and the 65- to 73-kilodalton guanylate-binding 
proteins (GBPs)21,22. GBPs are conserved among vertebrates, with 
11 GBPs in mice and 7 in humans, and exert anti-microbial effects 
on intracellular bacteria and protozoa23. GBP1 and GBP7 restrict 
Mycobacterium bovis bacillus Calmette-Guérin and L. monocytogenes 
by recruiting anti-microbial effectors to the pathogen-containing vac-
uole (PCV)24. Several GBPs are recruited onto the Toxoplasma para-
sitophorous vacuole25, and most are also required for restricting the 
replication of Toxoplasma gondii23,26–28. In addition, GBPs encoded 
by genes on mouse chromosome 3 promote recognition of the vacu-
olar, Gram-negative bacterium Salmonella typhimurium by the innate 
immune system by destabilizing its PCV, which leads to egress of the 
bacteria into the cytosol and subsequent detection of its lipopolysac-
charide (LPS) by the caspase-11 inflammasome29. In this study we 
found that GBPs encoded by genes on mouse chromosome 3 were a 
key factor for the activation of AIM2 during infection with F. novic-
ida. In particular, GBP2 and GBP5 controlled the activation of AIM2 
by targeting cytosolic F. novicida and inducing lysis of these bacte-
ria by an as-yet-uncharacterized mechanism. We demonstrated that 
GBP-deficient mice were unable to control infection with F. novicida 
in vivo. Together our data reveal a function for GBPs during micro-
bial infection, in that GBPs promoted bacteriolysis in the cytosol 
and the exposure of bacterial DNA to cytosolic sensors of the innate 
immune system.
RESULTS
AIM2 activation during F. novicida infection requires interferons
F. novicida is a facultative intracellular Gram-negative bacterium that 
avoids phagosomal degradation in phagocytes by escaping into the 
cytosol, a process that requires the Francisella pathogenicity island 
(FPI). After escaping from the phagosome, F. novicida replicates in 
the cytosol but also triggers AIM2-dependent activation of caspase-1 
(refs. 10,13). Infection of mouse bone marrow–derived macrophages 
(BMDMs) with wild-type F. novicida resulted in cell death (pyrop-
tosis; measured by the release of lactate dehydrogenase (LDH)) and 
the release of IL-1? dependent on AIM2, ASC and caspase-1, while 
a mutant lacking the FPI (?FPI) did not activate the inflammasome 
(Fig. 1a). STING is linked to the activation of AIM2 during infec-
tion with F. novicida10,12. Macrophages deficient in STING (via the 
‘goldenticket’ (Gt) N-ethyl-N-nitrosourea–induced nonfunctional 
mutation of alleles encoding Tmem173 (called ‘StingGt/Gt’ here)) had 
considerable attenuation of their ability to induce expression of type I 
interferons and activation of the AIM2 inflammasome upon infection 
with F. novicida5 (Fig. 1b and Supplementary Fig. 1a). Consistent 
with a role for type I interferons in activation of the AIM2 inflamma-
some17,19, macrophages from mice deficient in Ifnar1, which encodes 
the receptor for interferon-? (IFN-?) and IFN-? (IFNAR1), or Stat1, 
which encodes the transcription factor STAT1, displayed significantly 
less pyroptosis and release of IL-1? when infected with F. novicida 
than did their wild-type counterparts (Fig. 1c). To further confirm 
that activation of AIM2 during infection with F. novicida depended 
on signaling via type I interferons, we assessed whether exogenous 
interferons were able to restore inflammasome activation in STING-
deficient BMDMs. As expected, IFN-? restored cell death and the 
release of cytokines in StingGt/Gt BMDMs (Fig. 1d). The addition of 
IFN-? restored cell death and the release of cytokines in both StingGt/Gt 
BMDMs and Ifnar1−/− BMDMs (Fig. 1d), which indicated a require-
ment for a general interferon signature.
The induction of Aim2 mRNA could explain the considerable 
dependence on type I interferons and signaling via STAT1 during 
infection with F. novicida10. However, activation of the AIM2 inflam-
masome by transfection of DNA or infection with DNA viruses is 
independent of interferon signaling9,13,16. In accordance with those 
reports, induction of cell death by transfection of the synthetic 
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B-form double-stranded DNA poly(dA:dT) at a concentration of 
1 ?g/ml required AIM2 but was completely independent of STING 
and STAT1 (Fig. 1e). The transfection of large amounts of DNA 
might overload the system and render it independent of interferon 
signaling. To rule out this possibility, we ‘titrated down’ the amount 
of transfected DNA. The activation of AIM2 remained interferon 
independent even upon the transfection of small quantities of DNA 
(Fig. 1e). These results indicated that basal AIM2 was sufficient 
to initiate inflammasome activation9,13. Indeed, we observed only 
weak induction of Aim2 mRNA following infection with F. novicida 
(Supplementary Fig. 1b).
Finally, we confirmed that F. novicida genomic DNA was as stimu-
latory as synthetic DNA by transfecting increasing amounts of each 
into macrophages that had been primed with the synthetic lipopeptide 
Pam3CSK4 to induce expression of pro-IL-1?. Both types of DNA 
triggered similar cell death and release of IL-1? (Fig. 1f), which excluded 
the possibility that F. novicida DNA had properties that allowed it to 
evade recognition by AIM2. Together these results indicated that one 
(or several) IFN-?- or IFN-?-inducible gene(s) was (were) needed 
to activate AIM2 specifically during bacterial infection.
Identification of the GBP family by genetic screening
To identify ISGs encoding products involved in F. novicida–mediated 
activation of the AIM2 inflammasome, we screened BMDMs by 
RNA-mediated interference with small interfering RNA (siRNA). 
We selected 443 genes with at least twofold higher expression in 
F. novicida–infected wild-type macrophages than in F. novicida– 
infected Ifnar1−/− macrophages17 and selected 40 additional genes 
on the basis of published reports9,10,17,18 (data not shown and 
Supplementary Table 1). At 48 h after transfection of siRNA specific 
for those genes, we infected macrophages with F. novicida and moni-
tored inflammasome activation by measuring the release of IL-1? 
and incorporation of propidium iodide (as a measure of cell death). 
Knockdown of most of the 483 genes did not substantially affect the 
release of IL-1? or cell death (Fig. 2a). In contrast, knockdown of Gbp2 
or Gbp5 resulted in much less F. novicida–mediated release of IL-1? 
and macrophage death than that of cells treated with nontargeting 
siRNA, while knockdown of other GBP-encoding genes showed no 
comparable effect (Fig. 2a). Gbp2 and Gbp5 had the highest expres-
sion among the GBP-encoding genes in macrophages and were sub-
stantially and specifically induced upon infection with wild-type 
F. novicida in a STING- and IFNAR-dependent manner but independ-
ently of Toll-like receptor 2 and MyD88 (Fig. 2b and Supplementary 
Fig. 1c–e). We confirmed by RT-PCR the efficiency of siRNA- 
mediated knockdown of GBP-encoding genes expressed during 
infection with F. novicida (Supplementary Fig. 2a). We next 
confirmed the screening results by knocking down all 11 mouse 
GBP-encoding genes individually and measuring cell death and IL-1? 
release (Fig. 2c). Knockdown of Gbp2 and Gbp5 specifically decreased 
the F. novicida–mediated release of IL-1? and cell death, as assessed 
by two different techniques (Fig. 2c and Supplementary Fig. 2b). 
In conclusion, our screening approach identified GBP2 and GBP5 
as two possible ISG products that controlled the activation of AIM2 
during infection with F. novicida.
AIM2 activation requires GBP-encoding genes on chromosome 3
To confirm our screening data, we obtained macrophages from 
wild-type mice, mice deficient in both caspase-1 and caspase-11 
(Casp1−/−Casp4−/−; called ‘Casp1−/−Casp11−/−’ here) or mice that lack 
the locus on chromosome 3 encoding GBP1, GBP2, GBP3, GBP5 
and GBP7 (called ‘Gbpchr3’ here)23 and infected naive or primed 
macrophages with F. novicida. Consistent with defective activation 
of the AIM2 inflammasome, Gbpchr3-deficient BMDMs displayed a 
significant reduction in cell death and cytokine release and had a 
diminished abundance of processed caspase-1 p20 compared with 
that of their wild-type counterparts, even though their expression of 
pro-caspase-1, ASC and AIM2 protein was similar to that of wild-type 
cells (Fig. 3a,b and Supplementary Fig. 3a). Measuring the incorpo-
ration of propidium iodide in real time following infection showed 
that Gbpchr3-deficient BMDMs died with delayed kinetics compared 
with that of wild-type cells and similar to that of Ifnar1−/− BMDMs 
(Supplementary Fig. 3b). To determine if GBPs encoded by genes on 
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chromosome 3 were directly involved in the activation of AIM2, we 
engaged AIM2 by transfecting synthetic DNA into unprimed wild-
type and Gbpchr3-deficient macrophages. Cytosolic DNA triggered 
LDH release to a similar extent in both groups of cells, even when 
the amount of transfected DNA was ‘titrated down’ (Fig. 3c). Wild-
type, Gbpchr3-deficient and Ifnar1−/− cells also responded similarly 
to the transfection of purified F. novicida genomic DNA (Fig. 3d). 
Thus, GBPs were not required in the context of DNA transfection, 
which suggested that they functioned upstream of AIM2-mediated 
DNA detection.
GBP2 and GBP5 direct parallel pathways of AIM2 activation
Since our screening data suggested that mainly GBP2 and GBP5 were 
required for the activation of AIM2 (Fig. 2a), we infected BMDMs 
from wild-type, Casp1−/−Casp11−/−, Gbpchr3-deficient, Gbp2−/− or 
Gbp5−/− mice with F. novicida and measured activation of the AIM2 
inflammasome. Gbp2−/− BMDMs displayed less death and cytokine 
release than did wild-type BMDMs (Fig. 4a,b). Similarly, Gbp5−/− 
BMDMs also displayed attenuated inflammasome activation when 
infected with F. novicida relative to that of their wild-type counterparts 
(Fig. 4a,b). Deficiency in Gbp2 or Gbp5 did not affect cell death in 
response to DNA transfection, even when we used very small amounts 
of DNA (Fig. 4c). To determine if expression of GBP2 or GBP5 could 
restore activation of the AIM2 inflammasome in Ifnar1−/− cells, we 
retrovirally transduced macrophages with constructs expressing GBP2 
or GBP5 or with an empty vector (control) and infected them with 
F. novicida. Such ectopic expression was not able to complement the 
deficiency in inflammasome activation (Supplementary Fig. 4a–c), 
which suggested that other products of ISGs might be required for 
the function of GBP2 and GBP5, in line with data showing that 
GBPs are active and correctly targeted only in the context of the 
interferon response25.
Single deficiency in Gbp2 or Gbp5 did not reduce the activation of 
AIM2 during infection with F. novicida as much as Gbpchr3 deficiency 
did (Fig. 4a,b), which suggested that GBP2 and GBP5 promoted acti-
vation of AIM2 through independent pathways. To investigate whether 
GBP2 and GBP5 acted sequentially or in parallel, we knocked down 
Gbp2 expression in wild-type, Gbp2−/− and Gbp5−/− BMDMs (control 
Figure 3 Macrophages from Gbpchr3-deficient 
mice have deficient activation of AIM2 in 
response to F. novicida. (a) Release of LDH and 
IL-1? from naive or IFN-?-primed wild-type,  
Gbpchr3-deficient (Gbpchr3-KO) and  
Casp1−/−Casp11−/− BMDMs 8 h after infection 
with wild-type F. novicida strain U112.  
(b) Immunoblot analysis of cleaved caspase-1  
(p20) and IL-18 (p19) in culture supernatants  
(Sup), and of GBP2, GBP5, pro-caspase-1  
(Pro-Casp1), pro-IL-18, pro-IL-1?, ASC and  
?-actin (loading control) in extracts (Extract),  
of wild-type and Gbpchr3-deficient BMDMs  
primed with LPS, IFN-? or IFN-? (below blots)  
and then infected with wild-type F. novicida  
strain U112, assessed 8 h after infection.  
(c) Release of LDH from wild-type and Gbpchr3-
deficient BMDMs 8 h after transfection of 
increasing concentrations (wedges) of poly(dA:dT) or poly(dG:dC) (0.25, 0.5 or 1 ?g/ml). (d) Release of LDH from wild-type, Gbpchr3-KO and Ifnar1−/− 
BMDMs 8 h after transfection of increasing concentrations (wedges) of F. novicida genomic DNA (0.1, 0.25, 0.5 or 1 ?g/ml). *P < 0.001 (two-tailed 
unpaired t-test). Data are representative of six (a) three (b,c) or two (d) independent experiments (mean and s.d. of quadruplicate wells in a,c,d).
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Figure 4 GBP2 and GBP5 independently control activation of AIM2  
during infection with F. novicida. (a,b) Release of LDH (a) and  
IL-1? (b) from naive or IFN-?-primed wild-type, Casp1−/−Casp11−/−,  
Gbp2−/−, Gbp5−/− and Gbpchr3-deficient BMDMs 6 h after infection  
with wild-type F. novicida strain U112. (c) Release of LDH from  
naive wild-type, Gbpchr3-deficient, Gbp2−/− and Gbp5−/− BMDMs  
transfected with increasing concentrations (wedges) of poly(dA:dT)  
(0.1, 0.25, 0.5 or 1 ?g/ml). (d) Release of LDH and IL-1? from  
naive wild-type, Gbp2−/− and Gbp5−/− BMDMs treated with  
nontargeting control siRNA or siRNA specific for the gene encoding GBP2 or GBP5 (horizontal axis), then, 22 h later, infected with wild-type F. novicida 
U112, assessed 8 h after infection. *P < 0.05, **P < 0.01 and ***P < 0.001 (two-tailed unpaired t-test). Data are representative of four (a,b), three (c) 
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of siRNA knockdown efficacy, Supplementary Fig. 4d) and measured 
inflammasome activation after infection with F. novicida. Knockdown 
of Gbp2 reduced cell death and release of IL-1? in wild-type 
BMDMs but not in Gbp2-deficient BMDMs (Fig. 4d). Treatment 
with Gbp2-specific siRNA also significantly reduced inflammasome 
activation in Gbp5−/− BMDMs (Fig. 4d), which demonstrated that 
in Gbp5-deficient cells, GBP2 was still active and was able to pro-
mote activation of AIM2. Consistent with that, knockdown of Gbp5 
reduced activation of the inflammasome in both wild-type BMDMs 
and Gbp2−/− BMDMs (Fig. 4d). In conclusion, our data suggested 
that the interferon-inducible GTPases GBP2 and GBP5 controlled 
non-redundant, parallel pathways that promoted activation of AIM2 
during infection with F. novicida.
Escape of F. novicida from phagosomes is GBP independent
Since cytosolic localization of F. novicida is required for the activa-
tion of AIM2 and since GBPs promote the destabilization of phago-
somes and/or pathogen-containing vacuoles of protozoan parasites or 
bacteria23,27,29, we speculated that GBPs might facilitate the escape of 
F. novicida from phagosomes. We used a phagosome-protection
assay29,30 based on selective permeabilization of the plasma membrane 
with digitonin to assay the escape of F. novicida from phagosomes. As
reported before30, we observed that 90–95% of wild-type F. novicida
escaped from phagosomes within a few hours of infection, but this
frequency was similar for wild-type BMDMs and Gbpchr3-deficient 
BMDMs at various time points after infection (Fig. 5a). In contrast,
?FPI F. novicida remained in the phagosome (data not shown).
F. novicida is naturally resistant to ?-lactam antibiotics and secrete 
the ?-lactamase FTN_1072. Taking advantage of this, we developed 
an alternative assay to detect cytosolic bacteria based on cleavage of 
the FRET (Förster resonance energy transfer) reporter probe CCF4 by 
FTN_1072, which leads to a loss of FRET activity31,32 (Supplementary 
Fig. 5). We preloaded wild-type, Gbp2−/− and Gbpchr3-deficient 
BMDMs with CCF4-AM, the membrane-permeable form of the 
reporter, and subsequently infected the cells with wild-type F. novicida, 
an FTN_1072-deficient strain (the ?-lactamase mutant ?bla) or the 
?FPI mutant. We observed no difference among wild-type, Gbp2−/− or 
Gbpchr3-deficient BMDMs in terms of FRET activity after infection with 
wild-type F. novicida (Fig. 5b and Supplementary Fig. 5). The ?FPI 
and ?bla mutant strains did not produce any significant FRET signals, 
similar to the signaling of uninfected macrophages (Supplementary 
Fig. 5). Thus, we concluded that GBPs did not control the activation of 
AIM2 by promoting the escape of F. novicida from phagosomes but that 
they were active after F. novicida reached the cytosol. This was consist-
ent with our data showing that in unprimed cells, F. novicida–induced 
expression of GBP-encoding mRNA was dependent on the FPI and on 
the escape from phagosomes (Fig. 2b) and that cytosolic recognition 
was required for interferon induction (Supplementary Fig. 1a).
GBPs promote cytosolic lysis of F. novicida
To identify the mechanism by which GBPs controlled the activation of 
AIM2 during infection with F. novicida, we investigated the subcellular 
localization of GBPs in infected cells. GBPs are known to co-localize 
with vacuolar pathogens such as S. typhimurium, M. bovis bacillus 
Calmette-Guérin and T. gondii, consistent with the ability of GBPs 
to recruit anti-microbial effector mechanisms to the pathogen and 
to destabilize PCVs24,27,29. We observed that both GBP2 and GBP5 
were targeted to intracellular F. novicida (Fig. 6a). Closer examination 
of GBP-positive F. novicida revealed that GBPs localized to different 
spots close to or onto the surface of the bacterium (data not shown). 
However, it was unclear if GBPs targeted the bacterium directly or 
targeted remnants of the host membrane (i.e., lysed phagosomes) or 
another closely associated membrane compartment.
Since the irregular shape of GBP-positive bacteria suggested 
that they were lysed, we next determined if wild-type and Gbpchr3-
deficient cells differed in the abundance of lysed intracellular 
F. novicida. Viable and lysed intracellular bacteria can be quantified
on the basis of propidium iodide staining, since intact bacteria remain 
protected from the influx of propidium iodide33 (Fig. 6b). We tested
the assay by quantifying lysed bacteria in wild-type BMDMs infected 
with wild-type F. novicida or an F. novicida mutant in which the
gene encoding the outer membrane protein FopA is deleted (?fopA) 
and thus it has lower membrane stability that results in increased
intracellular lysis and hyperactivation of the AIM2 inflammasome15. 
We detected significantly larger amounts of propidium iodide–
positive ?fopA F. novicida than wild-type F. novicida (Fig. 6c), which 
confirmed the validity of our assay. We next compared the frequency 
of lysed bacteria in wild-type and Gbpchr3-deficient macrophages.
The Gbpchr3-deficient BMDMs had a significantly lower frequency
of lysed bacteria (positive for staining with antibodies to F. novicida
and propidium iodide) (23% on average) than the wild-type BMDMs 
had (40% on average) (Fig. 6c).
The macromolecular inflammasome complex known as the ‘ASC 
speck’ assembles on genomic DNA released from lysed cytosolic 
F. novicida10. Immunofluorescence analysis revealed mostly irreg-
ularly shaped F. novicida in the vicinity of ASC specks (Fig. 6d).
These bacteria released DNA and were often also positive for GBP
staining (Fig. 6d and Supplementary Fig. 6). Consistent with that,
the number of ASC speck-containing cells was significantly lower
in GBP-deficient (Gbp2−/−, Gbp5−/− or Gbpchr3-deficient) BMDMs
than in wild-type BMDMs (Fig. 6e). In conclusion, these findings
indicated that GBPs associated with cytosolic F. novicida and, by an 
as-yet-undefined mechanism, induced lysis of the bacterium, which 
resulted in DNA release and detection by the cytosolic DNA sensor 
AIM2, followed by oligomerization of ASC.
GBPs control F. novicida replication
Inflammasome-induced cell death (pyroptosis) restricts intra-
cellular bacteria by removing their replicative niche and reexposing 
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Figure 5 The escape of F. novicida from phagosomes is GBP  
independent. (a) Frequency of cytosolic F. novicida (FN) among total 
bacteria at 3 h and 6 h after infection of wild-type and Gbpchr3-deficient 
BMDMs with wild-type F. novicida strain U112, assessed by phagosome-
protection assay. (b) Quantification of cells with ruptured phagosomes  
at 16 h after infection of wild-type, Gbp2−/− and Gbpchr3-deficient 
BMDMs with wild-type F. novicida U112, the ?-lactamase-deficient 
mutant ?bla or the ?FPI mutant or in uninfected cells (UI), assessed 
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them to extracellular immunological mechanisms34. Cell-autonomous 
immunity, on the other hand, relies on cell-intrinsic mechanisms 
to restrict bacterial growth without the need for killing the host 
cell21. To determine whether GBPs restricted F. novicida growth 
through cell-autonomous mechanisms or inflammasome-dependent 
mechanisms, we infected wild-type, Aim2−/−, Gbpchr3-deficient 
and Ifnar1−/− BMDMs with wild-type F. novicida expressing green 
fluorescent protein (GFP) and used flow cytometry to quantify 
infected cells (more than two bacteria per cell, our specific 
fluorescence-detection threshold) among the live cell population. We 
observed a significantly higher percentage of live infected Aim2−/−, 
Gbpchr3-deficient and Ifnar1−/− BMDMs than live infected wild-
type BMDMs (Fig. 7a). This suggested that deficiency in Ifnar1 or 
Gbpchr3, similar to deficiency in Aim2, resulted in a reduction in 
inflammasome-mediated killing of host cells upon infection.
Cell-autonomous growth restriction is an interferon-induced 
mechanism that is at least partially independent of inflammasome-
mediated cell death35,36. Therefore, we next determined if Gbpchr3-
deficient BMDMs and Ifnar1-deficient BMDMs also had a defect 
in restricting intracellular bacterial replication. We infected mac-
rophages with GFP+ F. novicida and quantified bacteria (per cell) 
by both automated microscopy in flow and microscopy at various 
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Figure 7 GBPs restrict the intracellular replication 
of F. novicida. (a) Flow cytometry–based 
quantification of infected (GFP+) cells among 
live wild-type, Aim2−/−, Gbpchr3-deficient and 
Ifnar1−/− BMDMs 12 h after infection with GFP-
expressing wild-type F. novicida at a multiplicity  
of infection (MOI) of 1 (top) or 10 (bottom).  
*P < 0.001 (two-tailed unpaired t-test).  
(b) Quantification of bacterial loads in single cells 
among wild-type, Aim2−/−, Gbpchr3-deficient and 
Ifnar1−/− BMDMs 12 h after infection with GFP-
expressing wild-type F. novicida at a multiplicity 
of infection of 10, assessed by high-resolution 
microscopy in flow and presented as a comparison 
of all four genotypes (top left) or a comparison 
of wild-type cells with each other genotype, with 
bacteria-per-cell values grouped by increments of 
10 (horizontal axes). P < 0.0001, wild-type versus 
Aim2−/−, wild-type versus Gbpchr3-deficient, and  
wild-type versus Ifnar1−/− (Kolmogorov-Smirnov 
test with Bonferroni correction). Data are 
representative of three independent experiments 
(a; mean and s.d. of triplicate wells) or are pooled 
from three independent experiments (b).
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time points after infection. Wild-type macrophages efficiently 
controlled intracellular replication, but Aim2−/− BMDMs contained 
large numbers of intracellular F. novicida (30 or more per cell) 
(Fig. 7b and Supplementary Fig. 7a,b), consistent with a loss of 
inflammasome-mediated killing of host cells. Bacterial loads were even 
higher in Gbpchr3-deficient or Ifnar1-deficient BMDMs, with many cells 
containing up to 100 bacteria (Fig. 7b and Supplementary Fig. 7a,b). 
The production of reactive oxygen species and nitric oxide is a potent 
cell-intrinsic anti-microbial mechanism that can also be activated in 
an interferon-dependent manner. GBP7 has been shown to recruit 
subunits of the NADPH oxidase to intracellular L. monocytogenes  
and M. bovis bacillus Calmette-Guérin24, and inducible nitric oxide 
synthase can restrict bacterial growth in a cell-intrinsic manner21. 
However, deficiency in these mechanisms achieved through the use 
of BMDMs deficient in both inducible nitric oxide synthase and 
Nox2 did not significantly alter bacteriolysis and inflammasome 
activation after infection with F. novicida (P = 0.3081, P = 0.2786 and 
P = 0.0529; Supplementary Fig. 8a,b). Overall, these data indicated 
that GBPs encoded by the locus on chromosome 3 participated in 
growth restriction in two ways: directly, by promoting the lysis of 
intracellular bacteria by an as-yet-unknown mechanism; and indi-
rectly, by promoting the inflammasome-mediated killing of host cells, 
thereby removing the intracellular replicative niche of F. novicida.
GBPs control F. novicida replication in vivo
AIM2, ASC and caspase-1 control the replication of F. novicida in vivo 
in mice9,10,37. Since GBPs are required for inflammasome activation 
in vitro, we investigated whether these proteins also have a physiologi-
cal role in host defense. We infected age- and sex-matched wild-type, 
Casp1−/−Casp11−/−, Gbp2−/− and Gbpchr3-deficient mice subcutane-
ously with 5 × 103 colony-forming units of wild-type F. novicida strain 
U112 and measured the bacterial burden in the liver and spleen at 
2 d after infection. As published before37, Casp1−/−Casp11−/− mice 
displayed a significantly higher bacterial burden in the liver and 
spleen than that of wild-type mice (Fig. 8a). Similarly, Gbp2−/− and 
Gbpchr3-deficient mice showed higher bacterial counts than wild-
type mice, similar to or even higher than those of Casp1−/−Casp11−/− 
mice (Fig. 8a). Consistent with diminished inflammasome activa-
tion in vivo, we detected a significantly lower serum concentration 
of IL-18 in Casp1−/−Casp11−/−, Gbp2−/− and Gbpchr3-deficient mice 
than in wild-type mice (Fig. 8b). To further assess the effects of GBP 
deficiency in vivo, we analyzed survival. Within 4 d of infection, all 
Casp1−/−Casp11−/−, Gbp2−/− and Gbpchr3-deficient mice died, while 
most wild-type mice survived until the end of the experiment (day 10) 
(Fig. 8c). These results confirmed the relevance of our in vitro data 
and demonstrated that GBPs encoded by the locus on chromosome 3 
were important for inflammasome activation and host defense against 
F. novicida in vivo.
DISCUSSION
Since the activation of AIM2 during infection with the cytosolic path-
ogen F. novicida required interferon signaling, we investigated the role 
of the products of ISGs in this process. Our results showed that the 
interferon-inducible GTPases GBP2 and GBP5 promoted F. novicida– 
mediated activation of the AIM2 inflammasome but were dispensa-
ble for the activation of AIM2 upon transfection of DNA. Members 
of the GBP family take part in interferon-induced cell-autonomous 
immunity and are known to induce disruption of the PCVs of vacuolar 
bacteria and parasites23,27,29. However, the cytosolic localization of 
F. novicida was similar in wild-type and Gbpchr3-deficient cells, which 
indicated that GBPs must have been involved later during infection, 
after the bacteria had entered the cytosol. This was consistent with 
results showing that the escape from phagosomes is an interferon-
independent process36 and that cytosolic localization of F. novicida 
is a prerequisite for interferon induction17. Since the activation of 
AIM2 during infection with F. novicida or L. monocytogenes is known 
to require cytosolic bacteriolysis12,15, we investigated whether GBPs 
controlled the bacteriolysis and replication of F. novicida in the cytosol. 
Significantly fewer lysed and more overall F. novicida were present in 
cells deficient in GBP-encoding genes or Ifnar1 than in wild-type cells, 
which indicated that GBPs were required for interferon-mediated cell-
autonomous immunity to the pathogen. Furthermore, our results 
demonstrated that in addition to their known function in destabilizing 
PCVs, GBPs can also promote the lysis of cytosolic bacteria.
GBPs are also critical for the cytosolic recognition of LPS and for 
activation of the caspase-11 inflammasome pathway. In this context, 
they act by promoting the release of vacuolar S. typhimurium into the 
cytosol or by promoting activation of caspase-11 during infection with 
L. pneumophila29,38. At present, no model fully explains how GBPs 
restrict pathogen growth during infection with microbes or protozoa 
Figure 8 GBPs control host defense against  
F. novicida in vivo. (a) Bacterial burden  
(as colony-forming units (CFU) of F. novicida 
(FN) per gram tissue) in the liver and spleen  
at day 2 after subcutaneous infection of  
wild-type, Casp1−/−Casp11−/−, Gbp2−/− and 
Gbpchr3-deficient mice with 5 × 103 wild-type  
F. novicida. Each symbol represents an 
individual mouse (n = 8 (wild-type),  
10 (Casp1−/−Casp11−/−), 7 (Gbp2−/−) and  
10 (Gbpchr3-deficient) (spleen), or n = 8  
(wild-type), 13 (Casp1−/−Casp11−/−),  
8 (Gbp2−/−) and 9 (Gbpchr3-deficient) (liver)); 
small horizontal lines indicate the mean.  
*P < 0.05, **P < 0.01 and ***P < 0.001 
(Mann-Whitney test). (b) IL-18 in serum 
obtained from wild-type mice (n = 12),  
Casp1−/−Casp11−/− mice (n = 11), Gbp2−/− mice 
(n = 12) and Gbpchr3-deficient mice (n = 14)  
16 h after subcutaneous infection with 1.5 × 105 wild-type F. novicida. *P < 0.01 and **P < 0.001 (Mann-Whitney test). (c) Survival of wild-type, 
Casp1−/−Casp11−/−, Gbp2−/− and Gbpchr3-deficient mice (n = 10 per genotype) after subcutaneous infection with 5 × 103 wild-type F. novicida.  
P < 0.0001, wild-type versus Casp1−/−Casp11−/− or wild-type versus Gbpchr3-deficient, and P = 0.0005, wild-type versus Gbp2−/− (log-rank (Mantel-Cox)  
test). Data are representative of two independent experiments (a,c) or are pooled from two individual experiments (b; with 10th–90th percentiles).
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and at the same time control inflammasome signaling. It is, however, 
conceivable that the membrane-destabilizing activity of GBPs in com-
bination with their bacteriolytic activity could not only result in the 
entry of bacteria into the cytosol but also release microbe-associated 
molecular patterns (for example, LPS and DNA) directly. Such a model 
might explain their effect on both the caspase-11 pathway38 and the 
AIM2 pathway in response to cytosolic bacteria. Thus, bacteriolysis 
would also release F. novicida LPS into the cytosol. However, since 
F. novicida LPS is tetra-acylated, it does not trigger caspase-11 
activation39. Conversely, we would expect GBPs to lyse cytosolic 
Salmonella or Legionella, which would result in activation of AIM2. 
But in this case, activation of AIM2 is most probably masked by a high 
degree of caspase-11-dependent cell death and cytokine release.
GBP-mediated bacteriolysis might also be expected to release 
DNA and amplify the production of type I interferons via STING. 
Notably, what triggers initial STING signaling and the induction of 
GBP-encoding genes during infection with F. novicida is still unde-
fined, but two possibilities exist. One is the direct activation of STING 
via a secreted bacterial cyclic nucleotide, analogous to infection with 
L. monocytogenes40, and another is activation of the DNA sensor 
cGAS by F. novicida DNA and subsequent production of the cyclic 
dinucleotide cGAMP41,42. Lysis of F. novicida within the phagosome 
followed by translocation of its DNA into the cytosol could trigger 
interferon production9. Alternatively, low levels of F. novicida extra-
cellular DNA could reach the cytosol by sticking to the surface of the 
infecting bacteria, as suggested for infection with M. tuberculosis43. 
Finally, small amounts of spontaneous bacteriolysis might occur in 
the host-cell cytosol. If DNA indeed triggers initial STING-mediated 
production of interferons, it remains to be shown why it is insufficient 
to trigger activation of AIM2. Additional experiments are needed to 
determine the relative DNA-binding affinities of cGAS and AIM2 and 
how their signaling hierarchy is controlled.
Our results have revealed an underappreciated, close connection 
between cell-autonomous immunity and recognition by the innate 
immune system. The attack of GBPs on PCVs or pathogens liberates 
microbe-associated molecular patterns and thus ensures subsequent 
immunological recognition of the pathogen, which explains the role 
of interferon signaling in the detection of bacterial DNA by AIM2 
or LPS from vacuolar bacteria by the caspase-11 pathway9,10,13,44,45. 
Additional questions remain, such as how GBP targeting is regulated 
and how GBPs act mechanistically. Ectopic expression of GBP2 or 
GBP5 did not ‘rescue’ the inflammasome deficiency of Ifnar1−/− cells, 
which suggests that other products of ISGs are necessary for proper 
targeting and activity of GBPs24,25. Indeed, members of the IRGM 
family, a subclass of the immunity-related GTPases, can act as guanine-
 dissociation inhibitors and control the targeting of both immunity-
related GTPases and GBPs to pathogen-containing vacuoles, yet the 
molecular mechanism of this is still unclear46–49. Additional biochemi-
cal studies are needed to define the mechanism of GBP targeting and 
action during bacterial infection and how this promotes the exposure 
of bacterial ligands to cytosolic recognition pathways.
METHODS
Methods and any associated references are available in the online 
version of the paper.
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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ONLINE METHODS
Bacterial strains and plasmids. F. novicida strain U112 and isogenic ?FPI 
mutants have been published10. Where applicable, strains were transformed 
with the plasmid pKK219-GFP (Supplementary Table 2). The ?-lactamase 
mutant ?bla was generated by PCR-mediated homologous recombination 
with a kanamycin selection cassette through use of the following primers 
(upper case indicates F. novicida sequence; lower case indicates the 
 kanamycin-resistance casette sequence): ForUpstream, GTCGAGTACGCT
AATATAAAAATTCTAAAAA; RevUpstream, gcttatcgataccgtcgacctcGGGA 
TTAATGATAAAGTTGTAACTAATATACGC; ForDownstream, gatatcgat 
cctgcagctatgcCACTTATAAATAAGCGGTACGCCAC; and RevDownstream, 
AAGACGGTGATGTACCATTTGTCTATAG. The kanamycin-resistance 
casette was removed by transformation of the mutant obtained with the ther-
mosensitive plasmid pFFlp (provided by L. Gallagher and C. Manoil) encod-
ing the recombinase Flp. Following loss of the plasmid, genomic deletion was 
verified by sequencing.
Mice. Gbpchr3-deficient, Gbp2−/−, Gbp5−/−, Nos2−/−Cybb−/−, Casp1−/−Casp11−/− 
(‘caspase-1-knockout’), Asc−/−, Aim2−/−, Stat1−/−, Ifnar1−/−, StingGt/Gt, Tlr2−/− 
and Myd88−/− mice have been described3,10,23,27,29,44. Mice were bred in 
the animal facilities of the University of Basel or at the Plateau De Biologie 
Expérimentale De La Souris.
Animal infection. All animal experiments were approved (license 2535, 
Kantonales Veterinäramt Basel-Stadt and ENS_2012_061) and were per-
formed according to local guidelines (Tierschutz-Verordnung, Basel-Stadt and 
CECCAPP, Lyon) and the Swiss animal protection law (Tierschutz-Gesetz). 
Age- and sex-matched mice (8–10 weeks of age) were infected subcutaneously 
with 5 × 103 or 1.5 × 105 colony-forming units of stationary-phase wild-type 
F. novicida strain U112 in 50 ?l PBS. Mice were killed at the appropriate time 
point after infection. No randomization or ‘blinding’ of researchers to sample 
identity was used.
Cell culture and infection. BMDMs were differentiated in DMEM (Invitrogen) 
with 10% vol/vol FCS (Thermo Fisher Scientific), 10% MCSF (supernatants 
of L929 mouse fibroblasts), 10 mM HEPES (Invitrogen) and nonessential 
amino acids (Invitrogen). 1 d before infection, macrophages were seeded into 
6-, 24- or 96-well plates at a density of 1.25 × 106, 2.5 × 105 or 5 × 104 cells 
per well. Where required, macrophages were pre-stimulated with Pam3CSK4 
(tripalmitoyl cysteinyl seryl tetralysine), LPS (from Escherichia coli strain 
O111:B4 (InvivoGen)), mouse IFN-? or mouse IFN-?  (eBioscience). For infec-
tion with F. novicida, bacteria were grown overnight at 37 °C with aeration in 
brain-heart–infusion medium or tryptic soy broth. The bacteria were added to 
the macrophages at a multiplicity of infection of 100 or the appropriate value. 
The plates were centrifuged for 15 min at 500g to ensure similar adhesion of 
the bacteria to the cells and were incubated for 120 min at 37 °C. Next, cells 
were washed and fresh medium with 10 ?g/ml gentamycin (Invitrogen) was 
added to kill extracellular bacteria, then plates were incubated for the desired 
length of time. Transfection with poly(dA:dT) or poly(dG:dC) was done as 
described29 or as indicated in the figures and legends (Figs. 1 and 3).
siRNA-mediated knockdown. Genes were knocked down with GenMute 
(SignaGen Laboratories) and siRNA pools (siGenome; Dharmacon). Wild-
type BMDMs were seeded into 24- or 96-well plates at a density of 1.5 × 105 
or 3 × 104 cells per well. siRNA complexes were prepared at a concentration 
of 25 nM siRNA in GenMute Buffer according to the manufacturer’s instruc-
tions for forward knockdown (SignaGen laboratories). siRNA complexes were 
mixed with BMDM medium (described above) and were added onto the cells. 
After 22–48 h of gene knockdown, BMDMs were infected with F. novicida at a 
multiplicity of infection of 100:1 and were analyzed for inflammasome activa-
tion as outlined below. siRNA pools targeted the following genes (numbers 
in parentheses indicate Dharmacon reference): Aim2 (M-044968-01), Casp11 
(that is, Casp4) (M-042432-01), Gbp1 (M-040198-01), Gbp2 (M-040199-00), 
Gbp3 (M-063076-01), Gbp4 (M-047506-01), Gbp5 (M-054703-01), Gbp6 
(M-041286-01), Gbp7 (M- 061204-01), Gbp8 (M-059726-01), Gbp9 
(M-052281-01), Gbp10 (M-073912-00), Gbp11 (M-079932-00) and NT (non-
targeting) pool 2 (D-001206-14).
siRNA screening. Knockdown of the 483 selected genes was performed as 
described above in the 36 central wells of 96-well plates; this included the 
nontargeting control siRNA and siRNA specific for Asc and Aim2 on each 
plate. Macrophages were infected with F. novicida at a multiplicity of infection 
of 100:1 and, following a wash at 1 h after infection, cells were incubated with 
medium supplemented with propidium iodide at 5 ?g/ml. At 6 h after infec-
tion, the fluorescence of propidium iodide was determined on a plate reader 
(Tecan) and supernatants were collected for analysis of the release of IL-1? 
by enzyme-linked immunosorbent assay (DuoSet; R&D Systems). The fluo-
rescence of propidium iodide and concentration of IL-1? in cells transfected 
with each siRNA were normalized to the average value of the full plate set, set 
as 100, and to the value obtained with Aim2-specific siRNA, set as 0, with the 
following calculation (for gene ‘X’): normalized value obtained with X-specific 
siRNA = (value obtained with X-specific siRNAx − value obtained with 
Aim2-specific siRNA) / (average value obtained with siRNA − value obtained 
with Aim2-specific siRNA). All the siRNA presenting variation of more 
than 50% in either one of the two parameters have been retested two or three 
times. Average normalized values are presented in the display items.
Ectopic expression of GBP2 and GBP5. Mouse Gbp2 and Gbp5 were cloned 
into the lentiviral plasmid TRIP iziE-SSFV-GFP with the following prim-
ers and restriction enzymes (upper case indicates gene sequence; lower case 
indicates restriction site (underlined) and four bases flanking in the 5? direc-
tion): For_mGBP2_AvrII, attacctaggGACATGGCCTCAGAGATCCACATG; 
Rev_mGBP2_EcoRV, aatagataTCAGAGTATAGTGCACTTCCCAGACG; 
For_mGBP5_AvrII, aaatcctagGACATGGCCCCAGAGATTCACATG; and 
Rev_mGBP5_HpaI, atttgttaacTTAGCTTATAACACAGTCATGATGATGT 
CTAC. The production of lentiviruses in 293T human embryonic kidney cells 
and the transduction of primary BMDMs were performed by standard meth-
ods. IFNAR1-deficient macrophages were transduced after 8 d of differentia-
tion by spin-inoculation (1,500g for 2 h at room temperature). Transduced 
macrophages were infected 48 h later. Transduction frequency was determined 
by flow cytometry based on GFP expression. Specific ectopic expression was 
checked by quantitative RT-PCR.
Cytokine and LDH release measurement. IL-1?, IL-18 and tumor-necrosis 
factor were measured by enzyme-linked immunosorbent assay (eBioscience). 
LDH was measured with an LDH Cytotoxicity Detection Kit (Clontech). To 
normalize for spontaneous lysis, the percentage of LDH release was calcu-
lated as follows: (LDH infected − LDH uninfected) / (LDH total lysis − LDH 
uninfected) × 100.
Immunoblot analysis. Immunoblot analysis was done as described29. 
Antibodies used were rat anti–mouse caspase-1 (1:1,000 dilution; 4B4; 
Genentech), rabbit anti-IL-1? (1:1,000 dilution; ab109555; Abcam), rabbit 
anti-IL-18 (1:500 dilution; 5180R; Biovision), goat anti–mouse IL-1? (1:500 
dilution; AF-401-NA; R&D Systems), rabbit anti-GBP2 (1:1,000 dilution; 
11854-1-AP; Proteintech) and rabbit anti-GBP5 (1:1,000 dilution; 13220-1-AP; 
Proteintech). Cell lysates were probed with monoclonal anti-?-actin (1:2,000 
dilution; AC-15; A1978; Sigma). Secondary antibodies were as follows (all 
conjugated to horseradish peroxidase and all at a dilution of 1:3,000): goat anti-
rat (NA935V; GE Healthcare), goat anti-rabbit (G21234; Invitrogen), rabbit 
anti-goat (811620; Invitrogen) and rabbit anti-mouse (816720; Invitrogen).
Real-time PCR. Primers used for mRNA quantification are in Supplementary 
Table 3. Experiments were performed with an iCycler (Bio-Rad) and SYBR 
green (Applied Biosystems) with standard protocols.
Statistical analysis. Prism 5.0a software (GraphPad Software) was used for 
statistical analysis of data. For evaluation of the differences between two 
groups (cell death, cytokine release, flow cytometry, colony-forming units 
and immunofluorescence-based counts), a two-tailed t-test was used. The 
Kolmogorov-Smirnov test was used for comparison of the cell distribu-
tion as determined by ImageStream microscopy in flow. P values were 
adjusted for multiple comparisons with the Bonferroni correction approach. 
Animal experiments were evaluated with the Mann-Whitney or log-rank 
Cox-Mantel test.
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Immunofluorescence. Macrophages were seeded on glass coverslips and were 
infected as described above. At the desired time points, cells were washed 
three times with PBS and were fixed for 15 min at 37 °C with 4% parafor-
maldehyde. Following fixation, coverslips were washed, and the fixative was 
quenched for 10 min at room temperature with 0.1 M glycine. Coverslips were 
stained for 16 h at 4 °C with primary antibodies (identified below), then were 
washed with PBS and then incubated for 1 h at room temperature with the 
appropriate Alexa Fluor–conjugated secondary antibodies (identified below) 
(1:500 dilution; Invitrogen), then were washed with PBS and mounted on 
glass slides with Vectashield containing DAPI (6-diamidino-2-phenylindole; 
Vector Labs). Antibodies used were chicken anti–F. novicida (1:1,000 dilution; 
a gift from D. Monack), rat anti-ASC (1:1,000 dilution; Genentech), rabbit 
anti-GBP2 (1:100 dilution; 11854-1-AP; Proteintech) and rabbit anti-GBP5 
(1:100 dilution; 13220-1-AP; Proteintech). Secondary antibodies used were 
as folllows (all at a dilution of 1:500 and all from Life Technologies): goat anti-
rat coupled to Alexa Fluor 488 (A11006), Alexa Fluor 568 (A11077) or Alexa 
Fluor 633 (A21094); goat anti-rabbit coupled to Alexa Fluor 488 (A11008) or 
Alexa Fluor 568 (A10042); and goat anti-chicken coupled to Alexa Fluor 488 
(A11032), Alexa Fluor 568 (A11047) or Alexa Fluor 633 (A21103). Coverslips 
were imaged on a Zeiss LSM700 or a Leica SP8 at a magnification of ×63 and 
vacuolar versus cytosolic bacteria, total intracellular bacteria or ASC specks 
were quantified as described in the figure legends.
Phagosome protection assay. For quantification of cytoplasmic and vacuolar 
bacteria, macrophages were infected with GFP+ F. novicida as described 
above. At the desired time point, cells were washed with KHM buffer (110 mM 
potassium acetate, 20 mM HEPES and 2 mM MgCl2, pH 7.3), followed 
by incubation for 1 min in KHM buffer with 50 ?g/ml digitonin (Sigma). 
Cells were immediately washed three times with KHM buffer and then were 
stained for 12 min with Texas Red–coupled chicken antibody to F. novicida 
(identified above) in KHM buffer with 2% BSA. Cells were washed with PBS, 
then were fixed and analyzed by microscopy. Controls were included in every 
assay as described29.
Intracellular viability measurement. For measurement of the intracellu-
lar lysis of F. novicida, we adapted a published propidium iodide–staining 
method33. Infected BMDMs were incubated for 12 min at 37 °C with Alexa 
Fluor 488–conjugated mouse antibody to F. novicida (identified above) and 
2.6 ?M propidium iodide (Sigma) in KHM buffer (described above) for label-
ing of accessible cytosolic bacteria and compromised bacteria, respectively, 
in permeabilized cells. Cells were fixed and imaged as described above.
CCF4 measurements. Quantification of escape from vacuoles with the 
?-lactamase–CCF4 assay was performed following manufacturer’s instructions 
(Life Technologies). Macrophages seeded onto non-treated plates were 
infected for 1 h as described above, washed and then incubated for 1 h at 
room temperature in CCF4 in the presence of 2.5 mM probenicid (Sigma). 
Live (propidium iodide–negative) cells were used for quantification of cells 
containing cytosolic F. novicida, with excitation at 405 nm and detection at 
450 nm (cleaved CCF4) or 510 nm (intact CCF4).
Flow cytometry. For assessment of bacterial replication by flow cytometry, 
macrophages seeded onto untreated plates were infected as described above 
with GFP-expressing F. novicida strains. At 8 h after infection, cells were 
lifted with trypsin and were immediately analyzed by flow cytometry on a 
FACSCanto II cytometer (BD Biosciences). Dead cells were excluded on the 
basis of staining with propidium iodide.
ImageStream flow cytometry. Macrophages infected with GFP-expressing 
bacteria were fixed in 4% PFA and were analyzed on an ImageStream X Mark II 
(Amnis; EMD-Millipore) with Inspire software, with the extended depth- 
of-field function activated to increase the accuracy of spot counts. Images of 
single cells were analyzed with Ideas software (Amnis; EMD-Millipore) with 
the following steps (each step being confirmed by visualization of at least 20 
single cells). Doublets and debris were excluded by morphological param-
eters (aspect ratio and area in the brightfield channel). Defocused images 
were eliminated by the Gradient RMS function of the brightfield function. 
For spot counts and definition of the mean fluorescence of single bacterium, 
the specific GFP fluorescence signal was defined by application of a mask 
combining an intensity threshold and a spot to cell background ratio (peak) 
function. Automatic spot counts were performed with the mask described 
above. Cells containing a single spot (either a single bacterium or a tight cluster 
of several bacteria) were gated. The area of the specific signal was analyzed in 
single cells on the gated population. For the exclusion of bacterial clusters and 
quantification of the fluorescence of single bacterium, the mean fluorescence 
intensity was calculated on the GFP+ signal covering an area of 1 ? 0.5 ?m2 
in 1,599 cells.
Bacteria in single cells were quantified by the automatic spot count 
function or their numbers were calculated based on the fluorescence of single 
bacterium. The quantification was identical for cells containing fewer than 
seven bacteria (R2 > 0.99). For higher intracellular burden, the spot-count 
function largely underestimated the number of bacteria per cell due to 
the difficulty to discriminate bacterial cluster. We thus relied on the specific 
fluorescence of the bacteria within the cells as defined by the mask described 
above and the calculated fluorescence value of single intracellular bacterium 
to quantify bacteria per cell. The mask was applied to at least 10,000 images of 
single cells per sample to extract the specific fluorescence of the intracellular 
bacteria in single cells.np
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ASC ﬁlament formation serves as a signal
ampliﬁcation mechanism for inﬂammasomes
Mathias S. Dick1, Lorenzo Sborgi2, Sebastian Ru¨hl1, Sebastian Hiller2 & Petr Broz1
A hallmark of inﬂammasome activation is the ASC speck, a micrometre-sized structure
formed by the inﬂammasome adaptor protein ASC (apoptosis-associated speck-like protein
containing a CARD), which consists of a pyrin domain (PYD) and a caspase recruitment
domain (CARD). Here we show that assembly of the ASC speck involves oligomerization of
ASCPYD into ﬁlaments and cross-linking of these ﬁlaments by ASCCARD. ASC mutants with a
non-functional CARD only assemble ﬁlaments but not specks, and moreover disrupt
endogenous specks in primary macrophages. Systematic site-directed mutagenesis of
ASCPYD is used to identify oligomerization-deﬁcient ASC mutants and demonstrate that ASC
speck formation is required for efﬁcient processing of IL-1b, but dispensable for gasdermin-D
cleavage and pyroptosis induction. Our results suggest that the oligomerization of ASC
creates a multitude of potential caspase-1 activation sites, thus serving as a signal ampliﬁ-
cation mechanism for inﬂammasome-mediated cytokine production.
DOI: 10.1038/ncomms11929 OPEN
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D
etection of pathogens by the innate immune system relies
on germline-encoded pattern recognition receptors
(PRRs), which recognize a variety of pathogen-derived
molecules, known as pathogen-associated molecular patterns
(PAMPs), and host-derived danger signals, known as danger-
associated molecular patterns1. Although most PRRs initiate
transcriptional responses, such as the expression of cytokines2,3, a
subset of cytosolic PRRs promote the assembly of inﬂammasome
complexes and subsequent activation of the cysteine protease
caspase-1 (refs 4,5). To date, only members of the NOD-like
receptor (NLR) family, the PYHIN protein family and PYRIN
were shown to assemble inﬂammasomes in response to different
cytosolic PAMPs or danger-associated molecular patterns5,6.
A unifying feature of all these receptors is either a pyrin domain
(PYD) or a caspase recruitment domain (CARD), both of which
belong to the death-fold domain superfamily. On the basis of the
presence of these domains, the receptors can be classiﬁed as PYD-
containing receptors (NLRP3: NLR family, PYD containing 3;
AIM2: absent in myeloma 2; pyrin) or CARD-containing
receptors (NLRC4: NLR family, CARD containing 4; NLRP1:
NLR family, PYD containing 1). After receptor activation and
oligomerization, these domains recruit the adaptor protein ASC
(apoptosis-associated speck-like protein containing a CARD) and
pro-caspase-1 into the complex through homotypic domain–
domain interactions. Within the inﬂammasome, pro-caspase-1 is
activated by dimerization and auto-proteolysis, and the
proteolytically active hetero-tetramer is released7. Several
substrates of caspase-1 have been identiﬁed, among them
the pro-forms of the cytokines interleukin (IL)-1b and IL-18
(refs 7–9). Another consequence of inﬂammasome activation is
the induction of a pro-inﬂammatory cell death called
pyroptosis10. Pyroptosis is driven by the amino-terminal
cleavage fragment of gasdermin-D, a protein cleaved by
caspase-1, and results in the lysis of the host cell and
subsequent release of cytoplasmic content, among them
processed IL-1b and IL-18 (refs 11,12).
Recent studies have started to elucidate the role of the
inﬂammasome adaptor protein ASC13–15, a bipartite protein
composed of a PYD and a CARD, also known as PYCARD16,17.
ASC has previously been regarded as a simple adaptor protein
that links PYD-containing receptors to the CARD-containing
caspase-1, via homotypic PYD–PYD and CARD–CARD
interactions18. However, its role appears to be more complex,
as on receptor activation ASC also forms the so-called ASC speck,
a macromolecular form of the inﬂammasome with a diameter of
B1–2 mm19,20. Formation of the ASC speck is independent of
caspase-1 activity, but requires the oligomerization of ASC into
large insoluble aggregates20,21. These ASC aggregates are stable
and have even been shown to be released into the extracellular
space, after pyroptosis induction, where they can trigger
prolonged inﬂammasome activation in phagocytic cells22,23.
Analyses of stimulated emission depletion microscopy images
and electron micrographs suggest an irregular, ﬁlamentous
shape22,23. Consistently, we and others have shown that ASC
oligomerizes into long helical ﬁlaments via its PYD13–15. Despite
the advances regarding the atomic structure of the ASC ﬁlament,
whether the ASC speck is the functional unit of the
inﬂammasome is unclear. Several inﬂammasome receptors (for
example, NLRC4 and mouse Nlrp1b) contain a CARD instead of
a PYD and are able to recruit caspase-1 even in the absence of
ASC. Indeed, we and others have shown that ASC is not required
for cell death induction by these receptors24–28. Nonetheless,
activation of CARD-containing receptors results in ASC speck
formation in wild-type (WT) cells, but how their CARD initiates
ASC ﬁlaments is unknown. Furthermore, it is unclear whether
ASC oligomerization itself is required for inﬂammasome
signalling. Previous mutagenesis studies of ASC could not
address the role of ASC oligomerization in signalling, as they
were based on overexpression of ASC mutants in HEK293 cells,
which is prone to artefact generation and lacks the means to study
the effects on downstream signalling13,29,30.
Here we use retroviral expression of ASC mutants in
Asc-deﬁcient immortalized mouse macrophages, to address the
mechanism of ASC speck formation and the functional relevance
of ASC ﬁlament formation for inﬂammasome signalling.
Our results reveal an architectural role for the ASCCARD, showing
that it is required to link individual ASC ﬁlaments towards
forming the dense ASC speck. Furthermore, we show that ASC
bridging molecules are necessary to allow CARD-containing
receptors the initiation of ASC ﬁlament formation. Finally, we use
site-directed mutagenesis of the ASCPYD–ASCPYD interaction
interfaces to identify mutations that disrupt ASC ﬁlament
formation without affecting the interaction to receptor PYDs.
Surprisingly, such ASC mutants are still able to initiate caspase-1-
dependent gasdermin-D maturation and subsequent cell death,
but lack the ability to form ﬁlaments, to assemble ASC specks and
to process IL-1b, thus uncoupling the two major downstream
signalling pathways. In conclusion, our data show that the ASC
speck has a function in inﬂammasome signalling and support a
model in which the rapid oligomerization of ASC via its PYD
creates a multitude of potential caspase-1 activation sites, thus
serving as a signal ampliﬁcation mechanism for inﬂammasome
signalling.
Results
Distinct roles for the ASCPYD and ASCCARD in speck assembly.
Although ASC is the main structural component of the ASC
speck20,24, conﬂicting reports have implicated either the ASCPYD
or the ASCCARD in speck assembly13,31,32. To address the role of
the ASCPYD and the ASCCARD in speck formation and
downstream signalling, we transduced immortalized Asc /
murine bone marrow-derived macrophages (BMDMs) with
ﬂuorescently tagged full-length ASC (ASCFL) or ASCPYD and
ASCCARD alone (Fig. 1a). As overexpression of ASCFL can result
in aggregation even in the absence of activated receptor19, we
selected individual clonal lines that did not display any
autoactivation when unstimulated (Supplementary Fig. 1a).
To test the functionality of these constructs, cells were primed
with lipopolysaccharide (LPS) and transfected with the synthetic
DNA analogue poly(deoxyadenylic-deoxythymidylic) acid
(poly(dA:dT)), an activator of AIM2 (refs 33,34). mCherry-
tagged ASCFL, expressed in Asc / cells, promoted pyroptosis
(as measured by the release of lactate dehydrogenase (LDH)) and
IL-1b release (measured by enzyme-linked immunosorbent assay
(ELISA)), to levels seen in immortalized WT macrophage
controls (Fig. 1b). We also observed comparable levels of IL-
1b/-18 and caspase-1 processing and release by western blotting
(Supplementary Fig. 1b). In contrast, neither the ASCPYD nor
ASCCARD restored cell death, IL-1b/-18 secretion or caspase-1
cleavage on AIM2 activation (Fig. 1b and Supplementary Fig. 1b).
Similarly, expression of the individual domains did not restore
inﬂammasome signalling in response to extracellular ATP,
an NLRP3 activator35 (Supplementary Fig. 1c,d).
Heterologous expression of ASCPYD and ASCCARD or CARDs
of mitochondrial antiviral-signalling protein (MAVS), retinoic
acid-inducible gene 1 (RIG-I) and pro-caspase-1 results in the
formation of ﬁlaments of varying length in different cell types and
in vitro13,36–40. However, it is possible that such ASCPYD or
ASCCARD ﬁlaments are overexpression artefacts, as ASCFL
normally forms a distinct dense speck structure20. To assess the
ability of ASCPYD and ASCCARD to form macromolecular
assemblies, we examined the above described cell lines by
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microscopy, following inﬂammasome stimulation. As expected,
activation of AIM2 or NLRP3 induced the formation of
perinuclear specks in cells expressing mCherry-tagged ASCFL
(Fig. 1c and Supplementary Fig. 1e,f). In line with the reported
ability of ASC to form ﬁlaments13,15, specks formed by ASCFL
had a dense core with emanating ﬁlaments (Fig. 1c). Instead of
forming similarly dense specks, the ASCPYD assembled into
ﬁlaments on the engagement of NLRP3 or AIM2 (Fig. 1c). Of
note, ﬁlaments formed after NLRP3 or AIM2 activation differed
in their appearance, possibly due to distinct modes of how NLR
and PYHIN family members assemble complexes and initiate
ASC ﬁlaments13,41. Remarkably, these ﬁlaments had varying
lengths and widths, with some appearing clearly thicker than
90Å, the reported diameter of an ASCPYD ﬁlament13,15. Unlike
reported before, we observed that the ASCCARD was not able to
form macromolecular assemblies (Fig. 1c and Supplementary
Fig. 1e,f). Taken together, these data suggest that although
both domains of ASC are necessary for signalling, only the
ASCPYD forms ﬁlaments on inﬂammasome activation. This is
consistent with reports by us and others showing that full-length
ASC forms helical ﬁlaments in vitro via the ASCPYD (refs 13,15),
whereas the ASCCARD is exposed on the surface and not involved
in ASC ﬁlament formation15. As straight ﬁlaments are formed by
ASCPYD and compact specks are formed by ASCFL, our data also
suggest that the ASCCARD must contribute signiﬁcantly to the
macroscopic structure of the ASC speck.
ASCCARDs condense ASCPYD ﬁlaments into ASC specks. To
test whether ASCCARD is required to form ASC specks, we gen-
erated immortalized Asc / macrophage lines expressing
ASCD130R or ASCD134R (Fig. 2a and Supplementary Fig. 2a), two
mutations in surface-exposed residues of the ASCCARD that
abrogate interaction of the ASCCARD with the pro-caspase-1CARD
(ref. 31). As expected, Asc / macrophages expressing
ASCD130R or ASCD134R did not activate caspase-1, release
mature IL-1b or undergo pyroptosis in response to DNA
transfection or ATP treatment (Fig. 2b and Supplementary
Fig. 2b–d). ASCD130R and ASCD134R formed long ﬁlaments rather
than dense ASC specks in response to AIM2
and NLRP3 activation (Fig. 2c,d and Supplementary Fig. 2e,f),
similar to the ASCPYD alone, thus supporting our hypothesis
that a functional ASCCARD is required to assemble ASCPYD
ﬁlaments into a speck. To conﬁrm that these mutations not
only disrupt ASCCARD–pro-caspase-1CARD interactions but also
ASCCARD–ASCCARD interactions, we expressed enhanced green
ﬂuorescent protein (eGFP)-tagged ASCCARD in the presence of
reconstituted inﬂammasomes, formed by co-transfection of AIM2
with mCherry-tagged ASCFL, ASCPYD, ASCD130R or ASCD134R in
HEK293T cells. Co-localization and co-immunoprecipitation
assays demonstrated that GFP-ASCCARD was only able to interact
with WT ASC and not with ASCD130R or ASCD134R, conﬁrming
that the two mutations blocked ASCCARD–ASCCARD interaction
(Supplementary Fig. 2g,h).
If the ASCCARD organizes ASC ﬁlaments into dense specks,
we speculated that increasing levels of ASCCARD mutants would
disrupt specks formed by WT ASC, resulting in larger but less
dense ASC specks. Therefore, we retrovirally transduced various
ratios of mCherry-tagged WT and mCherry-tagged ASCD130R
into primary WT C57BL/6 macrophages (containing endogenous
ASC) and measured median speck size on the activation of AIM2
by poly(dA:dT) transfection or NLRP3 by Nigericin, a pore-
forming toxin35. Indeed, increasing levels of ASCD130R resulted in
a signiﬁcant increase in ASC speck size (Fig. 2e,f). As expected,
microscopy analysis of these large ASC specks showed that they
were also less dense and had a ﬁlamentous nature (Fig. 2g). Taken
together, these results support a model in which the ASC speck
observed in WT cells is composed of individual ASC ﬁlaments
that are formed via their PYDs and cross-linked to each other via
their CARDs (Supplementary Fig. 3a).
NLRC4 oligomerizes ASC via a bridging ASC molecule. Most
inﬂammasome-forming receptors contain a PYD and initiate
ASC ﬁlaments directly by homotypic PYD–PYD interactions.
Notable exceptions are NLRC4 and mouse Nlrp1b, which contain
a CARD and thus might recruit and activate caspase-1
directly42,43. Nevertheless, ASC promotes caspase-1 processing
and efﬁcient IL-1b/-18 release after NLRC4 and Nlrp1b
activation26,44. ASC specks can be observed after NLRC4
activation, but how CARD-containing receptors initiate
oligomerization of ASC is unknown. Theoretically, NLRC4
could initiate ASC oligomerization either by (i) NLRC4CARD–
ASCCARD interaction and ASCCARD oligomerization, (ii) hetero-
typic interaction between related death-fold domains, that is,
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Figure 1 | Both domains of ASC are required for signalling. (a) Schematic
representation of the domain organization of ﬂuorophore-tagged (mCherry
or enhanced GFP (eGFP)) WT ASC (ASCFL), ASCPYD and ASCCARD
constructs. (b) Release of LDH (assessing cell death) and IL-1b from
LPS-primed immortalized WT, Asc / or Asc / BMDMs expressing
ASCFL, ASCPYD or ASCCARD 3 h after poly(dA:dT) transfection (1mgml 1).
(c) Representative images of cell lines from (b) 3 h after poly(dA:dT)
transfection (1 mgml 1) or 1 h after ATP treatment (5mM). DNA (blue,
Hoechst), ASCFL or ASCPYD (red) and ASCCARD (green). Scale bars,
10mm. Data (b,c) are representative of three independent experiments.
Graphs show the mean and s.d. from quadruplicate wells. See also
Supplementary Fig. 1.
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by a non-canonical NLRC4CARD–ASCPYD interaction or (iii) via
bridging ASC molecules that would be linked with NLRC4 via
CARD–CARD interactions and provide their free PYDs as seeds
for ASCPYD ﬁlament formation. To determine which domain of
ASC was necessary for ASC speck formation after NLRC4
activation, we infected the above described cell lines harbouring
the single domains of ASC with log-phase Salmonella enterica
serovar Typhimurium SL1344 (Salmonella Typhimurium), a
robust activator of NLRC4 (refs 45,46). Consistent with
published reports24,27,47, immortalized Asc / BMDMs still
induced cell death, whereas efﬁcient IL-1b processing and release
required ASC (Fig. 3a). Expression of ASCFL in Asc / cells
restored IL-1b release, but neither the ASCPYD nor ASCCARD
alone were able to functionally restore inﬂammasome activation
(Fig. 3a). We next analysed whether the ASCPYD or ASCCARD
would form specks or ﬁlaments after NLRC4 activation by
microscopy. Although ASCFL formed specks, ASCPYD alone did
not initiate ﬁlaments following activation of NLRC4 (Fig. 3b,c),
which was in contrast to what we had observed for PYD-
containing receptors (Fig. 1c). In addition, cells expressing
ASCCARD alone did not form any specks or macromolecular
ﬁlaments, again suggesting that the ASCCARD in the endogenous
setting is not able to form ﬁlaments (Fig. 3b,c). These results
exclude the possibilities that ASC specks form via CARD
oligomerization after NLRC4 activation, or that a heterotypic
NLRC4CARD–ASCPYD interaction initiates ASC ﬁlament
formation. Instead, they suggest that one or several bridging
molecules of ASC are required to initiate ASC ﬁlament formation
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after NLRC4 activation, and that in these conditions ASC
oligomerization into ﬁlaments and specks also proceeds via the
ASCPYD.
We also examined cells expressing ASCD130R and ASCD134R
mutants, which are defective for CARD–CARD interactions
(Supplementary Fig. 2g,h (ref. 31)). As expected, expression of
these mutants in Asc / macrophages did not complement the
release of mature IL-1b after NLRC4 activation (Fig. 3d).
Furthermore, we did not observe the formation of ﬁlaments or
specks in cells expressing ASCD130R or ASCD134R (Fig. 3e),
conﬁrming the requirement for a functional ASCCARD for ASC
oligomerization by NLRC4. Finally, we also tested our notion that
the ASCCARD is required to condense ASC ﬁlaments into a speck
in the context of NLRC4 activation. Primary WT C57BL/6
BMDMs (containing endogenous ASC, thus enabling initiation of
ASC oligomerization) were retrovirally transduced with varying
ratios of mCherry-tagged ASCFL or ASCD130R and the speck
diameter was measured on S. Typhimurium infection (Fig. 3f).
The increase in speck size concurring with increasing concentra-
tions of the ASCD130R mutant indicated that also in the NLRC4
inﬂammasome the ASCCARD condenses the ASC ﬁlaments
into the speck. In conclusion, our results suggested a triple
functional role for ASCCARD in the NLRC4 inﬂammasome: (1)
mediating the interaction with pro-caspase-1 (refs 17,31), (2)
condensing ASCPYD ﬁlaments into the speck and (3) initiating
ASC oligomerization through bridging ASC molecules
(Supplementary Fig. 3b).
Pyroptosis induction is independent of ASC oligomerization.
Having elucidated the general architecture of the ASC speck, we
next investigated whether the ASC speck constitutes the active,
signalling-competent inﬂammasome. Higher-order signalosomes
were reported for other innate immune signalling pathways
(Toll-like receptors, receptor-interacting serine/threonine-protein
kinase 2 (RIP2K) and MAVS) and could promote signal ampli-
ﬁcation and digital all-or-nothing responses48, leading us to
hypothesize that ASC oligomerization and ﬁlament formation
might have a similar function for inﬂammasome signalling.
Within the ASCPYD ﬁlaments that form the backbone of ASC
specks in human and murine cells (Supplementary Fig. 4a
(refs 13,15)), individual ASCPYDs interact with other six adjacent
ASCPYDs through three asymmetric interfaces, types I–III
(Fig. 4a). Mutations targeting these interfaces can abrogate
ASC ﬁlament formation in vitro or in cell overexpression
systems13,29,49. As these mutations also most probably abrogate
the interaction between the receptorPYD and ASCPYD, and/or
were only tested in an artiﬁcial overexpression system, a deﬁnite
conﬁrmation that ASC ﬁlament formation is required for
inﬂammasome signalling is still missing50. Identiﬁcation of
mutations that abrogate ASC oligomerization but leave
ASC–receptor interaction intact allowed us to characterize the
role of ASC ﬁlaments in inﬂammasome signalling. Therefore, we
generated a number of clonal immortalized Asc / macrophage
lines expressing different mCherry-tagged ASC mutants targeting
all three interaction interfaces (Fig. 4a and Supplementary
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Fig. 4b–d). Next, we assessed the effects of these mutations on
ASC speck/ﬁlament formation on AIM2 activation by poly(dA:dT)
transfection. Mutations targeting interface I (that is, K21A, K26A,
D48N and D51R) completely abrogated the ﬁlament formation as
determined by microscopy (Fig. 4b upper panel and
Supplementary Fig. 4e). This is consistent with interface I being
the most extensive interface and required for the propagation of
single layers of the ﬁlament13,15. In contrast, mutations in
interfaces II and III displayed a larger variability, ranging from no
defect in ASC speck formation (Y36A, E62A (interface II) or
P40A (interface III)), intermediate phenotypes (M76A (interface
II) or L15A (interface III)) to complete abrogation in ASC speck
formation (Y59A, Q79E, E80R (interface II) or E13R and R41E
(interface III)) (Fig. 4c,d upper panels and Supplementary
Fig. 4e). Taken together, these data suggest that the formation
of ASC specks requires all three interfaces of ASCPYD.
We next tested how these mutations affect downstream
inﬂammasome signalling by measuring IL-1b secretion
(Fig. 4b–d middle panels) and pyroptosis (Fig. 4b–d lower
panels). In line with the loss of ASC speck formation, interface I
proved to be essential for induction of downstream inﬂamma-
some signalling (Fig. 4b). Macrophages expressing mutants in
interface III of ASCPYD displayed similar phenotypes as interface
I mutations: the ability to form ASC specks correlated with both
IL-1b secretion and pyroptosis, that is, mutants either lost all
inﬂammasome signalling (E13R and R41E), were partially
affected (L15A) or not affected at all (P40A) (Fig. 4d). These
results show that interface III is important for induction of
downstream inﬂammasome signalling, albeit some mutations are
tolerated.
Mutants in interface II displayed a differential signalling
phenotype (Fig. 4c). Although some mutations had no or only a
very small effect on inﬂammasome signalling (Y36A, E62A and
M76A) or abrogated inﬂammasome signalling altogether (Q79E),
we identiﬁed two mutations (Y59A and E80R) that retained the
ability to induce cell death, while losing the ability to release
mature IL-1b and to form ASC specks in response to AIM2
stimulation (Fig. 4c middle and lower panels, highlighted in grey).
Of note, the ELISA assay displays a higher sensitivity for the
mature form of IL-1b than the pro-form, thus pro-IL-1b, which is
potentially released into the supernatant by pyroptosis, is poorly
detected (Supplementary Fig. 5). To test whether the phenotype
of the different mutants is speciﬁc to the AIM2 inﬂammasome,
we analysed ASC speck formation, secretion of mature IL-1b and
pyroptosis in response to NLRP3 stimulation by ATP treatment.
Asc / macrophages expressing the ASC interface I, II and III
mutants showed the same phenotype for NLRP3 stimulation as
for AIM2 stimulation (Supplementary Fig. 6a–c). Importantly,
also ASCY59A and ASCE80R mutations abrogated speck formation
and IL-1b secretion but still promoted pyroptosis on NLRP3
stimulation (Supplementary Fig. 6b, highlighted in grey). Finally,
we also examined IL-1b release and pyroptosis of macrophages
expressing interface II mutants treated with Clostridium difﬁcile
Toxin B (TcdB). TcdB was recently described to activate the pyrin
inﬂammasome, which senses modiﬁcations of Rho GTPases6.
Again, Asc / macrophages expressing ASCY59A or ASCE80R
were competent for cell death induction but could not efﬁciently
release IL-1b (Supplementary Fig. 6d, highlighted in grey). In
conclusion, our site-directed mutagenesis approach identiﬁed two
mutations, Y59A and E80R, in the inﬂammasome adaptor ASC
that uncouple pyroptosis from ASC speck formation and cytokine
secretion.
ASC oligomerization mutants maintain receptor interaction.
As cell death was still observed in cells expressing ASCY59A and
ASCE80R, we speculated that the mutant proteins retained the
ability to interact with the PYD of the receptor, but lost the
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ability to oligomerize into ASC ﬁlaments. To investigate this,
we reconstituted the AIM2 inﬂammasome by co-expressing
V5-tagged AIM2 with ASCFL or the ASCK21A, ASCY59A or
ASCE80R mutants in HEK293T cells. AIM2 interactors were then
immunoprecipitated using an anti-V5 antibody and analysed by
western blotting (Fig. 5a). Consistent with our notion, ASCY59A
and ASCE80R retained the ability to interact with AIM2, similar to
WT ASC. In contrast, ASCK21A did not interact with AIM2,
possibly explaining the clear-cut phenotypes of interface I
mutants (Fig. 4b and Supplementary Fig. 6b).
Given that ASCY59A and ASCE80R mutants still interacted with
the receptor (Fig. 5a), but did not form any ASC ﬁlaments/specks
(Fig. 4c and Supplementary Fig. 4e), we speculated that the
mutations abolished or reduced the ability of ASC to organize
itself into ﬁlaments following the recruitment to the activated
receptor. Based on our previous observation that puriﬁed
ASCPYD or ASCFL form ﬁlaments in vitro15, we established an
assay to monitor the kinetics of this oligomerization process by
dynamic light scattering and analysed the kinetics of ﬁlament
formation for WT ASCPYD and the above-mentioned mutants
(Fig. 5b,c and Supplementary Fig. 7a,b). Although WT PYD
rapidly formed well-structured ﬁlaments, the K21A mutant was
no longer able to oligomerize correctly and formed unspeciﬁc
aggregates (Fig. 5d). Interestingly, E80R also lost the ability to
oligomerize into ordered ﬁlaments, whereas the Y59A mutant
formed well-ordered ﬁlaments, but at a much slower rate than the
WT protein (Fig. 5b–d and Supplementary Fig. 7a,b). Thus, these
results conﬁrmed that the ASC–receptor interaction and the ASC
ﬁlament formation can be uncoupled, and that the ability to
rapidly form ﬁlaments/specks strongly correlates with the levels
of cytokine production but not cell death.
Gasdermin-D cleavage is independent of ASC oligomerization.
The observation that even in the absence of ASC oligomerization
inﬂammasome activation still promotes cell death but not
cytokine release (Fig. 4c, Supplementary Fig. 4e) was reminiscent
of NLRC4 activation in Asc / macrophages24. In the absence
of ASC, NLRC4 interacts with pro-caspase-1 to initiate cell death
but not efﬁcient caspase-1 autoprocessing and cytokine secretion.
We therefore examined to what level ASCY59A and ASCE80R were
able to promote caspase-1 autoprocessing on activation of the
AIM2 inﬂammasome. In contrast to cells expressing ASCFL,
macrophages expressing the mutant proteins displayed
signiﬁcantly reduced levels of caspase-1 processing, as
determined by western blotting for the released p20 subunit
(Fig. 6a). Furthermore, caspase-1 autoprocessing correlated with
the amount of released bioactive IL-1b (Figs 4c and 6a), but not
with the induction of cell death (Fig. 4c) and the release of the
danger signal high mobility group box 1 (HMGB1) into the cell
supernatants (Fig. 6a), an alternative marker for cell lysis during
inﬂammasome activation51. Similarly, results were obtained on
activation of the NLRP3 inﬂammasome (Supplementary Fig. 8a).
To exclude the possibility that the observed cell death is induced
through caspase-1-independent pathways, we knocked out Casp1
by CRISPR-Cas9-mediated gene targeting52,53 in the cell lines
expressing ASCFL, ASCY59A or ASCE80R. Western blotting for
pro-caspase-1 conﬁrmed successful targeting (Supplementary
Fig. 8b). Casp1 deﬁciency signiﬁcantly abrogated pyroptosis
induction in cells expressing ASCFL, ASCY59A or ASCE80R
(Fig. 6b), thus conﬁrming that the cell death observed in the
parental cell lines was caspase-1 dependent. Taken together, these
data conﬁrm that caspase-1 processing is not a prerequisite
for induction of cell death, expanding previous ﬁndings from
CARD-containing inﬂammasome receptors24 to PYD-containing
receptors.
Recent reports showed that a major substrate of caspase-1
responsible for pyroptosis is gasdermin-D, and that Gsdmd-
deﬁciency abrogates pyroptosis11,12. Caspase-1 cleaves
full-length gasdermin-D, whereby the active N-terminal
fragment (gasdermin-DNterm) is generated (Supplementary
Fig. 8c,d), which induces pyroptotic cell death11,12.
Consistently, CRISPR-Casp9-mediated Gsdmd knockout
(Supplementary Fig. 8e) reduced cell death signiﬁcantly in
response to AIM2 and NLRP3 activation (Supplementary
Fig. 8f,g). As ASCY59A and ASCE80R mutants induced cell
death, we speculated that gasdermin-D is still processed in cells
expressing these mutant forms of ASC. Indeed, although
gasdermin-D was not processed in Asc / macrophages on
stimulation of AIM2 or NLRP3, we observed gasdermin-D
processing to its 30 kDa gasdermin-DNterm fragment in Asc /
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can be uncoupled genetically. (a) Western blot analysis of the interaction
of AIM2 with ASCFL or the indicated ASC mutants. AIM2-V5 was
immunoprecipitated from lysates of HEK293T cells co-transfected with
AIM2-V5 and the indicated ASC mutants. Co-immunoprecipitating proteins
were identiﬁed using anti-ASC and anti-V5. *Immunoglobulin heavy chain.
Results shown are representative from two independent experiments.
(b) Filament formation of WT ASCPYD and its single amino-acid variants
K21A, Y59A and E80R in vitro monitored by dynamic light scattering.
Normalized growth signals (IN) are reported as a function of time for one
representative experiment for each variant (dots). Best ﬁts to single
exponential functions are shown with solid lines. (c) Kinetic rate constants
kF of ﬁlament formation obtained from three independent experiments.
(d) Representative negative-stained TEM micrographs of ﬁlament formed
by ASCPYD and its variants after 350min of incubation at physiological pH
condition. Scale bars, 200nm. See also Supplementary Figs 7 and 9.
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macrophages expressing ASCFL, ASCY59A and ASCE80R (Fig. 6c
and Supplementary Fig. 8h). Furthermore, processing of
gasdermin-D on AIM2 stimulation is dependent on caspase-1
in cells harbouring oligomerization-deﬁcient ASC mutants, as
Casp1 deﬁciency abrogated gasdermin-D cleavage (Fig. 6c). These
results indicated that gasdermin-DNterm causes the cell death
observed in these mutations. As signiﬁcant levels of cell death can
be observed in Asc-deﬁcient macrophages after NLRC4
activation24, but caspase-1 processing is reduced below
detection levels, we next determined whether gasdermin-D is
processed under these conditions. Indeed, we found that the
induction of cell death in S. Typhimurium-infected WT, Asc /
and Casp1 / /Casp11 / macrophages (Fig. 6d) correlated
with detectable levels of processed gasdermin-D (Fig. 6e).
Furthermore, CRISPR-Cas9-mediated Gsdmd knockout
conﬁrmed that gasdermin-D played an essential role in
inducing pyroptosis during S. Typhimurium infections
(Supplementary Fig. 8i). Taken together, these results conﬁrm
that even the smallest amounts of active caspase-1, as judged by
the amount of processed caspase-1 p20 subunits, are sufﬁcient to
efﬁciently process gasdermin-D and trigger gasdermin-D-induced
cell death. On the other hand, large amounts of processed, active
caspase-1 are required to produce detectable amounts of mature,
bioactive IL-1b as seen by the direct correlation of the level of
caspase-1 processing with the levels of cytokine release.
Importantly, the ability of ASC to form ﬁlaments and ASC
specks correlates with caspase-1 activation and cytokine
processing, thus supporting a model in which the rapid
formation of ASC ﬁlaments acts as a signal ampliﬁcation
mechanism for inﬂammasomes, generating a multitude of
caspase-1 activation sites and thus enabling the cells to rapidly
mature IL-1b before the onset of pyroptosis.
Discussion
The formation of higher-order signalling machineries, signalo-
somes, for transmission of receptor activation information to
cellular responses is an emerging theme in signal transduction48.
It is particularly important in innate immune signalling, where
the signal generated by a few ligand–receptor interactions needs
to trigger an appropriate cellular response. Formation of
oligomers has been reported for different signalling adaptors,
for example, B-cell lymphoma/leukemia 10 (Bcl10) or MAVS
ﬁlaments, the Myddosome36,54,55 and others. However, the
archetypical supramolecular assembly formed during
inﬂammasome activation, the ASC speck, has remained
relatively poorly understood. Here we present evidence that the
formation of ASC speck by oligomerization of the inﬂammasome
adaptor protein ASC acts as a signal ampliﬁcation mechanism for
inﬂammasomes (Fig. 7), as the rapid formation of ASCPYD
ﬁlaments that expose ASCCARD on their surface creates a
multitude of pro-caspase-1 recruitment and activation sites. We
speculate that such a system might therefore be able to detect the
smallest amounts of PAMPs in the host cell cytosol, as recent
reports have shown that a single ligand molecule (ﬂagellin, PrgJ)
is sufﬁcient to initiate assembly of a NLR family, apoptosis
inhibitory protein (NAIP) and 10–12 NLRC4 proteins into a
wheel-shaped receptor oligomer that acts as seed for ASC
oligomerization39,56.
Our result reveals that this signal ampliﬁcation mechanism
only applies to cytokine maturation, whereas gasdermin-D-
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Figure 6 | Caspase-1 but not gasdermin-D processing depends on ASC oligomerization. (a) Western blot analysis for cleaved caspase-1 p20, IL-1b p17,
and HMGB-1 in cell supernatants (SN) and pro-caspase-1, pro-IL-1b and HMGB-1 in cell lysates (lys) of LPS-primed immortalized Asc / BMDMs or
Asc / BMDMs expressing ASCFL, ASCY59A or ASCE80R 3 h after poly(dA:dT) transfection (1mgml 1). (b) Release of LDH from LPS-primed
immortalized Asc / BMDMs or Asc / BMDMs expressing ASCFL, ASCY59A or ASCE80R, or derived Casp1 knockouts 3 h after poly(dA:dT) transfection
(1mgml 1). (c) Western blot analysis for processing of full-length gasdermin-D (GSDMDFL) into the active N-terminal fragment (GSDMDN-term) in
combined lysates and supernatants (lys þ SN) of LPS-primed immortalized Asc / BMDMs expressing ASCFL, ASCY59A or ASCE80R, or derived Casp1
knockouts 3 h after poly(dA:dT) transfection (1 mgml 1). Arrowhead, gasdermin-DNterm p30; *a cross-reacting band. (d) Release of LDH from LPS-primed
primary C57BL/6 WT (WT), Casp1 //Casp11 / or Asc / BMDMs infected with S. Typhimurium (multiplicity of infection (MOI)¼ 10, 1 h). (e)
Western blot analysis for processing of full-length gasdermin-D (GSDMDFL) into the active N-terminal fragment (GSDMDN-term) in combined lysates and
supernatants (lysþ SN) of LPS-primed primary C57BL/6 WT (WT), Casp1 //Casp11 / or Asc / BMDMs infected with S. Typhimurium (MOI¼ 10,
1 h) or left uninfected. Arrowhead, gasdermin-DNterm p30; *a cross-reacting band; ** a S. Typhimurium-speciﬁc cross-reactive band. See also
Supplementary Figs 8 and 9.
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induced pyroptotic cell death could be observed even in the
absence of ASC oligomerization. Why would cells need to amplify
the receptor-generated signal to process IL-1b/-18? We speculate
that a cell will inevitably progress towards pyroptosis, once a few
molecules of caspase-1 have been activated, given the rapid
kinetics by which gasdermin-D is processed57 and the strong
toxicity of the gasdermin-DNterm fragment11,12. This fate leaves a
limited time window to mature the pro-forms of IL-1b/-18 to
their bioactive form. As processing of IL-1b/-18 occurs with slow
kinetics, increasing the amount of active caspase-1 is a means to
generate large amounts of bioactive IL-1b/-18 in the available
time window. Consistent with this notion we have observed that
gasdermin-D processing does not correlate with the overall level
of active caspase-1. Furthermore, pyroptosis has been observed to
occur within 30–60min in stimulated cells, whereas ASC speck
formation was reported to proceed much faster23,58, with all
cytosolic ASC being incorporated into a speck in o3min20,59.
Thus, ASC speck formation might serve to activate sufﬁcient
amounts of caspase-1 to generate enough bioactive cytokines
before the cell lyses and releases its intracellular content,
including proteolytically matured cytokines.
Although recent studies revealed that ASC specks are
ﬁlamentous in nature22,23, consistent with recently reported
structures of human and murine ASCPYD ﬁlaments13,15, it was so
far unknown how these ﬁlaments assemble into a speck. Our
mutagenesis studies indicates that the clustering of ASCPYD
ﬁlaments and ﬁnally their condensation into a dense ASC speck
structure is mediated by the ASCCARD, which, as we have
shown15, is exposed on the surface of the ASCPYD ﬁlament. These
results have uncovered a function for the ASCCARD in ASC speck
formation, beyond its role as adaptor domain between receptor
and caspase-1. How ASCCARDs condense ASCPYD ﬁlaments is
unknown, but it can be assumed that either dimeric interactions
between ASCCARDs or limited oligomerization of ASCCARD from
different ﬁlaments could build lattices interconnecting the
ASCPYD ﬁlaments. Interestingly, the same residues in ASCCARD
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Figure 7 | Model of signal ampliﬁcation by ASC ﬁlaments. (a) CARD-containing receptors recruit the adaptor protein ASC via homotypic CARD–CARD
interactions, that is, a bridging ASC molecule. This step nucleates the ASCPYD of several bridging ASC molecules, leading to the formation of an ASCPYD
ﬁlament, which is condensed into the ASC speck by the ASCCARD. Filament formation promotes the activation of large quantities of caspase-1, thus
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pro-caspase-1 processing might not happen. The few molecules of caspase-1 are sufﬁcient to effectively induce pyroptosis, but cytokine processing is
reduced. (b) PYD-containing receptors can directly interact with ASC via homotypic PYD–PYD interactions, leading to ASCPYD ﬁlaments and ﬁnally the
ASC speck. As for CARD-containing receptors, this leads to caspase-1 activation and subsequent cytokine processing and pyroptosis. Mutations blocking or
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that are required for ASC–pro-caspase-1 interaction are also
needed for ASC speck formation. Notably, it has previously been
shown that phosphorylation of the ASCCARD at Y144/Y146 is not
only required for caspase-1 activation, but also for ASC speck
formation60,61 Our model of the ASC speck, which includes
interactions between the ASCCARD domains, now provides a
structural rationale for these data. To which extent ASC ﬁlaments
are still formed in the absence of ASCCARD phosphorylation
remains to be determined.
Recently, a uniﬁed assembly mechanism was proposed for the
PYD-containing receptors AIM2 and NLRP3: the receptors
nucleate clusters of ASC through PYD–PYD interactions, which
in turn nucleate caspase-1 ﬁlaments13. In analogy, it was
proposed that the CARD-containing receptor NLRC4 directly
nucleates caspase-1 ﬁlaments13,39, as in theory CARD-containing
receptors do not require ASC for caspase-1 recruitment.
Although direct recruitment of pro-caspase-1 to NLRC4 might
indeed happen in Asc-deﬁcient cells as we hypothesized before24,
it does not seem to efﬁciently activate caspase-1, because we and
others have reported that caspase-1 processing into its p20/p10
subunits and the levels of released mature cytokines are reduced.
Furthermore, a large number of ASC specks can be observed in
WT cells on NLRC4 activation24–28, indicating that ASC
nevertheless plays an important role in NLRC4 signalling. Our
results now indicate that the ASCCARD lacks the ability to form
higher-order oligomers at physiological concentrations, and that
even on NLRC4 activation ASC speck formation relies on the
ASCPYD. Our data thus support a model in which CARD-
containing receptors initiate ASC speck formation with the help
of ASC bridging molecules, and that the PYDs of these ASC
molecules nucleates an ASCPYD ﬁlament. Thus, the ASCCARD can
have a triple function in inﬂammasome signalling on CARD-
receptor activation.
In conclusion, our study gives insights into the architecture of
the ASC speck and the mechanism by which ASC ﬁlaments
assemble this structure. Furthermore, we provide experimental
evidence that ASC ﬁlament formation serves as an ampliﬁcation
mechanism in inﬂammasome signalling, and that this ampliﬁca-
tion serves to generate sufﬁcient mature cytokines before the
onset of pyroptotic cell death. Nevertheless, important questions
remain; the higher-resolution structure of the activated NLRC4
receptor has been recently reported39,56, yet how exactly such
receptor complexes with C10–C12 stoichiometry initiate the
3-start ASCPYD ﬁlaments is still unknown. Furthermore, the
structure of the whole ASC speck assembly, including receptor,
ASC and caspase-1, is still lacking and it remains unknown
whether other proteins participate in its formation. Finally,
additional theoretical and experimental approaches will be
necessary to understand if and how ASC speck formation
might impart threshold responses, reduce biological noise and
control temporal and spatial control of inﬂammasome signalling.
Methods
Cell culture. Immortalized BMDM cell lines were generated from bone marrow
using infection with a v-myc/v-raf-expressing J2 retrovirus24,62. WT and Asc /
immortalized murine BMDMs were cultured in DMEM (Sigma) supplemented
with 10% FCS (Bioconcept) and 10% 3T3-MCSF supernatant, and incubated at
37 C with 5% CO2.
Generation of monoclonal cell lines with mutations in ASC. Murine AscFL and
AscPYD were cloned with a carboxy-terminal mCherry tag and AscCARD with an
N-terminal enhanced GFP tag into V48, a derivative of the replication-defective
murine stem cell retroviral construct pMSCV2.2 (excision of the IRES-GFP by
EcoRI digestion, gift from Thomas Henry). Mutations were introduced by SOE
PCR using appropriate oligonucleotides (Supplementary Table 1) and cloned into
V48. GP2 packaging cells were transfected with the individual vectors (9 mg per
1.5 106 cells) and the lentviral envelope vector VSV-G (Addgene, 6 mg per
1.5 106 cells), and the retroviral particles were used to transduce Asc /
iBMDMs (106 cells). Seven days later, the transduced iBMDMs were sorted into
single cells based on the mCherry or enhanced GFP expression (FACS) and
grown up to clonal cell lines. Up to ten clones of each cell line were tested for
inﬂammasome activation and the level of ASC expression was assessed by western
blotting and a representative clone was selected for further analysis.
Retroviral transduction of primary BMDMs. For transduction of primary bone
marrow cells, retroviral particles were generated in Phoenix-Eco packaging cells
and used to transduce WT C57BL/6 bone marrow cells after 48 and 72 h of culture
in medium with 10% 3T3-MCSF supernatant. Inﬂammasome stimulation was
performed 4 days after the ﬁrst transduction24.
Inﬂammasome stimulation. Immortalized BMDMs (seeded at 250 000 cells
per ml in 96-well plates) were primed for 4 h with 100 ngml 1 LPS O55:B5
(Invivogen). The NLRP3 inﬂammasome was triggered by addition of 5mM
extracellular ATP (Sigma-Aldrich) for 60min. The AIM2 inﬂammasome was
triggered by transfection of 1 mgml 1 of the synthetic DNA analogue poly(dA:dT)
(Invivogen) using Lipofectamine 2000 (Invitrogen), according to the manu-
facturer’s protocol, in OptiMEM (Gibco) for 3 h. The NLRC4 inﬂammasome
was triggered by infection of the cells with S. enterica serovar Typhimurium
SL1344 at a multiplicity of infection of 10. The infection was synchronized by
centrifugation and continued for 60min. The pyrin inﬂammasome was triggered
by addition of 1 mgml 1 (ﬁnal concentration) of C. difﬁcile toxin B (CdtB, Enzo
Biotech) for 2.5 h.
Cell death and IL-1b release measurements. IL-1b release was measured by
ELISA (eBiosciences). Cell death was quantiﬁed by measuring LDH release
using the LDH Cytotoxicity detection kit (TaKaRa Clontech). To normalize
for spontaneous cell lysis, the percentage of cell death was calculated as follows:
[(LDH sample) (LDH negative control)]/[(LDH positive control) (LDH
negative control)] 100.
Imaging and quantiﬁcation of ASC speck formation. Cells were seeded on
coverslips (150 000 cells per coverslip) and treated as described above with the
addition of 25 mM Z-VAD-fmk (Bachem) to prevent detachment of pyroptotic
cells and therefore loss of cells with ASC specks. Coverslips were ﬁxed with 4%
paraformaldehyde (PFA) (15min, 37 C, Alfa Aesar) and washed with PBS. Nuclei
were stained with Hoechst 33342 (Life Technologies) for 10min and the slides
mounted using Vectashield (Vector Laboratories). For quantiﬁcations of ASC
aggregates (specks or ﬁlaments), ten random regions of interest were imaged at
 20 magniﬁcation (Leica DMI3000B inverted ﬂuorescence microscope, HCX PL
FLUOTAR objective, Leica DFC3000G camera and LAS AF Version 3 software)
and the number of ASC aggregates and cells were counted. For representative
images, the slides were imaged at  63 magniﬁcation (Leica point scanning
confocal ‘SP8’, HC PL APO CS2  63 objective, Leica AF software version 3).
For measurements of speck sizes, random regions of interest were images at
 63 magniﬁcation (Leica point scanning confocal ‘SP8’) and the largest diameters
of individual specks were measured using Fiji63.
Western blotting. For western blotting of supernatant and lysate samples, cells
were seeded at 106 cells per well in six-well plates and treated as described above.
Supernatants were precipitated with 10% trichloracetic acid, precipitates washed
with acetone and resuspended in 40ml 1 SDS–PAGE sample buffer and boiled at
95 C for 10min. Cells were lysed with 200ml 1 RIPA (50mM Tris-HCl pH 7.5,
150mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% NP-40, 1 protease
inhibitor cocktail (Roche)) for 30min on ice. Lysates were re-suspended in
5 SDS–PAGE sample buffer and boiled at 95 C for 10min64. For combined
supernatant and lysates, samples were prepared as above, but supernatant
precipitates were resuspended in lysate samples. Samples were run on 14%
(supernatants or lysates) or 12% (combined SNþ lysates) acrylamide gels (1 h,
170V, 40mA per gel), transferred to polyvinylidene diﬂuoride membranes (1 h,
100V constant), blocked in 5% milk in Tris-buffered salineþTween-20 (TBS-T)
and incubated with primary antibodies in 5% BSA–TBS-T for 16 h at 4 C or 2 h at
room temperature with agitation. Secondary antibodies were diluted 1:5,000 in 5%
milk–TBS-T and incubated for 1 h at room temperature. The membranes were
developed using either LumiGLO (KPL) or LumiGLO Reserve (KPL). The
following antibodies and dilutions were used: rat anti-Caspase-1 p20 (Genentech,
1:1,000; Supplementary Figs 1b,d and 2c,d) or mouse anti-Caspase 1 p20 (1:4,000,
AG20B-0042, AdipoGen; Fig. 6a and Supplementary Fig. 8a), rat anti-ASC
(Genentech, 1:2,000; Fig. 5a and Supplementary Fig. 2a,h) or rabbit anti-ASC
(1:1,000, AG25B-006, Adipogen, all other ﬁgures), rabbit anti-IL-18 (5180R-100,
Biovision, 1:1,000), goat anti-IL-1b (AF-401-NA, R&D, 1:1,000), mouse anti-GFP
(632381, Clontech, 1:1,000), mouse anti-mCherry (ab125096, Abcam, 1:1,000),
mouse anti-V5 (R960-25, Invitrogen, 1:1,000), rabbit anti-HMGB1 (GTX-101277,
Genetex, 1:1,000), mouse anti-gasdermin-D (GSDMDC1 (A-7), Santa Cruz
Biotechnology, 1:1,000; Supplementary Fig. 7), rabbit anti-gasdermin-D (1:2,000,
G7422, Sigma, all other ﬁgures) and mouse anti-b-actin (A1987, Sigma, 1:1,000).
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Co-immunoprecipitation. Co-immunoprecipitation was done according to a
modiﬁed protocol published previously49. For assessment of ASC/AIM2
interactions, 3 800,000 HEK293T cells were transfected with 2 mg per
well AIM2-V5 and ASC-mCherry (ASCFL, ASCK21A, ASCY59A or ASCE80R)
encoding plasmids at a ratio of 1:4 using linear polyethylenimine (PEI,
Polysciences) at a ratio DNA:PEI of 1:4 (refs 65,66). Twenty-four hours after
transfection, the cells were washed twice with ice-cold 1 PBS and lysed using
HEK lysis buffer (20mM HEPES pH 7.4, 10mM KCl, 1mM EDTA, 0.1mM
phenylmethylsulfonyl ﬂuoride, 1mM Na3VO4, 5mM NaF, 0.5 % Nonidet P-40 and
1 protease inhibitor cocktail (Roche)). Lysates were sonicated for 5 7 s before
removing debris and non-lysed cells by centrifugation (10,000 g, 15min, 4 C). The
samples were incubated with 1 mg mouse anti-V5 antibody (R960-25, Invitrogen)
or a control antibody (mouse anti-GFP, 632381, Clontech) with agitation for 16 h
at 4 C. For assessment of ASCCARD/ASCCARD interactions, 3 800 000 HEK293T
cells were transfected with 1 mg per well ASC-mCherry (ASCFL, ASCPYD,
ASCD130R or ASCD134R), 1 mg per well ASCCARD-GFP and 0.2 mg AIM2-V5, to
initiate ASC/ASC interactions using linear PEI. Forty hours after transfection, the
cells were washed, lysed and sonicated as described above. The samples were then
incubated with 1 mg mouse anti-mCherry antibody (ab125096, Abcam) or a control
antibody (mouse anti-HA, MMS-101R-200, Covance). The samples were then
incubated with agitation for 2 h at 4 C with 25 ml Pierce Protein A Plus Agarose
bead slurry (22810, Thermo Scientiﬁc). Beads were washed three times with lysis
buffer (centrifugation 1min 1,000 g, 4 C), resuspended in 2 SDS–PAGE sample
buffer (30 ml) and boiled at 95 C, before analysing the eluted proteins by western
blotting as described above.
CRISPR-Cas9-mediated Caspase1 and Gasdermin-D knockout. Two guide
RNAs52 targeting exon 4 of Casp1 (50-gagggcaagacgtgtacgag-30 and 50-cgagtgg
ttgtattcattat-30) and one guide RNA targeting exon 2 of Gsdmd (50-ggtca
agaatgtgatcaagg-30) were cloned into lentiCRISPRv2 harbouring a puromycin
resistance cassette (Addgene53). These constructs were transfected into HEK293T
cells using PEI (as described above) together with the lentiviral packaging vector
PsPax2 (Addgene) and the lentviral envelope vector VSV-G (Addgene). Sixteen
hours after transfection, medium was exchanged with macrophage medium and
incubated at 37 C for 2 days to produce lentiviral particles. The lentiviral particles
were used to transfect the immortalized macrophage cell lines (800,000 cells per
well in 6-well plates) using polybrene (Merck) to favour virus attachment.
Two days after viral transduction, the macrophages were expanded. Attached
macrophages were then treated with 10 mgml 1 puromycin (Gibco) for 6 days to
select for successful lentiviral transduction. After puromycin selection, the cells
were tested for successful knockout by western blotting.
Expression and puriﬁcation of ASCPYD. The ASCPYD (residues 1–91) was cloned
with a C-terminal His6 tag into the pET28a vector under the control of a T7
promoter. Protein expression was induced by isopropyl-b-D-thiogalactopyranosid
addition in BL21(DE3) Escherichia coli at an OD600 of 0.8 for 4 h at 37 C. Bacteria
were harvested by centrifugation and resuspended in 50mM phosphate buffer pH
7.5, 300mM NaCl, with Complete protease inhibitor (Roche).
Resuspended bacteria were incubated for 1 h at room temperature with DNase I,
sonicated on ice and centrifuged at 20,000 g at 4 C for 30min. The pellet, including
ASCPYD-containing inclusion bodies, was solubilized in 50mM phosphate buffer
pH 7.5, 300mM NaCl, 6M guanidinium hydrochloride and centrifuged at 20,000 g
at 4 C for 30min. The supernatant was incubated for 2 h at room temperature
with pre-equilibrated Ni-NTA afﬁnity resin (Thermo Scientiﬁc) and then passed
through a plastic body column for gravity ﬂow puriﬁcation. The column was
washed with 20 column volumes of solubilization buffer containing 20mM
imidazole and eluted with 3 column volumes of solubilization buffer with 500mM
imidazole. The pH of the elution fraction was decreased to 3.8 and dialysed against
50mM glycine buffer pH 3.8, 150mM NaCl. The protein was further puriﬁed
on a pre-equilibrated Superdex 75 gel ﬁltration column (GE Healthcare). This
gel-ﬁltration step removed traces of pre-existing aggregates and yielded highly
pure, monomeric soluble form of ASCPYD. Samples were either used immediately
or stored after ﬂash-freezing in small aliquots in liquid N2.
Measurements of ASCPYD ﬁlament formation kinetics in vitro. Immediately
before the experiments, samples of monomeric soluble ASCPYD were centrifuged at
20,000 g at 4 C for 30min and ﬁltered with 0.1 mM ﬁlter (Millipore). The protein
concentration was adjusted to 25 mM by dilution from a higher-concentrated stock
solution. Filament formation was triggered by rapid dilution to neutral pH.
Thereby, 70 ml of monomeric ASCPYD was mixed with 0.45 ml of 2.75M NaOH
solution to a reach the pH of 7.5. The solution was mixed at room temperature by
careful pipetting, to avoid introduction of air bubbles, and immediately transferred
to a quartz cuvette with 1 cm path length. Between runs, cuvettes were carefully
cleaned with 1M Hellmanex solution (Sigma-Aldrich) to avoid cross-seeding
effects between sequential measurements. Filament growth was monitored by
dynamic light scattering with a Malvern Zetasizer Nano ZS series instrument. The
laser focal spot was positioned in the middle of the cuvette and maintained ﬁxed
for all the measurements. To maximize the intensity of the scattered light, the
minimal attenuation level was used. Data were acquired in 60 s intervals by
averaging three runs of 20 s, until a total time of 350min. Afterwards, the protein
solution was blotted on EM grids, negatively stained and imaged with transmission
electron microscopy to visualize ﬁlament formation.
Data analysis. Filament growth was modelled assuming pseudo-ﬁrst-order
kinetics where the ﬁlament propagation step occurs by the addition of monomers
to the initial growth centre. The time-dependent growth signal I was ﬁtted
independently for each measurement by a single exponential function,
I tð Þ ¼ I1 1 e  kF tð Þ
 
where IN corresponds to the signal at time t and at inﬁnitive time, respectively, and
kF is the ﬁrst-order rate constant. Fits were done with nonlinear least-square
minimization.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author upon request.
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The gasdermin-D pore: Executor of pyroptotic cell death
Sebastian Rühl and Petr Broz
Pyroptosis is a lytic type of programmed cell death 
that is initiated in response to pathogen- or host-derived 
perturbations of the cytosol. It is characterized by cell 
swelling, lysis, and the release of cytoplasmic content; thus 
restricting the replication of intracellular pathogens and 
attracting effector cells of the immune system. The name 
??????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????
properties. Pyroptosis is induced by a dedicated set of 
??????????? ????????????????????????????????????????????
caspase-1, -4 and -5 in humans, and caspase-1 and -11 in 
??????????????????????????????????? ????????????????????
multi-protein complexes that are assembled by cytosolic 
pattern-recognition receptors upon recognition various 
cytosolic danger- or pathogen-associated molecular 
?????????????? ???????????????????????????????????????
and caspase activation has been well established, the 
exact mechanism of pyroptosis remained unclear for over 
a decade. 
This picture changed dramatically in 2015 when 
Shi et al. and Kayagaki et al. independently discovered 
????????????????????????????????????????????????????
central mediator of pyroptotic cell death downstream of 
both caspase-1 and caspase-11 [2, 3]. The two groups 
also found that GSDMD is cleaved by these caspases 
into a 31 kDa N-terminal fragment (GSDMDNterm????????
22 kDa C-terminal fragment (GSDMDCterm????????????????
N-terminus by itself had the ability to induce pyroptosis
when expressed ectopically. A series of papers by us
and other groups has now shown that the cytotoxicity
of this N-terminal fragment is due to its ability to target,
insert and permeabilize cellular membranes, therefore
representing a novel class of pore forming proteins (Figure
?????????????????
To understand how the GSDMDNterm induces 
pyroptosis, we started by investigating its subcellular 
localization using biochemical fractionation and 
membrane extraction methods. We found that that 
Editorial: Autophagy and Cell Death
Figure 1: Mechanism of GSDMD-induced pyroptosis. ???????????????????????????????????????????????????????????????????????
caspases, such as caspase-1 in humans and mice, caspase-4 and -5 in humans and caspase-11 in mice. These caspases cleave gasdermin 
?????????????????????????????????????????????????????????????????????????????Nterm, GSDMDCterm????????????Nterm assembles large 
permeability pores in the plasma membrane which in a lytic type of cell death, known as pyroptosis.
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after caspase cleavage the cytotoxic GSDMDN-term re-
localized to cellular membranes and inserted into these, 
while the GSDMDC-term remained soluble. Strikingly, the 
generation of the GSDMDNterm also correlated with the 
appearance of large plasma membrane pores and cell 
lysis, a characteristic feature of pyroptosis. These results 
indicated that GSDMDNterm either forms a pore in the host 
cell plasma membrane or interacts with additional proteins 
to promote assembly of such a pore. 
To demonstrate that the GSDMDNterm is the sole 
executor of pyroptosis and that it has intrinsic pore 
forming ability, we next established a liposome-based 
in vitro assay to measure membrane permeabilization. 
??????????? ??? ???????? ???????????? ?????? ?????
recombinant caspase-1 in the presence of dye-loaded 
liposomes of different lipid compositions showed that 
GSDMDNterm targets membranes, whereas GSDMDCterm 
and full-length GSDMD remained soluble. Furthermore, 
this interaction resulted in a rapid release of the dye from 
the liposomes, indicating that the GSDMDNterm can by 
itself permeabilize membranes. 
How does the GSDMDNterm permeabilize liposomes? 
To visualize the morphology of the permeabilized 
liposomes and possibly any pore-like structures formed by 
the GSDMDNterm, we used a combination of Cryo-electron 
???????????????????????????? ?????????????????????????
liposomes incubated with cleaved GSDMD were covered 
with multiple trans-membrane holes or pores, which were 
????????????????????????????????????????????????????????
that pyroptotic cell death is the result of the formation of a 
large permeability pore by GSDMD in plasma membrane 
of host cells. 
GSDMD is just one member of the ill-characterized 
?????????? ???????? ??????? ????? ????????? ?? ???????? ???
humans and nine in mice. Intriguingly, all gasdermin 
family members share similar N-terminal domains and 
these domains all exhibit comparable pore forming activity 
[2, 5]. While the exact stoichiometry and structure of the 
GSDMD pore has not yet been determined, Ding et al. 
were recently able to show that the pore formed by mouse 
??????????????????????????????????????????????????
inner diameter of 10-14 nm5. Moreover the high-resolution 
crystal structure of mouse gasdermin A3 revealed the 
structural basis for the auto-inhibitory mechanism by 
?????? ???? ??????? ?????????? ??????????? ????????? ????
activity of the N-terminus, an architecture that is most 
likely conserved in the gasdermin family. 
Gasdermins have emerged as a family of new 
class of cell death inducers, but many questions remain 
unanswered. For example, it is still unclear how other 
family members beside GSDMD are activated and how 
this is regulated on the post-translation level. Furthermore, 
if and how these proteins are implicated in physiological 
and pathological cell death pathways, will be an extremely 
interesting question to address. As caspase-11 and 
GSDMD were shown to be the central mediators in a 
murine model of sepsis, the GSDMD pore might also be 
a possible target for treating symptoms of septic shock. 
Beyond that, pyroptotic activity of all gasdermin family 
members could be a useful tool or target to modulate cell 
?????????????????????????????????????????????
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4.7 CRISPR-Cas9 screen for novel regulators of the non-canonical inflammasome 
pathway 
4.7.1 Intro 
In recent years the development of novel genome editing tools has facilitated the 
identification and study of unknown genes tremendously. The discovery of the CRISPR Cas9 
system represented probably the most important advancement in the field of gene editing. 
This system is found in several bacteria where it acts as a defence mechanism against 
bacteriophages through degradation of foreign DNA elements (Pourcel et al, 2005),(Mojica 
et al). The development of CRISPR as a genome editing tool was pioneered by several 
groups(Jinek et al, 2012),(Le Cong et al, 2013). The CRISPR Cas9 system relies on two 
major components for its function. The Cas9 nuclease, which is proficient in inducing breaks 
in double stranded DNA and the guideRNA (gRNA), which is capable of directing the Cas9 
protein to virtually any DNA sequence of interest by using a complementary 20bp DNA 
sequence. As these components can be functionally expressed independently from each other, 
this allows for design of any gRNA to direct the Cas9 nuclease to any (genomic) DNA 
sequence desired. Upon induction of the double strand break in the genomic DNA by Cas9, 
eukaryotic cells will repair the damage by 2 possible mechanisms 1) non-homologous end 
joining (NHEJ) or 2) homology directed repair. NHEJ is not always correct therefore leading 
to insertions or deletions (INDELs) at the cutting site, which can lead to frameshift mutations 
and can be employed to render a gene of interest non-functional. Homology directed repair 
instead by default uses the second allele of the gene as a correction template, however this 
mechanism can be exploited by providing a template of interest, allowing the generation of a 
knock-in around the Cas9 cutting site. Further applications of the CRISPR system are 
reviewed in(Sander & Joung, 2014), and include among other CRISPR silencing.  
As mentioned above, single gRNAs are sufficient to direct the Cas9 to a gene of interest, so 
this made it possible to design libraries containing several guide RNAs against all genes in 
the genome (Shalem et al, 2014). Generation of these libraries allowed forward genetic 
screens by means of negative selection, making studies of different cell death pathways 
particularly amenable to these negative selection screen (Sanjana et al, 2014). Shortly after 
the introduction of these CRISPR Cas9 libraries along with Cas9tg mice (Platt et al, 2014) it 
became apparent that these screens could also be used in primary cells and were not limited 
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to negative selection by cell death (Parnas et al, 2015).  Nevertheless, meaningful results, like 
the discovery of gasdermin-D describe above, could be obtained using cell death based 
CRISPR Cas9 screens(Shi et al, 2015a). However, the complete spectrum of genes involved 
in promoting survival during non-canonical inflammasome activation was not disclosed in 
the study by Shi et al. We therefore sought to investigate the non-canonical inflammasome 
pathway using a negative selection based CRISPR/Cas9 screen to find previously unknown 
regulators of this pathway. 
4.7.2 Experimental design 
Following established protocols(Sanjana et al, 2014),(Shi et al, 2015a) we obtained the 
murine GeCKO V2 library from addgene containing 130 000 gRNAs, amplified and purified 
the plasmids from E. Coli and produced lentiviral particles in HEK293T cells. The titer of the 
obtained viral supernatant was determined by transducing primary BMDMs and assessing 
puromycin resistance post transduction. Immortalized, Cas9tg BMDMs were transduced at a 
low MOI and transduced cells were selected using puromycin. A sample of cells was 
collected as a not stimulated reference to verify representation of the gRNAs present. To 
stimulate the non-canonical inflammasome pathway, cells were electroporated with LPS. 
Surviving cells were grown and genomic DNA was prepared for three independent 
experiments. The gRNA sequences were amplified using specific primers, purified and 
submitted for next-generation-sequencing (NGS). 
4.7.3 Results 
Analysis of the NGS results obtained revealed that representation of all gRNAs prior to 
stimulation was comparable across all biological repeats. Unfortunately, only replicate two 
showed and enrichment of a small number of gRNAs and a depletion of a majority of genes, 
which is the desired result for a cell death-based screen as the majority of cell should 
succumb to the cell death stimulus. The other two replicates showed incomplete selection of a 
subpool of gRNAS most likely due to high survival (i.e. too little cell death) of cells. 
However, replicate two revealed caspase-11 as a top hit, serving as a positive control. Why 
exactly gasdermin-D as another known essential component was not found enriched after 
LPS electroporation remains unclear. 
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To reduce the amount of hits we eliminated all genes, where only one gRNA was found and 
considered only genes with a p value higher than 0.01 for further analysis. 287 genes matched 
these criteria (Supplementary Table 1). Using KEGG pathway analysis, 11 pathways were 
detected, which contained more than 3 proteins present. These pathways with the proteins 
present are summarized in table 1. TLR2 and TLR4 were prominent hits, potentially 
indicating that our experimental setup used, induced TLR dependent cell death, which might 
be due to prolonged LPS exposure over 10 days. It has actually been shown that the non-
canonical inflammasome pathway is independent of TLR4 ((Kayagaki et al, 2013; Hagar et 
al, 2013). There were some histone proteins detected, which were previously implicated in 
the necroptotic pathway. Multiple gRNAs of all members were detected, potentially 
indicating that the whole histone cluster could be important for pyroptosis induction. Lama2 
is a member of the extracellular matrix proteins and implicated in the activation of the 
PI3K/AKT pathway, which is crucial for cell survival and proliferation. Another hit, Gngt2, 
potentially also acts in this pathway (Table 3). It might be conceivable that cells lacking 
these proteins had a significant growth advantage during the experiment, however it might be 
worth investigating the importance of the AKT pathway during caspase-11 mediated 
pyroptosis, especially as there are highly potent and specific pharmacological inhibitors for 
this pathway. 
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Pathway Number of 
proteins 
Gene_IDs; name 
Metabolism/ 
Biosynthetic  
pathway 
8 • Acly; ATP citrate lyase 
• Anpep; alanyl (membrane) aminopeptidase 
• Cbr3; carbonyl reductase 3 
• Ctps; cytidine 5'-triphosphate synthase 
• Fut1; fucosyltransferase 1 
• Mboat2; membrane bound O-acyltransferase domain 
containing 2 
• Piga; phosphatidylinositol glycan anchor biosynthesis, 
class A 
• pigyl; phosphatidylinositol glycan anchor biosynthesis, 
class Y-like 
 
Olfactory 
transduction 
7 • Cnga4; cyclic nucleotide gated channel alpha 4 
• Olfr1037; olfactory receptor 1037 
• Olfr1094; olfactory receptor 1094 
• Olfr1314; olfactory receptor 1314 
• Olfr1450; olfactory receptor 1450 
• Olfr389; olfactory receptor 389 
• Olfr799; olfactory receptor 799 
 
Necroptosis 4 • Hist1h2ad; histone cluster 1, H2ad 
• Hist1h2ai; histone cluster 1, H2ai 
• Hist1h2an; histone cluster 1, H2an 
• Tlr4; toll-like receptor 4 
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Pathway Number of 
proteins 
Gene_IDs; name 
PIK3/AKT  4 • Gngt2; guanine nucleotide binding protein (G protein), 
gamma transducing activity polypeptide 2 
• Lama2; laminin, alpha 2 
• Tlr2; toll-like receptor 2 
• Tlr4; toll-like receptor 4 
Alcohol abuse 4 • Gngt2; guanine nucleotide binding protein (G protein), 
gamma transducing activity polypeptide 2 
• Hist1h2ad; histone cluster 1, H2ad 
• Hist1h2ai; histone cluster 1, H2ai 
• Hist1h2an; histone cluster 1, H2an 
Tuberculosis 3 • Coro1a; coronin, actin binding protein 1A 
• Tlr2; toll-like receptor 2 
• Tlr4; toll-like receptor 4 
SLE 3 • Hist1h2ad; histone cluster 1, H2ad 
• Hist1h2ai; histone cluster 1, H2ai 
• Hist1h2an; histone cluster 1, H2an 
RNA transport 3 • Gm8994; predicted gene 8994 
• Nup50; nucleoporin 50 
• Prmt5; protein arginine N-methyltransferase 5 
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Pathway Number of 
proteins 
Gene_IDs; name 
Toxplasmosis 3 • Tlr2; toll-like receptor 2 
• Tlr4; toll-like receptor 4 
• Lama2; laminin, alpha 2 
Amoebiasis 3 • Tlr2; toll-like receptor 2 
• Tlr4; toll-like receptor 4 
• Lama2; laminin, alpha 2 
 
Phagosome 3 • Coro1a; coronin, actin binding protein 1A 
• Tlr2; toll-like receptor 2 
• Tlr4; toll-like receptor 4 
 
4.7.4 Discussion 
 
Although we tested repeatedly the efficiency of cell death upon LPS electroporation, the 
induction of cell death across all biological replicates using one round of LPS electroporation 
was not sufficient to obtain consistent enrichment of the genes known to be involved in the 
non-canonical inflammasome pathway. Further CRISPR-Cas9 screen need to be performed 
using a stimulus, which is applied for multiple rounds to ensure complete depletion of 
insignificant gRNAs from the pool. The procedure furthermore should be optimized using 
recently published protocols and guidelines for genetic forward CRISPR screens(Joung et al, 
2017). These guidelines include for example a more sophisticated and precise protocol for 
determination of viral titers as well as technical considerations for performance of 
CRISPR/Cas9 based screen.  
Potentially other interesting screens to be performed using the cell lines generated might 
include screening for essential genes involved in activation of the pyrin inflammasome, as 
this inflammasome is probably the least well understood. Delivery of bacterial effectors that 
modify RhoA using the anthrax lethal factor-protective antigen (LF-PA) could be evaluated 
as potential stimuli. 
  
Table 3 Enriched pathways after NGS sequencing of surviving cells upon LPS electroporation 
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 4.7.5 Material and Methods 
 
Preparation and amplification of library 
The GeCKOv2 library comes in two half libraries (A and B). They need to be amplified 
separately. The steps described below are representative for ONE half library. The library 
was diluted to 50 ng/ml and 2 µl of this solution was added to 25 µl of Lucigen Endura 
electrocompetent cells. Bacteria were electroporated and recovered in 2 ml of media. This 
was repeated for a total of 4 electroporations and the bacteria were put on a rotating wheel at 
37 °C for 1 hour. 8 ml of bacterial solution were plated on 20 pre-warmed 10 cm agar plates 
+ ampicillin. To estimate transformation efficiency the bacterial suspension was diluted 
1:100 in LB (10 µl in 1ml) and 20 µl of this dilution (40 000-fold final dilution) was plated as 
well. Plates were grown overnight at 32 °C. Bacteria were scraped off in LB and pelleted by 
centrifugation. 6 endotoxin free maxipreps (Qiagen) were performed per half library, dilution 
of DNA solution was adjusted to 1 µg/µl and 50 µl aliquots were frozen to -80 °C.  
 
Transduction of macrophages 
To prepare viral particles, HEK293T cells were seeded at a density of 5 million per 10 cm 
dish one day prior to transfection. Cells were transfected with GeCKO plasmids, PsPax2 and 
VSV-G at a ratio of 9:9:1 µg and 60 µl of linear PEI. Medium was exchanged 8 hours post 
transfection, viral particles were collected after 36 hours and aliquots were frozen to -80 °C. 
To estimate viral titers, primary wildtype BMDMs were differentiated for 6 days and 
transduced with different volumes of the viral supernatant by spin transduction (1900 xg 90 
min). After 2 days cells were treated with 5 µg/ml puromycin for 6 days and number of 
surviving cells was enumerated using flow cytometry. Immortalized Cas9tg BMDMs were 
seeded at a density of 400’000 cells per well of a 12 well plate (24 wells in total). Cells were 
transduced at a MOI of 0.3 by spin infection and transduced cells were selected after 48 hours 
with 10 µg/ml puromycin for 6 days. 
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Electroporation 
Prior to electroporation 4x107 cells were pelleted by centrifugation and frozen to -80 °C as a 
not stimulated reference. Before electroporation, cells were washed 3 times with PBS and 
counted whereafter they were electroporated with 1µg/106 cells LPS O111:B4 using the 
NEON electroporation system (settings: 1300 volts/20 ms width/2 pulses) and recovered in 
medium without antibiotics. After cells had grown to confluency (approximately 10 days), 4 
x 107 cells were pelleted by centrifugation and frozen to -80 °C. 
 
Genomic DNA prep and PCR amplification 
Genomic DNA was isolated using the Qiagen DNeasy Blood and Tissue kit according to the 
manufacturer’s instructions. Two elutions per column were performed in the end to enhance 
the amount of recovered DNA. DNA was precipitated using sodium acetate and isopropanol. 
1/5 5M sodium acetate of the volume of the DNA solution was added and the solution was 
vortexed well. An equal volume of isopropanol was added to precipitate the gDNA. Samples 
were centrifuged at 21 000 xg, 4 °C for 15 minutes, washed once with 70% Ethanol and 
centrifuged again as described above. Samples were resuspended to approximately 4-5 µg/µl. 
Next gRNAs were amplified by PCR. Per screen, at least 200 µg of DNA (approx. 30 Million 
cells), divided into 6x50 µl PCR reactions were used for amplification of gRNA sequences.  
Primers flanking the gRNA 
FW:  
TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGtcttgtggaaaggacgaaacaccg. 
REV: 
GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTCTACTATTCTTTCCCCTGCA
CTGT   
were used for PCR amplification. Reactions were prepared using the NEBNext Ultra Q5 2x 
Master Mix. The following protocol was used: 
95°C 60s, 40 cycles of [94°C for 30s,55°C for 10s and 72°C for 10s] and final 2-min 
extension at 72°C. PCR reactions were combined and loaded on a 1% agarose gel, separated 
by electrophoresis and purified using a commercial gel extraction kit. PCR products were 
stored at -20 °C and submitted for NGS. 
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4.7.6 Supplementary Table 1 
 
Gene_ID Number of 
gRNAs  
p value detected gRNAs 
Casp4 6 2.25E-05 5 
mmu-mir-1943 4 6.52E-05 2 
Ctps 6 6.84E-05 5 
Olfr1314 6 0.0001002 6 
Ceacam10 6 0.00011792 5 
Lama2 6 0.00013246 4 
Pnma3 6 0.00013564 3 
Vmn2r46 6 0.00021289 6 
D830030K20Rik 6 0.00022697 6 
Olfr1109 6 0.0002347 3 
Mup7 6 0.00029604 6 
LOC100048884 6 0.00029604 5 
Mup9 6 0.00029604 5 
Mup19 6 0.00029604 5 
Gm2083 6 0.00029604 5 
Mup10 6 0.00029604 5 
Mup16 6 0.00029604 5 
Gart 6 0.00033103 2 
Trp53rk 6 0.0003583 3 
Six4 6 0.00038783 3 
Vmn2r30 6 0.00039874 6 
Vmn2r37 6 0.00039874 6 
Vmn2r47 6 0.00039874 6 
Dzip1l 6 0.00039919 6 
Krtap31-2 6 0.00044009 4 
Cbr3 6 0.00046508 5 
4833423E24Rik 6 0.00047508 6 
Hs3st3b1 6 0.00052688 2 
Gm2863 6 0.00053461 5 
Zbtb45 6 0.00056369 6 
Rpa2 6 0.00057959 5 
Igf2r 6 0.00070728 4 
Piga 6 0.00071182 4 
4930447A16Rik 6 0.00077771 2 
Rhox3g 6 0.00086995 5 
Gm3763 6 0.00087132 4 
Amacr 6 0.00090994 3 
Zfp760 6 0.0010454 6 
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Gene_ID Number of 
gRNAs  
p value detected gRNAs 
Hist1h2an 6 0.0010894 5 
Zbtb7a 6 0.001173 2 
Emilin1 6 0.0011912 4 
Stab2 6 0.0012444 6 
Gm17019 6 0.0012848 6 
Chst2 6 0.0012907 4 
Cst11 6 0.0013148 3 
Gm2933 6 0.0013439 5 
Gm21951 6 0.0013439 5 
Styk1 6 0.0013603 4 
Rars 6 0.001388 3 
Fbxw7 6 0.0014434 2 
Scgb2b12 6 0.0015588 3 
Fermt3 6 0.0015752 3 
Zfp72 6 0.0016193 5 
Fam102a 6 0.0016274 5 
Olfr95 6 0.0017433 2 
Dnpep 6 0.001781 2 
Vmn2r42 6 0.0018601 6 
Cxx1a 6 0.001866 5 
Cxx1b 6 0.001866 5 
Tmem141 6 0.0018842 3 
Gm4305 6 0.0019164 5 
Gm4302 6 0.0019164 5 
Gm4303 6 0.0019164 5 
Gm4307 6 0.0019164 5 
Kif26b 6 0.0019305 5 
Klhl33 6 0.0019346 4 
Tlr4 6 0.0020041 4 
Ska3 6 0.002065 4 
Gm8994 6 0.0020928 5 
Ctr9 6 0.0021396 4 
Pcdhgb5 6 0.0022722 6 
Mup17 6 0.0023145 5 
Tor1a 6 0.0023145 4 
Aspdh 6 0.0023622 2 
Ildr2 6 0.0023763 3 
6030468B19Rik 6 0.002474 3 
Vmn1r142 6 0.002504 6 
Vmn1r127 6 0.002504 6 
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Gene_ID Number of 
gRNAs  
p value detected gRNAs 
Gm4216 6 0.002504 6 
Gm4177 6 0.002504 6 
Vmn1r94 6 0.002504 6 
Prmt5 6 0.0025415 4 
AU022751 6 0.0025567 2 
Cd300e 6 0.0026439 2 
Olfr1094 6 0.0026653 4 
1700008P02Rik 6 0.0026771 4 
Anpep 6 0.0027294 5 
Lce1a2 6 0.0027553 6 
Irgc1 6 0.0027621 3 
Dcun1d1 6 0.0027685 3 
Rtel1 6 0.0027685 5 
Olfr628 6 0.0027807 3 
Egr4 6 0.0027998 3 
Foxh1 6 0.0028957 2 
Ddx55 6 0.0029234 4 
Gtf3c1 6 0.0029275 3 
Sigirr 6 0.0029289 4 
Srgn 6 0.0029548 2 
Cntnap5a 6 0.0029616 6 
Rtbdn 6 0.002972 5 
Fam132a 6 0.0029793 4 
Grhl3 6 0.0029947 6 
Amph 6 0.0030234 3 
Fam83f 6 0.0030488 4 
Mrgpre 6 0.003112 4 
Gm17252 6 0.0031474 2 
Slc35f1 6 0.0031706 4 
mmu-mir-493 4 0.0031829 2 
Chml 6 0.0032574 5 
Gm14479 6 0.0032869 5 
Gm14484 6 0.0032869 5 
Gm14474 6 0.0032869 5 
Gm14475 6 0.0032869 5 
Gm14501 6 0.0032869 5 
Gm14478 6 0.0032869 5 
Gm14476 6 0.0032869 5 
Gm14477 6 0.0032869 5 
Gm14482 6 0.0032869 5 
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Gene_ID Number of 
gRNAs  
p value detected gRNAs 
Gm14483 6 0.0032869 5 
Apopt1 6 0.0033142 5 
Tlr2 6 0.0033546 4 
Fadd 6 0.0034746 2 
Coro1a 6 0.0034955 4 
Pou1f1 6 0.0035064 4 
Csrp3 6 0.0035114 5 
Defb25 6 0.0035169 3 
Bzw1 6 0.0035341 2 
Acly 6 0.0037288 4 
Vmn2r36 6 0.0037559 5 
Sypl 6 0.003819 5 
Esyt1 6 0.003859 3 
Glt25d1 6 0.0038613 2 
Ccdc41 6 0.0039317 2 
Ptpn20 6 0.0039494 3 
mmu-mir-7647 4 0.0039722 3 
Cltc 6 0.0040431 4 
Fjx1 6 0.0040612 4 
Synb 6 0.0041267 2 
Cnga4 6 0.0041385 5 
Slc25a29 6 0.0041457 4 
Zcchc8 6 0.0041798 3 
Pigyl 6 0.0042734 5 
Scgb2b20 6 0.004303 5 
Stard7 6 0.0043816 2 
Sipa1l1 6 0.0043911 5 
Kng1 6 0.0044075 4 
Prkacb 6 0.0044234 3 
Gm14436 6 0.0044288 4 
Gm14306 6 0.0044288 4 
Olfr1450 6 0.004542 5 
Proc 6 0.0045597 4 
Cyp2c54 6 0.0045806 3 
Gm10142 6 0.0046415 4 
Gm527 6 0.0046588 3 
Igf2bp1 6 0.0046933 5 
mmu-mir-6952 4 0.0047465 3 
Ripk2 6 0.004781 3 
Polg 6 0.004898 3 
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Gene_ID Number of 
gRNAs  
p value detected gRNAs 
Hist1h2ad 6 0.0049191 5 
Gria4 6 0.0049355 4 
Npl 6 0.0049419 5 
Lsp1 6 0.0050118 3 
Psmd9 6 0.005192 2 
Gm10408 6 0.0052818 5 
Gm5795 6 0.0052818 5 
Gm10413 6 0.0052818 5 
Spag1 6 0.0053054 3 
Cyp3a16 6 0.0053926 3 
Ovol1 6 0.0054108 2 
Tgfa 6 0.0054122 3 
Dgkh 6 0.0054326 2 
Tmem39b 6 0.0054617 3 
Zfp516 6 0.005503 5 
Fcrla 6 0.0055412 4 
Olfr799 6 0.0055671 4 
Kctd16 6 0.0056035 2 
Lingo4 6 0.0056053 5 
1700065D16Rik 6 0.0056235 2 
Tmco1 6 0.005648 2 
Pura 6 0.0056953 5 
Morc2b 6 0.0058107 3 
Tnfrsf14 6 0.0058852 3 
Cpeb2 6 0.0059206 4 
Nup50 6 0.0059261 4 
Gm2825 6 0.0060024 5 
Gm14346 6 0.0060024 5 
Gm14374 6 0.0060024 5 
Gm14345 6 0.0060024 5 
Gm14347 6 0.0060024 5 
Gm14351 6 0.0060024 5 
Gm10922 6 0.0060024 5 
Olfr389 6 0.0060497 5 
Tgif2 6 0.0061338 3 
Car4 6 0.0061715 4 
Dnaja3 6 0.0061824 3 
Tmem219 6 0.0062265 4 
Wdr77 6 0.0062674 3 
Vmn1r48 6 0.0062896 3 
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Gene_ID Number of 
gRNAs  
p value detected gRNAs 
Lrrc4c 6 0.0063264 4 
Pbld1 6 0.0063787 5 
Tmem167b 6 0.0064355 5 
A330070K13Rik 6 0.0064846 2 
Tekt5 6 0.0064986 3 
Krtap5-5 6 0.0065459 5 
Ogg1 6 0.0066168 2 
Gm5916 6 0.006635 2 
Rnf145 6 0.0066677 5 
Pcdha5 6 0.0066999 5 
Hist1h2ai 6 0.0067227 4 
Pum2 6 0.0067663 2 
Gtf2h3 6 0.0068172 2 
Rapgef6 6 0.0068958 4 
Casp12 6 0.0069894 3 
Repin1 6 0.0069989 2 
Olfr1037 6 0.0070576 4 
Gm6370 6 0.0070607 5 
Gm3415 6 0.0070607 5 
Gm3402 6 0.0070607 5 
4930449I24Rik 6 0.0070607 5 
mmu-mir-6336 4 0.0071344 3 
Enpp1 6 0.0071484 3 
Lamtor4 6 0.0071812 4 
Mboat2 6 0.0072461 4 
Rilpl1 6 0.0072461 3 
Pcdhgb6 6 0.007257 5 
Pcdhga9 6 0.007257 5 
Abcc3 6 0.0073347 4 
Mrpl20 6 0.0074565 3 
Oplah 6 0.0074702 3 
Krtap5-3 6 0.0074788 5 
Phc1 6 0.0074924 2 
Vmn2r39 6 0.0075515 5 
Aifm3 6 0.0075651 4 
Rnf2 6 0.0075951 2 
Laptm4a 6 0.0077074 2 
Rad54l2 6 0.0077573 5 
Tm9sf1 6 0.007801 4 
Trim61 6 0.0078396 5 
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Gene_ID Number of 
gRNAs  
p value detected gRNAs 
mmu-mir-3081 4 0.0079709 2 
Vmn1r103 6 0.0080323 4 
Vmn1r151 6 0.0080323 4 
Slc12a9 6 0.0080641 5 
Dnah9 6 0.0082604 4 
Vmn2r41 6 0.0082717 5 
Vmn2r48 6 0.0082717 5 
Vmn2r91 6 0.0082776 4 
mmu-mir-8120 4 0.0083149 3 
Kctd18 6 0.008354 4 
Slc35a1 6 0.0084299 3 
Ceacam9 6 0.0084303 4 
Acer1 6 0.0084426 3 
Brd1 6 0.0084967 2 
Gngt2 6 0.0086398 4 
Sval2 6 0.0086566 5 
Bri3 6 0.0086961 3 
Vmn2r87 6 0.008697 4 
Ncbp1 6 0.0087139 2 
9930111J21Rik1 6 0.0087311 3 
Ung 6 0.0088852 5 
Mkrn3 6 0.008897 4 
Trim43b 6 0.0089402 2 
Trim43c 6 0.0089402 2 
Wt1 6 0.0089538 4 
Nlgn1 6 0.0089742 5 
Fxn 6 0.0090528 3 
Slc6a14 6 0.0090797 5 
Cbll1 6 0.0091106 2 
Gm2799 6 0.0091355 4 
Gmcl1l 6 0.0091355 4 
Bcas3 6 0.0091555 3 
Ptprk 6 0.0092442 4 
Arsg 6 0.0093014 3 
Park7 6 0.0093278 3 
Aff4 6 0.0093382 4 
Gucy2c 6 0.0095086 4 
Micalcl 6 0.0095168 3 
Syp 6 0.0096222 4 
Reps1 6 0.0096886 4 
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gRNAs 
p value detected gRNAs 
Lyst 6 0.0097086 3 
Fut1 6 0.0097604 4 
Rxfp1 6 0.0097713 4 
5031410I06Rik 6 0.0097958 5 
37135 6 0.0098072 4 
Vmn2r44 6 0.0098376 4 
Vmn2r38 6 0.0098376 4 
Vmn2r33 6 0.0098376 4 
Chd5 6 0.0099912 5 
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5 Discussion 
5.1 Regulation of immunity by ectosomes 
A direct membrane contact is the easiest and most apparent way of two neighbouring cells to 
communicate. For longer distances in turn, soluble proteins like interleukins, chemokines, 
cytokines and bioactive mediators are needed for efficient transmission of information in the 
body. In recent years the shedding of extracellular microvesicles (EVs) from cells has been 
brought forward as an alternative for intermediate to long distance communications 
(Johnstone, 2006; Théry et al, 2009; Cocucci et al, 2009). EVs can be classified into 
exosomes, ectosomes or shedding microvesicles (SMVs) and apoptotic bodies(Kalra et al, 
2016). They share the common trait that they are vesicles, surrounded by a lipid bi-layer and 
encapsulating cellular content, whereas they are very heterogeneous in size, ranging from 1-
100 nm for exosomes, 50-1000 nm for ectosomes and up to 5 µm for apoptotic bodies. 
Exosomes are the best studied type of EVs(Mathivanan et al, 2010) and the term exosome 
refers actually to intraluminal vesicles (ILVs) of MVB that are released to the extracellular 
space when an MVB fuses with the PM. ILV require the ESCRT machinery for formation, by 
budding into the MVB luminal space(Colombo et al, 2013). MVB trafficking to the cell 
periphery and fusion with the PM requires multidimensional changes in the actin 
cytoskeleton, actin-PM interactions, local enzymatic degradation and activation of the 
membrane fusion machinery (Simons & Raposo, 2009). As mentioned above, ectosomes are 
more heterogeneous in terms of size distribution. Shedding of these microvesicles happens at 
sites of Ca2+ influx, which leads to rearrangement of the actin cytoskeleton and exposure of 
phosphatidylserine (PS) through the action of the calcium dependent scramblase TMEM16F 
(Suzuki et al, 2010). Generation of lipid asymmetry primes the PM for curvature to the 
outside, however the generation and pinching off of the ectosomes strictly requires the 
ESCRT-III machinery(Nabhan et al, 2012; Jimenez et al, 2014; Scheffer et al, 2014).  
Interestingly ectosomes shed by human polymorphonuclear neutrophils (hPMNs) upon 
stimulation with LPS or N-formyl-methionyl-leucyl-phenylalanine (fMLP) are PS positive 
(Zwaal & Schroit, 1997; Hess et al, 1999). To date, we know that human monocytes undergo 
inflammasome dependent IL-1β secretion without pyroptosis(Gaidt et al, 2016), which might 
be gasdermin-D dependent. It has been observed that Annexin-V staining on stimulated 
PMNs is patchy(Frasch et al, 2004) and although we lack thorough analysis about the 
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distribution of PS on the PM membrane during inflammasome stimulation in murine 
BMDMs or human monocytes one can easily imagine, that the patchy Annexin-V staining is 
the result of ESCRT-III mediated membrane shedding is response to gasdermin-D pore 
formation. More research will be required to determine the spatiotemporal assembly of 
ESCRT during inflammasome signalling and possibly visualize ectosome shedding. 
One of the main challenges in the future will be to develop reliable isolation methods for 
ectosomes. As ectosomes are, both in size and composition, a very heterogeneous population 
of EVs, it will be important to define transmembrane antigens, common to ectosomes, which 
will allow affinity based isolation of these vesicles(Kalra et al, 2016). 
Ectosomes from PMNs, probably due to their high concentration of PS (Refs), have been 
shown act in an anti-inflammatory manner (Gasser & Schifferli, 2004) by inhibiting cytokine 
secretion from activated macrophages .  
In case future research will be able to demonstrate, that cells which undergo inflammasome 
activation secrete ectosomes in a significant quantity, it will be of interest if (a) these 
ectosomes are comparable to the vesicles discovered in PMN in terms of composition and (b) 
what the effect of these vesicle on other immune and non-immune cells are. 
 
5.2 Gasdermin-D mediated pore formation as the mechanism of unconventional 
secretion 
 
Since its discovery by Dinarello et al in 1984, IL-1β has been of great interest for 
immunologists and cell biologists. Over time the IL-1 family grew and to date consists of 11 
members and most of them, although being released to the extracellular environment do not 
have a signal sequence, which directs them to the conventional ER-GOLGI mediated 
secretion. Therefore, multiple pathways of ‘unconventional secretion’ for mature IL-1β have 
been proposed(Monteleone et al, 2015). ‘Unconventional secretion’ is a catch-all term for 
different models ranging from secretion in secretory lysosomes, to autophagy mediated 
secretion, transport across a hyperpermeable membrane, release by PM pores and release by 
passive lysis. All models proposed suffer from incomplete data and most importantly genetics 
to prove one or the other mechanism as a valid pathway of IL-1β secretion (discussed in 
Monteleone et al., 2015). The discovery of gasdermin-D for the first time allowed researchers 
to uncouple cell death from IL-1β secretion(Shi et al, 2015a; Kayagaki et al, 2015; He et al, 
2015). Our results and studies from several other groups (Aglietti et al, 2016; Chen et al, 
2016b; Ding et al, 2016; Sborgi et al, 2016; Liu et al, 2016) for the first time defined a 
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possible mechanism for lysis independent release of IL-1β mechanism, by showing that the 
GSDMDNterm forms pore of a certain range of sizes in the PM prior to pyroptosis. Follow up 
studies from our lab(Heilig et al, 2017) proved this hypothesis by showing that blocking cell 
lysis, does not reduce gasdermin-D dependent IL-1β secretion and that gasdermin-D pores 
allow the passage of mature IL-1β in liposomes. Evavold et al. confirmed these findings 
further characterizing the role of gasdermin-D mediated pore formation during a process they 
call macrophage (or DC) ‘hyperactivation’(Evavold et al, 2017). Macrophage or DC 
hyperactivation is characterized by IL-1β secretion, stimulated by inflammasome activation, 
without detectable cell death and lysis. Several stimuli in different cell types have been 
proposed to lead to IL-1β secretion without detectable levels of cell lysis. These were for 
example the aforementioned stimulation of human monocytes with LPS, which mediates IL-
1β release through a TRIF/RIPK1/CASP8/Nlrp3 dependent signalling axis(Gaidt et al, 2016) 
or stimulation of murine cells with PGN(Wolf et al, 2016)or OxPAPC(Zanoni et al, 2016). 
Both studies show that IL-1β release during stimulation of DCs or macrophages with PGN 
and OxPAPC is gasdermin-D dependent. These studies therefore suggest convincingly for the 
first time by genetic means that release of IL-1β through gasdermin-D pores is one, if not the 
only mechanism of cytokine release in the absence of cell lysis. It should be noted that both, 
in vitro and in vivo, the contribution of pyroptosis to IL-1β release is much higher than the 
release through gasdermin-D pores without pyroptosis. This means that the relative cytokine 
levels measured in the absence of pyroptosis are much lower than the levels of IL-1b elicited 
by stimuli, which induce pyroptosis (Zanoni et al, 2017). It remains to be investigated if the 
alternative inflammasome pathway in human monocytes also relies on gasdermin-D mediated 
pore formation for IL-1β secretion. 
These results lead to several questions, one of them being: How do cells manage to survive in 
the face of gasdermin-D pore formation? Our results provide an answer to this question, 
suggesting that membrane repair mechanisms allow cells to survive during hyperactivation 
without succumbing to gasdermin-D pore formation but mediating IL-1β release at the same 
time via GSDMD pores. Furthermore, as the ESCRT-III machinery leads to budding of 
ectosomes at the site of PM injury(Jimenez et al, 2014; Scheffer et al, 2014) one could 
hypothesize that these ectosomes might contain IL-1β and that ectosome release also 
contributes to unconventional IL-1β secretion, in line with previous reports that suggested 
that IL-1b is released within vesicles. I think this rather unlikely because our data suggest that 
upon inactivation of the ESCRT machinery, IL-1β secretion is enhanced during canonical and 
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non-canonical inflammasome stimulation. However, since ESCRT inactivation enhances the 
levels of GSDMD pores formed in the PM and cell lysis, most IL-1 is then released in a 
manner dependent on lysis. Thus, by only inhibiting ESCRT it is difficult to unravel the 
contribution of each possible pathway to the overall level of IL-1 release.  One goal for future 
research will be to develop more sophisticated methods of ectosome isolation to clarify the 
question if mature IL-1β is contained within these or other extracellular vesicles. 
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